#  @GravAnalytica Gravity Analytica News Gravity Analytica News posts on X about nasdaq, business, investment, $bntc the most. They currently have [--] followers and [----] posts still getting attention that total [---] engagements in the last [--] hours. ### Engagements: [---] [#](/creator/twitter::1874146095762153473/interactions)  - [--] Week [-----] +55% - [--] Month [-----] +13% - [--] Months [------] +75% - [--] Year [------] +4,655% ### Mentions: [--] [#](/creator/twitter::1874146095762153473/posts_active)  - [--] Month [--] -56% - [--] Months [---] +33% - [--] Year [-----] +2,622% ### Followers: [--] [#](/creator/twitter::1874146095762153473/followers)  - [--] Week [--] no change - [--] Month [--] +3.70% - [--] Months [--] +93% - [--] Year [--] +460% ### CreatorRank: [---------] [#](/creator/twitter::1874146095762153473/influencer_rank)  ### Social Influence **Social category influence** [stocks](/list/stocks) [finance](/list/finance) [exchanges](/list/exchanges) [cryptocurrencies](/list/cryptocurrencies) [countries](/list/countries) [technology brands](/list/technology-brands) [financial services](/list/financial-services) [travel destinations](/list/travel-destinations) [currencies](/list/currencies) **Social topic influence** [nasdaq](/topic/nasdaq) #1413, [business](/topic/business), [investment](/topic/investment), [$bntc](/topic/$bntc) #6, [$arvn](/topic/$arvn), [$kura](/topic/$kura), [announces](/topic/announces), [gravity](/topic/gravity), [$naut](/topic/$naut), [$algs](/topic/$algs) **Top accounts mentioned or mentioned by** [@home](/creator/undefined) **Top assets mentioned** [Arvinas, Inc (ARVN)](/topic/$arvn) [Gravity (G)](/topic/gravity) [Aligos Therapeutics, Inc. (ALGS)](/topic/$algs) [Evaxion Biotech A/S (EVAX)](/topic/$evax) [Taraxa (TARA)](/topic/$tara) [Werewolf Therapeutics, Inc. (HOWL)](/topic/$howl) [Xilio Therapeutics, Inc. (XLO)](/topic/$xlo) [Nyxoah SA (NYXH)](/topic/$nyxh) [Context Therapeutics Inc. (CNTX)](/topic/$cntx) [Molecular Partners AG (MOLN)](/topic/$moln) [Morgan Stanley (MS)](/topic/morgan-stanley) [ALX Oncology Holdings Inc (ALXO)](/topic/$alxo) [Bicara Therapeutics Inc. (BCAX)](/topic/$bcax) [Virax Biolabs Group Limited (VRAX)](/topic/$vrax) [Entrada Therapeutics, Inc. (TRDA)](/topic/$trda) [Foghorn Therapeutics Inc. (FHTX)](/topic/$fhtx) [4D Molecular Therapeutics Inc. (FDMT)](/topic/$fdmt) [Kyverna Therapeutics, Inc. (KYTX)](/topic/$kytx) [BioAge Labs, Inc. (BIOA)](/topic/$bioa) [RenovoRx, Inc. (RNXT)](/topic/$rnxt) [Sage Therapeutics, Inc (SAGE)](/topic/$sage) [Marblex (MBX)](/topic/$mbx) [Liquity BOLD (BOLD)](/topic/$bold) [Connect Biopharma Holdings Limited (CNTB)](/topic/$cntb) [Keros Therapeutics, Inc. (KROS)](/topic/$kros) [Sensei Biotherapeutics, Inc. (SNSE)](/topic/$snse) [Maravai LifeSciences Holdings, Inc. (MRVI)](/topic/$mrvi) [Pyxis Oncology, Inc. (PYXS)](/topic/$pyxs) [Goldman Sachs (GS)](/topic/goldman-sachs) [Nurix Therapeutics, Inc. (NRIX)](/topic/$nrix) [Contineum Therapeutics, Inc (CTNM)](/topic/$ctnm) [UBIX Network (UBX)](/topic/$ubx) [NEO (NEO)](/topic/$neo) [Zenas BioPharma, Inc. (ZBIO)](/topic/$zbio) [Treace Medical Concepts, Inc. (TMCI)](/topic/$tmci) [TScan Therapeutics, Inc. (TCRX)](/topic/$tcrx) [Vigil Neuroscience, Inc. (VIGL)](/topic/$vigl) [Zentalis Pharmaceuticals, LLC (ZNTL)](/topic/$zntl) [Inhibikase Therapeutics, Inc. (IKT)](/topic/$ikt) [IO Biotech, Inc. (IOBT)](/topic/$iobt) ### Top Social Posts Top posts by engagements in the last [--] hours "$CRIS Grzegorz Nowakowski MD #biotechs https://www.curis.com/grzegorz-nowakowski-md/ https://gravityanalytica.com/analyzer/CRIS https://www.curis.com/grzegorz-nowakowski-md/ https://gravityanalytica.com/analyzer/CRIS" [X Link](https://x.com/GravAnalytica/status/1878215883455189047) 2025-01-11T23:02Z [--] followers, [--] engagements "$CRIS Christian Grommes MD #biotechs https://www.curis.com/christian-grommes-md/ https://gravityanalytica.com/analyzer/CRIS https://www.curis.com/christian-grommes-md/ https://gravityanalytica.com/analyzer/CRIS" [X Link](https://x.com/GravAnalytica/status/1878215884386234420) 2025-01-11T23:02Z [--] followers, [--] engagements "$CRIS Lakshmi Nayak MD #biotechs https://www.curis.com/lakshmi-nayak-md/ https://gravityanalytica.com/analyzer/CRIS https://www.curis.com/lakshmi-nayak-md/ https://gravityanalytica.com/analyzer/CRIS" [X Link](https://x.com/GravAnalytica/status/1878215885313245278) 2025-01-11T23:02Z [--] followers, [--] engagements "$CRIS Andrs Jos Mara Ferreri MD #biotechs https://www.curis.com/andres-jose-maria-ferreri-md/ https://gravityanalytica.com/analyzer/CRIS https://www.curis.com/andres-jose-maria-ferreri-md/ https://gravityanalytica.com/analyzer/CRIS" [X Link](https://x.com/GravAnalytica/status/1878215886223339890) 2025-01-11T23:02Z [--] followers, [--] engagements "$ALVR Report of proposed sale of securities #biotechs https://www.sec.gov/Archives/edgar/data/1754068/000095017025004443/0000950170-25-004443-index.htm https://gravityanalytica.com/analyzer/ALVR https://www.sec.gov/Archives/edgar/data/1754068/000095017025004443/0000950170-25-004443-index.htm https://gravityanalytica.com/analyzer/ALVR" [X Link](https://x.com/GravAnalytica/status/1878215893861249472) 2025-01-11T23:02Z [--] followers, [--] engagements "$ALVR Prospectuses and communications business combinations #biotechs https://www.sec.gov/Archives/edgar/data/1754068/000119312525004529/0001193125-25-004529-index.htm https://gravityanalytica.com/analyzer/ALVR https://www.sec.gov/Archives/edgar/data/1754068/000119312525004529/0001193125-25-004529-index.htm https://gravityanalytica.com/analyzer/ALVR" [X Link](https://x.com/GravAnalytica/status/1878215894821744983) 2025-01-11T23:02Z [--] followers, [--] engagements "$FULC Sickle Cell Disease (HbF Induction) P1 START #biotechs https://www.sec.gov/Archives/edgar/data/1680581/000119312525004942/d714885dex991.htm https://gravityanalytica.com/analyzer/FULC https://www.sec.gov/Archives/edgar/data/1680581/000119312525004942/d714885dex991.htm https://gravityanalytica.com/analyzer/FULC" [X Link](https://x.com/GravAnalytica/status/1879303027405779285) 2025-01-14T23:02Z [--] followers, [--] engagements "$ALVR Prospectuses and communications business combinations #biotechs https://www.sec.gov/Archives/edgar/data/1754068/000119312525007084/0001193125-25-007084-index.htm https://gravityanalytica.com/analyzer/ALVR https://www.sec.gov/Archives/edgar/data/1754068/000119312525007084/0001193125-25-007084-index.htm https://gravityanalytica.com/analyzer/ALVR" [X Link](https://x.com/GravAnalytica/status/1880027829695385795) 2025-01-16T23:02Z [--] followers, [--] engagements "$SEER Sintilimab in Combination with Cetuximab and Chemotherapy As First-line Treatment for RAS/BRAF Wild-type Advanced Colorectal Cancer #biotechs https://ClinicalTrials.gov/show/NCT06776757 https://gravityanalytica.com/analyzer/SEER https://ClinicalTrials.gov/show/NCT06776757 https://gravityanalytica.com/analyzer/SEER" [X Link](https://x.com/GravAnalytica/status/1880027834783064499) 2025-01-16T23:02Z [--] followers, [--] engagements "$SAGE Statement of Beneficial Ownership by Certain Investors #biotechs https://www.sec.gov/Archives/edgar/data/1597553/000095017025006473/0000950170-25-006473-index.htm https://gravityanalytica.com/analyzer/SAGE https://www.sec.gov/Archives/edgar/data/1597553/000095017025006473/0000950170-25-006473-index.htm https://gravityanalytica.com/analyzer/SAGE" [X Link](https://x.com/GravAnalytica/status/1880752602012430653) 2025-01-18T23:02Z [--] followers, [--] engagements "$ALVR Registration of securities business combinations #biotechs https://www.sec.gov/Archives/edgar/data/1754068/000119312525008421/0001193125-25-008421-index.htm https://gravityanalytica.com/analyzer/ALVR https://www.sec.gov/Archives/edgar/data/1754068/000119312525008421/0001193125-25-008421-index.htm https://gravityanalytica.com/analyzer/ALVR" [X Link](https://x.com/GravAnalytica/status/1880752615291490643) 2025-01-18T23:02Z [--] followers, [--] engagements "$ZVSA Special Meeting of Stockholders (Virtual) #biotechs https://zyversa.gcs-web.com/events/event-details/special-meeting-stockholders-virtual-0 https://gravityanalytica.com/analyzer/ZVSA https://zyversa.gcs-web.com/events/event-details/special-meeting-stockholders-virtual-0 https://gravityanalytica.com/analyzer/ZVSA" [X Link](https://x.com/GravAnalytica/status/1881477408278081607) 2025-01-20T23:02Z [--] followers, [--] engagements "$SAGE Sage and Tractics Announce Partnership to Deliver a Powerhouse Cloud Solution for Heavy Civil Contractors #biotechs https://www.globenewswire.com/news-release/2025/01/21/3012885/0/en/Sage-and-Tractics-Announce-Partnership-to-Deliver-a-Powerhouse-Cloud-Solution-for-Heavy-Civil-Contractors.html https://gravityanalytica.com/analyzer/SAGE https://www.globenewswire.com/news-release/2025/01/21/3012885/0/en/Sage-and-Tractics-Announce-Partnership-to-Deliver-a-Powerhouse-Cloud-Solution-for-Heavy-Civil-Contractors.html https://gravityanalytica.com/analyzer/SAGE" [X Link](https://x.com/GravAnalytica/status/1881839795233603799) 2025-01-21T23:02Z [--] followers, [--] engagements "$RLYB Safety Tolerability Pharmacokinetics and Pharmacodynamics Study of RLYB116 in Healthy Participants #biotechs https://ClinicalTrials.gov/show/NCT06797375 https://gravityanalytica.com/analyzer/RLYB https://ClinicalTrials.gov/show/NCT06797375 https://gravityanalytica.com/analyzer/RLYB" [X Link](https://x.com/GravAnalytica/status/1884738869301555238) 2025-01-29T23:02Z [--] followers, [--] engagements "$STSS Sharps Technology Inc. Announces Pricing of Upsized $20.0 Million Underwritten Public Offering #biotechs https://ir.sharpstechnology.com/sharps-technology-inc-announces-pricing-of-upsized-20-0-million-underwritten-public-offering/ https://gravityanalytica.com/analyzer/STSS https://ir.sharpstechnology.com/sharps-technology-inc-announces-pricing-of-upsized-20-0-million-underwritten-public-offering/ https://gravityanalytica.com/analyzer/STSS" [X Link](https://x.com/GravAnalytica/status/1884738871327391942) 2025-01-29T23:02Z [--] followers, [---] engagements "$STSS Sharps Technology Inc. Announces Closing of Upsized $20.0 Million Underwritten Public Offering #biotechs https://ir.sharpstechnology.com/sharps-technology-inc-announces-closing-of-upsized-20-0-million-underwritten-public-offering/ https://gravityanalytica.com/analyzer/STSS https://ir.sharpstechnology.com/sharps-technology-inc-announces-closing-of-upsized-20-0-million-underwritten-public-offering/ https://gravityanalytica.com/analyzer/STSS" [X Link](https://x.com/GravAnalytica/status/1884738873558716859) 2025-01-29T23:02Z [--] followers, [---] engagements "$MIST Statement of changes in beneficial ownership of securities #biotechs https://www.sec.gov/Archives/edgar/data/1408443/000141588925002269/0001415889-25-002269-index.htm https://gravityanalytica.com/analyzer/MIST https://www.sec.gov/Archives/edgar/data/1408443/000141588925002269/0001415889-25-002269-index.htm https://gravityanalytica.com/analyzer/MIST" [X Link](https://x.com/GravAnalytica/status/1885101306001371276) 2025-01-30T23:02Z [--] followers, [--] engagements "$EVAX Evaxion announces closing of $10.8 million public offering #biotechs https://investors.evaxion.ai/news-releases/news-release-details/evaxion-announces-closing-108-million-public-offering https://gravityanalytica.com/analyzer/EVAX https://investors.evaxion.ai/news-releases/news-release-details/evaxion-announces-closing-108-million-public-offering https://gravityanalytica.com/analyzer/EVAX" [X Link](https://x.com/GravAnalytica/status/1885463695083376759) 2025-01-31T23:02Z [--] followers, [--] engagements "$EVAX Evaxion announces pricing of $10.8 million public offering #biotechs https://investors.evaxion.ai/news-releases/news-release-details/evaxion-announces-pricing-108-million-public-offering https://gravityanalytica.com/analyzer/EVAX https://investors.evaxion.ai/news-releases/news-release-details/evaxion-announces-pricing-108-million-public-offering https://gravityanalytica.com/analyzer/EVAX" [X Link](https://x.com/GravAnalytica/status/1885463696115134705) 2025-01-31T23:02Z [--] followers, [--] engagements "$SRZN Matthew Caufield #biotechs https://surrozen.gcs-web.com/analyst/matthew-caufield https://gravityanalytica.com/analyzer/SRZN https://surrozen.gcs-web.com/analyst/matthew-caufield https://gravityanalytica.com/analyzer/SRZN" [X Link](https://x.com/GravAnalytica/status/1885826091106910677) 2025-02-01T23:02Z [--] followers, [--] engagements "$DNA Report of proposed sale of securities #biotechs https://www.sec.gov/Archives/edgar/data/1830214/000195917325000560/0001959173-25-000560-index.htm https://gravityanalytica.com/analyzer/DNA https://www.sec.gov/Archives/edgar/data/1830214/000195917325000560/0001959173-25-000560-index.htm https://gravityanalytica.com/analyzer/DNA" [X Link](https://x.com/GravAnalytica/status/1885826098224628171) 2025-02-01T23:02Z [--] followers, [--] engagements "$NURO Preliminary proxy statements relating to merger or acquisition #biotechs https://www.sec.gov/Archives/edgar/data/1289850/000149315225004287/0001493152-25-004287-index.htm https://gravityanalytica.com/analyzer/NURO https://www.sec.gov/Archives/edgar/data/1289850/000149315225004287/0001493152-25-004287-index.htm https://gravityanalytica.com/analyzer/NURO" [X Link](https://x.com/GravAnalytica/status/1885826099273167298) 2025-02-01T23:02Z [--] followers, [--] engagements "$AADI Definitive proxy statement relating to merger or acquisition #biotechs https://www.sec.gov/Archives/edgar/data/1422142/000119312525018470/0001193125-25-018470-index.htm https://gravityanalytica.com/analyzer/AADI https://www.sec.gov/Archives/edgar/data/1422142/000119312525018470/0001193125-25-018470-index.htm https://gravityanalytica.com/analyzer/AADI" [X Link](https://x.com/GravAnalytica/status/1885826100346982791) 2025-02-01T23:02Z [--] followers, [--] engagements "$ARVN Arvinas 4Q24 Earnings Call #biotechs https://ir.arvinas.com/events/event-details/arvinas-4q24-earnings-call https://gravityanalytica.com/analyzer/ARVN https://ir.arvinas.com/events/event-details/arvinas-4q24-earnings-call https://gravityanalytica.com/analyzer/ARVN" [X Link](https://x.com/GravAnalytica/status/1886550860836020647) 2025-02-03T23:02Z [--] followers, [---] engagements "$ARVN Arvinas to Report Fourth Quarter and Full Year [----] Financial Results on Tuesday February [--] [----] #biotechs https://ir.arvinas.com/news-releases/news-release-details/arvinas-report-fourth-quarter-and-full-year-2024-financial https://gravityanalytica.com/analyzer/ARVN https://ir.arvinas.com/news-releases/news-release-details/arvinas-report-fourth-quarter-and-full-year-2024-financial https://gravityanalytica.com/analyzer/ARVN" [X Link](https://x.com/GravAnalytica/status/1886550861871996948) 2025-02-03T23:02Z [--] followers, [---] engagements "$ARVN Events and Presentations #biotechs https://arvinas.gcs-web.com/news-releases/news-release-details/arvinas-report-fourth-quarter-and-full-year-2024-financial https://gravityanalytica.com/analyzer/ARVN https://arvinas.gcs-web.com/news-releases/news-release-details/arvinas-report-fourth-quarter-and-full-year-2024-financial https://gravityanalytica.com/analyzer/ARVN" [X Link](https://x.com/GravAnalytica/status/1886550863017066808) 2025-02-03T23:02Z [--] followers, [---] engagements "$IVVD Invivyd Announces Preliminary Fourth Quarter [----] Financial Results Strong Revenue Growth and Reiterates Goal of Near-Term Profitability #biotechs https://adagiotx.gcs-web.com/news-releases/news-release-details/invivyd-announces-preliminary-fourth-quarter-2024-financial https://gravityanalytica.com/analyzer/IVVD https://adagiotx.gcs-web.com/news-releases/news-release-details/invivyd-announces-preliminary-fourth-quarter-2024-financial https://gravityanalytica.com/analyzer/IVVD" [X Link](https://x.com/GravAnalytica/status/1886550867622465554) 2025-02-03T23:02Z [--] followers, [--] engagements "$PMVP TD Cowen 45th Annual Health Care Conference #biotechs https://ir.pmvpharma.com/events/event-details/td-cowen-45th-annual-health-care-conference https://gravityanalytica.com/analyzer/PMVP https://ir.pmvpharma.com/events/event-details/td-cowen-45th-annual-health-care-conference https://gravityanalytica.com/analyzer/PMVP" [X Link](https://x.com/GravAnalytica/status/1886913265554399496) 2025-02-04T23:02Z [--] followers, [--] engagements "$ALVR Registration of securities business combinations #biotechs https://www.sec.gov/Archives/edgar/data/1754068/000119312525019332/0001193125-25-019332-index.htm https://gravityanalytica.com/analyzer/ALVR https://www.sec.gov/Archives/edgar/data/1754068/000119312525019332/0001193125-25-019332-index.htm https://gravityanalytica.com/analyzer/ALVR" [X Link](https://x.com/GravAnalytica/status/1886913266569429338) 2025-02-04T23:02Z [--] followers, [--] engagements "$NXTC Statement of changes in beneficial ownership of securities #biotechs https://www.sec.gov/Archives/edgar/data/1661059/000090514825000337/0000905148-25-000337-index.htm https://gravityanalytica.com/analyzer/NXTC https://www.sec.gov/Archives/edgar/data/1661059/000090514825000337/0000905148-25-000337-index.htm https://gravityanalytica.com/analyzer/NXTC" [X Link](https://x.com/GravAnalytica/status/1886913268674924798) 2025-02-04T23:02Z [--] followers, [--] engagements "$RNAZ TransCode Therapeutics Announces Completion of Cohort [--] Initial Dosing with Lead Candidate in Phase [--] Clinical Trial #biotechs https://ir.transcodetherapeutics.com/news-releases/news-release-details/transcode-therapeutics-announces-completion-cohort-3-initial https://gravityanalytica.com/analyzer/RNAZ https://ir.transcodetherapeutics.com/news-releases/news-release-details/transcode-therapeutics-announces-completion-cohort-3-initial https://gravityanalytica.com/analyzer/RNAZ" [X Link](https://x.com/GravAnalytica/status/1887638041218417115) 2025-02-06T23:02Z [--] followers, [--] engagements "$RNAZ TransCode Therapeutics Inc. Announces Adjournment of Special Meeting and Information for Adjourned Special Meeting #biotechs https://ir.transcodetherapeutics.com/news-releases/news-release-details/transcode-therapeutics-inc-announces-adjournment-special-meeting https://gravityanalytica.com/analyzer/RNAZ https://ir.transcodetherapeutics.com/news-releases/news-release-details/transcode-therapeutics-inc-announces-adjournment-special-meeting https://gravityanalytica.com/analyzer/RNAZ" [X Link](https://x.com/GravAnalytica/status/1887638042304790610) 2025-02-06T23:02Z [--] followers, [--] engagements "$FDMT 4DMT Presents Positive 52-Week Results from Phase 2b Cohort of PRISM Wet AMD Study and Long-term Durability Data Supporting 4D-150 4FRONT Global Registration Program #biotechs https://ir.4dmoleculartherapeutics.com/news-releases/news-release-details/4dmt-presents-positive-52-week-results-phase-2b-cohort-prism-wet https://gravityanalytica.com/analyzer/FDMT https://ir.4dmoleculartherapeutics.com/news-releases/news-release-details/4dmt-presents-positive-52-week-results-phase-2b-cohort-prism-wet https://gravityanalytica.com/analyzer/FDMT" [X Link](https://x.com/GravAnalytica/status/1888362797144125882) 2025-02-08T23:02Z [--] followers, [---] engagements "$PLUR Investor Presentation Q1 [----] #biotechs https://pluri-biotech.com/wp-content/uploads/2025/02/Pluri-Investor-Deck-Q1-2025.pdf https://gravityanalytica.com/analyzer/PLUR https://pluri-biotech.com/wp-content/uploads/2025/02/Pluri-Investor-Deck-Q1-2025.pdf https://gravityanalytica.com/analyzer/PLUR" [X Link](https://x.com/GravAnalytica/status/1888725181650108798) 2025-02-09T23:02Z [--] followers, [--] engagements "$PLUR Pluri secures additional $3.5 million investment #biotechs https://pluri-biotech.com/news/pluri-secures-additional-3-5-million-investment/ https://gravityanalytica.com/analyzer/PLUR https://pluri-biotech.com/news/pluri-secures-additional-3-5-million-investment/ https://gravityanalytica.com/analyzer/PLUR" [X Link](https://x.com/GravAnalytica/status/1888725182610579788) 2025-02-09T23:02Z [--] followers, [--] engagements "$PLUR Yaky Yanay on the Big Biz Show #biotechs https://pluri-biotech.com/news/23253/ https://gravityanalytica.com/analyzer/PLUR https://pluri-biotech.com/news/23253/ https://gravityanalytica.com/analyzer/PLUR" [X Link](https://x.com/GravAnalytica/status/1888725183608807825) 2025-02-09T23:02Z [--] followers, [--] engagements "$PMCB 10-Q - Quarterly report Sections [--] or 15(d) #biotechs https://ir.pharmacyte.com/annual-reportspage=1#document-2771-0001683168-25-001669 https://gravityanalytica.com/analyzer/PMCB https://ir.pharmacyte.com/annual-reportspage=1#document-2771-0001683168-25-001669 https://gravityanalytica.com/analyzer/PMCB" [X Link](https://x.com/GravAnalytica/status/1901967145707450636) 2025-03-18T12:01Z [--] followers, [--] engagements "$NAUT Tau proteoforms as potential drivers of cognitive decline #biotechs https://www.nautilus.bio/blog/tau-proteoforms-as-potential-drivers-of-cognitive-decline/ https://gravityanalytica.com/analyzer/NAUT https://www.nautilus.bio/blog/tau-proteoforms-as-potential-drivers-of-cognitive-decline/ https://gravityanalytica.com/analyzer/NAUT" [X Link](https://x.com/GravAnalytica/status/1902755940895781152) 2025-03-20T16:15Z [--] followers, [--] engagements "$DTIL Precision BioSciences to Report Fourth Quarter and Fiscal Year [----] Results on March [--] [----] #biotechs https://investor.precisionbiosciences.com/news-releases/news-release-details/precision-biosciences-report-fourth-quarter-and-fiscal-year-2024 https://gravityanalytica.com/analyzer/DTIL https://investor.precisionbiosciences.com/news-releases/news-release-details/precision-biosciences-report-fourth-quarter-and-fiscal-year-2024 https://gravityanalytica.com/analyzer/DTIL" [X Link](https://x.com/GravAnalytica/status/1903042120669417947) 2025-03-21T11:12Z [--] followers, [---] engagements "$UBX UNITY Biotechnology to Host Virtual Investor Event to Discuss 24- and 36-Week Data from the Phase 2b ASPIRE Study of UBX1325 in Patients with Diabetic Macular Edema (DME) on March [--] [----] #biotechs https://www.globenewswire.com/news-release/2025/03/23/3047498/0/en/UNITY-Biotechnology-to-Host-Virtual-Investor-Event-to-Discuss-24-and-36-Week-Data-from-the-Phase-2b-ASPIRE-Study-of-UBX1325-in-Patients-with-Diabetic-Macular-Edema-DME-on-March-24-.html https://gravityanalytica.com/analyzer/UBX" [X Link](https://x.com/GravAnalytica/status/1903961444418195887) 2025-03-24T00:05Z [--] followers, [--] engagements "$UBX Virtual Investor Event to Discuss 24- and 36-Week Data from the Phase 2b ASPIRE Study of UBX1325 in Patients with Diabetic Macular Edema (DME) #biotechs https://ir.unitybiotechnology.com/events/event-details/virtual-investor-event-discuss-24-and-36-week-data-phase-2b-aspire-study https://gravityanalytica.com/analyzer/UBX https://ir.unitybiotechnology.com/events/event-details/virtual-investor-event-discuss-24-and-36-week-data-phase-2b-aspire-study https://gravityanalytica.com/analyzer/UBX" [X Link](https://x.com/GravAnalytica/status/1903961444682551354) 2025-03-24T00:05Z [--] followers, [--] engagements "$UBX UNITY Biotechnology to Host Virtual Investor Event to Discuss 24- and 36-Week Data from the Phase 2b ASPIRE Study of UBX1325 in Patients with Diabetic Macular Edema (DME) on March [--] [----] #biotechs https://unitybiotechnology.gcs-web.com/news-releases/news-release-details/unity-biotechnology-host-virtual-investor-event-discuss-24-and https://gravityanalytica.com/analyzer/UBX https://unitybiotechnology.gcs-web.com/news-releases/news-release-details/unity-biotechnology-host-virtual-investor-event-discuss-24-and https://gravityanalytica.com/analyzer/UBX" [X Link](https://x.com/GravAnalytica/status/1903961453037596715) 2025-03-24T00:05Z [--] followers, [--] engagements "$UBX UNITY Biotechnology Announces Topline Results from the ASPIRE Phase 2b Study in Diabetic Macular Edema #biotechs https://unitybiotechnology.gcs-web.com/news-releases/news-release-details/unity-biotechnology-announces-topline-results-aspire-phase-2b https://gravityanalytica.com/analyzer/UBX https://unitybiotechnology.gcs-web.com/news-releases/news-release-details/unity-biotechnology-announces-topline-results-aspire-phase-2b https://gravityanalytica.com/analyzer/UBX" [X Link](https://x.com/GravAnalytica/status/1904128800000274488) 2025-03-24T11:10Z [--] followers, [--] engagements "$LRMR Larimar Therapeutics Provides Nomlabofusp Development Update and Reports Fourth Quarter and Full Year [----] Financial Results #biotechs https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-provides-nomlabofusp-development-update-and https://gravityanalytica.com/analyzer/LRMR https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-provides-nomlabofusp-development-update-and https://gravityanalytica.com/analyzer/LRMR" [X Link](https://x.com/GravAnalytica/status/1904128836205494526) 2025-03-24T11:11Z [--] followers, [---] engagements "$PYXS May [--] [----] - May [--] [----] : [----] RBC Capital Markets Global Healthcare Conference #biotechs https://ir.pyxisoncology.com/events/event-details/2025-rbc-capital-markets-global-healthcare-conference https://gravityanalytica.com/analyzer/PYXS https://ir.pyxisoncology.com/events/event-details/2025-rbc-capital-markets-global-healthcare-conference https://gravityanalytica.com/analyzer/PYXS" [X Link](https://x.com/GravAnalytica/status/1904147690180509980) 2025-03-24T12:26Z [--] followers, [--] engagements "$PHGE BiomX Reports Fourth Quarter and Full Year [----] Financial Results and Provides Business and Program Updates #biotechs https://ir.biomx.com/news-events/press-releases/detail/129/biomx-reports-fourth-quarter-and-full-year-2024-financial https://gravityanalytica.com/analyzer/PHGE https://ir.biomx.com/news-events/press-releases/detail/129/biomx-reports-fourth-quarter-and-full-year-2024-financial https://gravityanalytica.com/analyzer/PHGE" [X Link](https://x.com/GravAnalytica/status/1904481090439680256) 2025-03-25T10:30Z [--] followers, [--] engagements "$NAUT Proteoforms and Alzheimers disease #biotechs https://www.nautilus.bio/blog/proteoforms-and-alzheimers-disease/ https://gravityanalytica.com/analyzer/NAUT https://www.nautilus.bio/blog/proteoforms-and-alzheimers-disease/ https://gravityanalytica.com/analyzer/NAUT" [X Link](https://x.com/GravAnalytica/status/1904565398382461392) 2025-03-25T16:05Z [--] followers, [--] engagements "$CING Cingulate Inc. Reports Full Year [----] Fourth Quarter Resultsand Provides Development Update on Major Milestones Achieved #biotechs https://www.cingulate.com/news-releases/news-release-details/cingulate-inc-reports-full-year-2024-fourth-quarter-results-and https://gravityanalytica.com/analyzer/CING https://www.cingulate.com/news-releases/news-release-details/cingulate-inc-reports-full-year-2024-fourth-quarter-results-and https://gravityanalytica.com/analyzer/CING" [X Link](https://x.com/GravAnalytica/status/1905047382040985782) 2025-03-27T00:01Z [--] followers, [--] engagements "$IVVD Invivyd Appoints Ajay Royan Founder of Mithril Capital to its Board of Directors #biotechs https://adagiotx.gcs-web.com/news-releases/news-release-details/invivyd-appoints-ajay-royan-founder-mithril-capital-its-board https://gravityanalytica.com/analyzer/IVVD https://adagiotx.gcs-web.com/news-releases/news-release-details/invivyd-appoints-ajay-royan-founder-mithril-capital-its-board https://gravityanalytica.com/analyzer/IVVD" [X Link](https://x.com/GravAnalytica/status/1905047391213891627) 2025-03-27T00:01Z [--] followers, [---] engagements "$NAUT US HUPO [----] Key Takeaways Trends and Future Directions for Proteomics #biotechs https://www.nautilus.bio/blog/us-hupo-2025-key-takeaways-trends-and-future-directions-for-proteomics/ https://gravityanalytica.com/analyzer/NAUT https://www.nautilus.bio/blog/us-hupo-2025-key-takeaways-trends-and-future-directions-for-proteomics/ https://gravityanalytica.com/analyzer/NAUT" [X Link](https://x.com/GravAnalytica/status/1905098050588078317) 2025-03-27T03:22Z [--] followers, [--] engagements "$EYPT EyePoint to Present at [----] RBC Capital Markets Ophthalmology Virtual Conference #biotechs https://investors.eyepointpharma.com/news-releases/news-release-details/eyepoint-present-2025-rbc-capital-markets-ophthalmology-virtual https://gravityanalytica.com/analyzer/EYPT https://investors.eyepointpharma.com/news-releases/news-release-details/eyepoint-present-2025-rbc-capital-markets-ophthalmology-virtual https://gravityanalytica.com/analyzer/EYPT" [X Link](https://x.com/GravAnalytica/status/1905213495580164374) 2025-03-27T11:01Z [--] followers, [--] engagements "$EYPT RBC Capital Markets Ophthalmology Virtual Conference #biotechs https://investors.eyepointpharma.com/events/event-details/rbc-capital-markets-ophthalmology-virtual-conference https://gravityanalytica.com/analyzer/EYPT https://investors.eyepointpharma.com/events/event-details/rbc-capital-markets-ophthalmology-virtual-conference https://gravityanalytica.com/analyzer/EYPT" [X Link](https://x.com/GravAnalytica/status/1905213674114982161) 2025-03-27T11:01Z [--] followers, [--] engagements "$VYGR Voyager and KOL AD/PD [----] Recap #biotechs https://ir.voyagertherapeutics.com/events/event-details/voyager-and-kol-adpdtm-2025-recap https://gravityanalytica.com/analyzer/VYGR https://ir.voyagertherapeutics.com/events/event-details/voyager-and-kol-adpdtm-2025-recap https://gravityanalytica.com/analyzer/VYGR" [X Link](https://x.com/GravAnalytica/status/1906665500404281671) 2025-03-31T11:10Z [--] followers, [--] engagements "$NGNE Neurogene Announces Peer-Reviewed Publication Demonstrating Gene Therapy Candidate NGN-401 with EXACT Technology Regulates Transgene Expression in Preclinical Models of Rett Syndrome #biotechs https://neurogene.gcs-web.com/news-releases/news-release-details/neurogene-announces-peer-reviewed-publication-demonstrating-gene https://gravityanalytica.com/analyzer/NGNE https://neurogene.gcs-web.com/news-releases/news-release-details/neurogene-announces-peer-reviewed-publication-demonstrating-gene https://gravityanalytica.com/analyzer/NGNE" [X Link](https://x.com/GravAnalytica/status/1907584075440771345) 2025-04-03T00:00Z [--] followers, [--] engagements "$ATXS Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) #biotechs https://ir.astriatx.com/news-releases/news-release-details/astria-therapeutics-announces-inducement-grants-under-nasdaq-29 https://gravityanalytica.com/analyzer/ATXS https://ir.astriatx.com/news-releases/news-release-details/astria-therapeutics-announces-inducement-grants-under-nasdaq-29 https://gravityanalytica.com/analyzer/ATXS" [X Link](https://x.com/GravAnalytica/status/1907584114242339020) 2025-04-03T00:01Z [--] followers, [--] engagements "$NTLA Intellia Therapeutics Announces First Patient Dosed in the MAGNITUDE-2Phase [--] Study of Nexiguran Ziclumeran (nex-z) a One-Time Gene Editing-Based Treatment for Transthyretin (ATTR) Amyloidosis with Polyneuropathy #biotechs https://ir.intelliatx.com/news-releases/news-release-details/intellia-therapeutics-announces-first-patient-dosed-magnitude-2 https://gravityanalytica.com/analyzer/NTLA https://ir.intelliatx.com/news-releases/news-release-details/intellia-therapeutics-announces-first-patient-dosed-magnitude-2 https://gravityanalytica.com/analyzer/NTLA" [X Link](https://x.com/GravAnalytica/status/1907757852166394320) 2025-04-03T11:31Z [--] followers, [--] engagements "$NAUT How AI is Changing the Future of Biotech Research #biotechs https://www.nautilus.bio/blog/how-ai-is-changing-the-future-of-biotech-research/ https://gravityanalytica.com/analyzer/NAUT https://www.nautilus.bio/blog/how-ai-is-changing-the-future-of-biotech-research/ https://gravityanalytica.com/analyzer/NAUT" [X Link](https://x.com/GravAnalytica/status/1907821916477419574) 2025-04-03T15:46Z [--] followers, [--] engagements "$NXTC 24th Annual Needham Virtual Healthcare Conference #biotechs https://ir.nextcure.com/events/event-details/24th-annual-needham-virtual-healthcare-conference https://gravityanalytica.com/analyzer/NXTC https://ir.nextcure.com/events/event-details/24th-annual-needham-virtual-healthcare-conference https://gravityanalytica.com/analyzer/NXTC" [X Link](https://x.com/GravAnalytica/status/1908115821374603618) 2025-04-04T11:13Z [--] followers, [--] engagements "$CNTX April [--] [----] - April [--] [----] : Stifel Virtual Targeted Oncology Forum #biotechs https://ir.contexttherapeutics.com/events/event-details/stifel-virtual-targeted-oncology-forum https://gravityanalytica.com/analyzer/CNTX https://ir.contexttherapeutics.com/events/event-details/stifel-virtual-targeted-oncology-forum https://gravityanalytica.com/analyzer/CNTX" [X Link](https://x.com/GravAnalytica/status/1908342871603687734) 2025-04-05T02:16Z [--] followers, [---] engagements "$PLUR Pluri CEO Yaky Yanay on pioneering cell-tech solutions for global needs #biotechs https://pluri-biotech.com/news/pluri-ceo-yaky-yanay-on-pioneering-cell-tech-solutions-for-global-needs/ https://gravityanalytica.com/analyzer/PLUR https://pluri-biotech.com/news/pluri-ceo-yaky-yanay-on-pioneering-cell-tech-solutions-for-global-needs/ https://gravityanalytica.com/analyzer/PLUR" [X Link](https://x.com/GravAnalytica/status/1909935808703836578) 2025-04-09T11:45Z [--] followers, [--] engagements "$TARA Protara Therapeutics to Present Interim Analysis from the Phase [--] ADVANCED-2 Trial of TARA-002 in Patients with NMIBC at the American Urological Association Annual Meeting #biotechs https://protaratx.gcs-web.com/news-releases/news-release-details/protara-therapeutics-present-interim-analysis-phase-2-advanced-2 https://gravityanalytica.com/analyzer/TARA https://protaratx.gcs-web.com/news-releases/news-release-details/protara-therapeutics-present-interim-analysis-phase-2-advanced-2 https://gravityanalytica.com/analyzer/TARA" [X Link](https://x.com/GravAnalytica/status/1910483258728472986) 2025-04-11T00:01Z [--] followers, [---] engagements "$VERV Verve Therapeutics Receives U.S. FDA Fast Track Designation for VERVE-102 an In Vivo Base Editing Medicine Targeting PCSK9 #biotechs https://ir.vervetx.com/news-releases/news-release-details/verve-therapeutics-receives-us-fda-fast-track-designation-verve https://gravityanalytica.com/analyzer/VERV https://ir.vervetx.com/news-releases/news-release-details/verve-therapeutics-receives-us-fda-fast-track-designation-verve https://gravityanalytica.com/analyzer/VERV" [X Link](https://x.com/GravAnalytica/status/1910649338876797231) 2025-04-11T11:01Z [--] followers, [--] engagements "$VERV Verve Therapeutics Announces Positive Initial Data from the Heart-2 Phase 1b Clinical Trial of VERVE-102 an In Vivo Base Editing Medicine Targeting PCSK9 #biotechs https://vervetx.gcs-web.com/news-releases/news-release-details/verve-therapeutics-announces-positive-initial-data-heart-2-phase https://gravityanalytica.com/analyzer/VERV https://vervetx.gcs-web.com/news-releases/news-release-details/verve-therapeutics-announces-positive-initial-data-heart-2-phase https://gravityanalytica.com/analyzer/VERV" [X Link](https://x.com/GravAnalytica/status/1911737733665477029) 2025-04-14T11:06Z [--] followers, [--] engagements "$VERV Verve Therapeutics Announces Positive Initial Data from the Heart-2 Phase 1b Clinical Trial of VERVE-102 an In Vivo Base Editing Medicine Targeting PCSK9 #biotechs https://ir.vervetx.com/news-releases/news-release-details/verve-therapeutics-announces-positive-initial-data-heart-2-phase https://gravityanalytica.com/analyzer/VERV https://ir.vervetx.com/news-releases/news-release-details/verve-therapeutics-announces-positive-initial-data-heart-2-phase https://gravityanalytica.com/analyzer/VERV" [X Link](https://x.com/GravAnalytica/status/1911737733703225776) 2025-04-14T11:06Z [--] followers, [--] engagements "$SPRB Corporate Update Conference Call #biotechs https://investors.sprucebio.com/events/event-details/corporate-update-conference-call https://gravityanalytica.com/analyzer/SPRB https://investors.sprucebio.com/events/event-details/corporate-update-conference-call https://gravityanalytica.com/analyzer/SPRB" [X Link](https://x.com/GravAnalytica/status/1912099862457340128) 2025-04-15T11:05Z [--] followers, [--] engagements "$NAUT Nautilus Biotechnology to Announce First Quarter [----] Financial Results on April [--] [----] #biotechs https://investors.nautilus.bio/news-releases/news-release-details/nautilus-biotechnology-announce-first-quarter-2025-financial https://gravityanalytica.com/analyzer/NAUT https://investors.nautilus.bio/news-releases/news-release-details/nautilus-biotechnology-announce-first-quarter-2025-financial https://gravityanalytica.com/analyzer/NAUT" [X Link](https://x.com/GravAnalytica/status/1912479647087861957) 2025-04-16T12:14Z [--] followers, [--] engagements "$NAUT Intro to Proteomics Translating Proteomics #biotechs https://www.nautilus.bio/blog/intro-to-proteomics-on-translating-proteomics/ https://gravityanalytica.com/analyzer/NAUT https://www.nautilus.bio/blog/intro-to-proteomics-on-translating-proteomics/ https://gravityanalytica.com/analyzer/NAUT" [X Link](https://x.com/GravAnalytica/status/1912658774130676209) 2025-04-17T00:06Z [--] followers, [--] engagements "$PLUR Miracle cure to save Ukrainians in case of nuclear attack (German) #biotechs https://pluri-biotech.com/news/miracle-cure-to-save-ukrainians-in-case-of-nuclear-attack-german/ https://gravityanalytica.com/analyzer/PLUR https://pluri-biotech.com/news/miracle-cure-to-save-ukrainians-in-case-of-nuclear-attack-german/ https://gravityanalytica.com/analyzer/PLUR" [X Link](https://x.com/GravAnalytica/status/1912751511492264250) 2025-04-17T06:14Z [--] followers, [--] engagements "$DRIO DarioHealth Collaborates with Leading National Benefit Plan Administrator to Offer Cardiometabolic Solution including a GLP-1 Support Program to Employers #biotechs https://dariohealth.investorroom.com/2025-04-17-DarioHealth-Collaborates-with-Leading-National-Benefit-Plan-Administrator-to-Offer-Cardiometabolic-Solution-including-a-GLP-1-Support-Program-to-Employers https://gravityanalytica.com/analyzer/DRIO" [X Link](https://x.com/GravAnalytica/status/1912846564730486882) 2025-04-17T12:32Z [--] followers, [--] engagements "$PLUR Coffee that Costs More Than Whiskey: the Israeli Foodtech Revolution (Hebrew) #biotechs https://pluri-biotech.com/news/coffee-that-costs-more-than-whiskey-the-israeli-foodtech-revolution-hebrew/ https://gravityanalytica.com/analyzer/PLUR https://pluri-biotech.com/news/coffee-that-costs-more-than-whiskey-the-israeli-foodtech-revolution-hebrew/ https://gravityanalytica.com/analyzer/PLUR" [X Link](https://x.com/GravAnalytica/status/1913856637355303388) 2025-04-20T07:25Z [--] followers, [--] engagements "$PLUR Radiation and Bone Marrow Regeneration Podcast (Hebrew) #biotechs https://pluri-biotech.com/news/radiation-and-bone-marrow-regeneration-hebrew/ https://gravityanalytica.com/analyzer/PLUR https://pluri-biotech.com/news/radiation-and-bone-marrow-regeneration-hebrew/ https://gravityanalytica.com/analyzer/PLUR" [X Link](https://x.com/GravAnalytica/status/1913861589960184073) 2025-04-20T07:45Z [--] followers, [--] engagements "$ARVN Arvinas to Present Preclinical Data for PROTAC BCL6 Degrader ARV-393 at [----] American Association for Cancer Research (AACR) Annual Meeting #biotechs https://ir.arvinas.com/news-releases/news-release-details/arvinas-present-preclinical-data-protac-bcl6-degrader-arv-393 https://gravityanalytica.com/analyzer/ARVN https://ir.arvinas.com/news-releases/news-release-details/arvinas-present-preclinical-data-protac-bcl6-degrader-arv-393 https://gravityanalytica.com/analyzer/ARVN" [X Link](https://x.com/GravAnalytica/status/1914276862496243948) 2025-04-21T11:15Z [--] followers, [---] engagements "$ARVN Arvinas to Present Preclinical Data for PROTAC BCL6 Degrader ARV-393 at [----] American Association for Cancer Research (AACR) Annual Meeting #biotechs https://arvinas.gcs-web.com/news-releases/news-release-details/arvinas-present-preclinical-data-protac-bcl6-degrader-arv-393 https://gravityanalytica.com/analyzer/ARVN https://arvinas.gcs-web.com/news-releases/news-release-details/arvinas-present-preclinical-data-protac-bcl6-degrader-arv-393 https://gravityanalytica.com/analyzer/ARVN" [X Link](https://x.com/GravAnalytica/status/1914276862559219797) 2025-04-21T11:15Z [--] followers, [---] engagements "$DRIO DarioHealth Announces CFO Transition #biotechs https://dariohealth.investorroom.com/2025-04-21-DarioHealth-Announces-CFO-Transition https://gravityanalytica.com/analyzer/DRIO https://dariohealth.investorroom.com/2025-04-21-DarioHealth-Announces-CFO-Transition https://gravityanalytica.com/analyzer/DRIO" [X Link](https://x.com/GravAnalytica/status/1914297043205366165) 2025-04-21T12:35Z [--] followers, [--] engagements "$MBX Jonathan Wolleben #biotechs https://mbxbio.gcs-web.com/analyst/jonathan-wolleben https://gravityanalytica.com/analyzer/MBX https://mbxbio.gcs-web.com/analyst/jonathan-wolleben https://gravityanalytica.com/analyzer/MBX" [X Link](https://x.com/GravAnalytica/status/1914311497158664478) 2025-04-21T13:33Z [--] followers, [--] engagements "$MBX Jonathan Wolleben #biotechs https://investors.mbxbio.com/analyst/jonathan-wolleben https://gravityanalytica.com/analyzer/MBX https://investors.mbxbio.com/analyst/jonathan-wolleben https://gravityanalytica.com/analyzer/MBX" [X Link](https://x.com/GravAnalytica/status/1914311832803627405) 2025-04-21T13:34Z [--] followers, [--] engagements "$MBX May [--] [----] 3:00 PM EDT - May [--] [----] 3:25 PM EDT : The Citizens Life Sciences Conference #biotechs https://mbxbio.gcs-web.com/events/event-details/citizens-life-sciences-conference https://gravityanalytica.com/analyzer/MBX https://mbxbio.gcs-web.com/events/event-details/citizens-life-sciences-conference https://gravityanalytica.com/analyzer/MBX" [X Link](https://x.com/GravAnalytica/status/1914650716452380781) 2025-04-22T12:01Z [--] followers, [--] engagements "$MBX May [--] [----] 3:35 PM EDT - May [--] [----] 4:00 PM EDT : RBC [----] Global Healthcare Conference #biotechs https://mbxbio.gcs-web.com/events/event-details/rbc-2025-global-healthcare-conference https://gravityanalytica.com/analyzer/MBX https://mbxbio.gcs-web.com/events/event-details/rbc-2025-global-healthcare-conference https://gravityanalytica.com/analyzer/MBX" [X Link](https://x.com/GravAnalytica/status/1914650742469673143) 2025-04-22T12:01Z [--] followers, [--] engagements "$DAWN Day One to Report First Quarter [----] Financial Results Tuesday May [--] [----] #biotechs https://ir.dayonebio.com/news-releases/news-release-details/day-one-report-first-quarter-2025-financial-results-tuesday-may https://gravityanalytica.com/analyzer/DAWN https://ir.dayonebio.com/news-releases/news-release-details/day-one-report-first-quarter-2025-financial-results-tuesday-may https://gravityanalytica.com/analyzer/DAWN" [X Link](https://x.com/GravAnalytica/status/1914658936675840058) 2025-04-22T12:33Z [--] followers, [--] engagements "$DAWN Day One Biopharmaceuticals Q1 [----] Earnings Conference Call #biotechs https://ir.dayonebio.com/events/event-details/day-one-biopharmaceuticals-q1-2025-earnings-conference-call https://gravityanalytica.com/analyzer/DAWN https://ir.dayonebio.com/events/event-details/day-one-biopharmaceuticals-q1-2025-earnings-conference-call https://gravityanalytica.com/analyzer/DAWN" [X Link](https://x.com/GravAnalytica/status/1914661968788541713) 2025-04-22T12:46Z [--] followers, [--] engagements "$NAUT Nautilus Q1 [----] Earnings Conference Call #biotechs https://investors.nautilus.bio/events/event-details/nautilus-q1-2025-earnings-conference-call https://gravityanalytica.com/analyzer/NAUT https://investors.nautilus.bio/events/event-details/nautilus-q1-2025-earnings-conference-call https://gravityanalytica.com/analyzer/NAUT" [X Link](https://x.com/GravAnalytica/status/1914831922888352167) 2025-04-23T00:01Z [--] followers, [--] engagements "$APTO Aptose to Present at the [----] Bloom Burton & Co. Healthcare Investor Conference #biotechs https://www.aptose.com/investors/news-events/press-releases/detail/315/aptose-to-present-at-the-2025-bloom-burton-co-healthcare https://gravityanalytica.com/analyzer/APTO https://www.aptose.com/investors/news-events/press-releases/detail/315/aptose-to-present-at-the-2025-bloom-burton-co-healthcare https://gravityanalytica.com/analyzer/APTO" [X Link](https://x.com/GravAnalytica/status/1915006481876795764) 2025-04-23T11:34Z [--] followers, [--] engagements "$TARA Protara Therapeutics to Host Conference Call and Webcast to Review Interim Data from Phase [--] ADVANCED-2 Trial of TARA-002 in Patients with NMIBC on Monday April [--] [----] #biotechs https://ir.protaratx.com/news-releases/news-release-details/protara-therapeutics-host-conference-call-and-webcast-review https://gravityanalytica.com/analyzer/TARA https://ir.protaratx.com/news-releases/news-release-details/protara-therapeutics-host-conference-call-and-webcast-review https://gravityanalytica.com/analyzer/TARA" [X Link](https://x.com/GravAnalytica/status/1915013106041839646) 2025-04-23T12:01Z [--] followers, [--] engagements "$TARA ADVANCED-2 Data Update Call #biotechs https://protaratx.gcs-web.com/events/event-details/advanced-2-data-update-call https://gravityanalytica.com/analyzer/TARA https://protaratx.gcs-web.com/events/event-details/advanced-2-data-update-call https://gravityanalytica.com/analyzer/TARA" [X Link](https://x.com/GravAnalytica/status/1915016799004787118) 2025-04-23T12:15Z [--] followers, [---] engagements "$PRTC PureTech to Present [----] Annual Report and Financial Results #biotechs https://investors.puretechhealth.com/events/event-details/puretech-present-2024-annual-report-and-financial-results https://gravityanalytica.com/analyzer/PRTC https://investors.puretechhealth.com/events/event-details/puretech-present-2024-annual-report-and-financial-results https://gravityanalytica.com/analyzer/PRTC" [X Link](https://x.com/GravAnalytica/status/1915437035961123172) 2025-04-24T16:05Z [--] followers, [--] engagements "$PRTC PureTech to Present [----] Annual Report and Financial Results #biotechs https://puretechhealth.gcs-web.com/events/event-details/puretech-present-2024-annual-report-and-financial-results https://gravityanalytica.com/analyzer/PRTC https://puretechhealth.gcs-web.com/events/event-details/puretech-present-2024-annual-report-and-financial-results https://gravityanalytica.com/analyzer/PRTC" [X Link](https://x.com/GravAnalytica/status/1915437036527403449) 2025-04-24T16:05Z [--] followers, [--] engagements "$TARA Protara Therapeutics Announces Positive Interim Results Demonstrating Durable Responses in the Ongoing Phase [--] ADVANCED-2 Trial of TARA-002 in Patients with NMIBC #biotechs https://ir.protaratx.com/news-releases/news-release-details/protara-therapeutics-announces-positive-interim-results https://gravityanalytica.com/analyzer/TARA https://ir.protaratx.com/news-releases/news-release-details/protara-therapeutics-announces-positive-interim-results https://gravityanalytica.com/analyzer/TARA" [X Link](https://x.com/GravAnalytica/status/1916131319618093421) 2025-04-26T14:04Z [--] followers, [---] engagements "$TARA Protara Therapeutics Announces Positive Interim Results Demonstrating Durable Responses in the Ongoing Phase [--] ADVANCED-2 Trial of TARA-002 in Patients with NMIBC #biotechs https://protaratx.gcs-web.com/news-releases/news-release-details/protara-therapeutics-announces-positive-interim-results https://gravityanalytica.com/analyzer/TARA https://protaratx.gcs-web.com/news-releases/news-release-details/protara-therapeutics-announces-positive-interim-results https://gravityanalytica.com/analyzer/TARA" [X Link](https://x.com/GravAnalytica/status/1916131334092689522) 2025-04-26T14:04Z [--] followers, [---] engagements "$ARVN Arvinas Shares New Preclinical Combination Data for the PROTAC BCL6 Degrader ARV-393 at the [----] American Association for Cancer Research Annual Meeting #biotechs https://ir.arvinas.com/news-releases/news-release-details/arvinas-shares-new-preclinical-combination-data-protac-bcl6 https://gravityanalytica.com/analyzer/ARVN https://ir.arvinas.com/news-releases/news-release-details/arvinas-shares-new-preclinical-combination-data-protac-bcl6 https://gravityanalytica.com/analyzer/ARVN" [X Link](https://x.com/GravAnalytica/status/1916808611495350659) 2025-04-28T10:56Z [--] followers, [---] engagements "$ARVN Arvinas to Report First Quarter [----] Financial Results on Thursday May [--] [----] #biotechs https://arvinas.gcs-web.com/news-releases/news-release-details/arvinas-report-first-quarter-2025-financial-results-thursday-may https://gravityanalytica.com/analyzer/ARVN https://arvinas.gcs-web.com/news-releases/news-release-details/arvinas-report-first-quarter-2025-financial-results-thursday-may https://gravityanalytica.com/analyzer/ARVN" [X Link](https://x.com/GravAnalytica/status/1916810712585773152) 2025-04-28T11:04Z [--] followers, [---] engagements "$ARVN Arvinas to Report First Quarter [----] Financial Results on Thursday May [--] [----] #biotechs https://ir.arvinas.com/news-releases/news-release-details/arvinas-report-first-quarter-2025-financial-results-thursday-may https://gravityanalytica.com/analyzer/ARVN https://ir.arvinas.com/news-releases/news-release-details/arvinas-report-first-quarter-2025-financial-results-thursday-may https://gravityanalytica.com/analyzer/ARVN" [X Link](https://x.com/GravAnalytica/status/1916811143252750629) 2025-04-28T11:06Z [--] followers, [---] engagements "$ARVN Arvinas 1Q25 Earnings Call #biotechs https://ir.arvinas.com/events/event-details/arvinas-1q25-earnings-call https://gravityanalytica.com/analyzer/ARVN https://ir.arvinas.com/events/event-details/arvinas-1q25-earnings-call https://gravityanalytica.com/analyzer/ARVN" [X Link](https://x.com/GravAnalytica/status/1916813544617619730) 2025-04-28T11:15Z [--] followers, [---] engagements "$PHAT Phathom Pharmaceuticals to Present VOQUEZNA (vonoprazan) Data at DDW [----] Annual Meeting #biotechs https://www.globenewswire.com/news-release/2025/04/28/3069111/0/en/Phathom-Pharmaceuticals-to-Present-VOQUEZNA-vonoprazan-Data-at-DDW-2025-Annual-Meeting.html https://gravityanalytica.com/analyzer/PHAT https://www.globenewswire.com/news-release/2025/04/28/3069111/0/en/Phathom-Pharmaceuticals-to-Present-VOQUEZNA-vonoprazan-Data-at-DDW-2025-Annual-Meeting.html https://gravityanalytica.com/analyzer/PHAT" [X Link](https://x.com/GravAnalytica/status/1916825210214363335) 2025-04-28T12:01Z [--] followers, [--] engagements "$PHAT Phathom Pharmaceuticals to Present VOQUEZNA (vonoprazan) Data at DDW [----] Annual Meeting #biotechs https://investors.phathompharma.com/news-releases/news-release-details/phathom-pharmaceuticals-present-voqueznar-vonoprazan-data-ddw-0 https://gravityanalytica.com/analyzer/PHAT https://investors.phathompharma.com/news-releases/news-release-details/phathom-pharmaceuticals-present-voqueznar-vonoprazan-data-ddw-0 https://gravityanalytica.com/analyzer/PHAT" [X Link](https://x.com/GravAnalytica/status/1916825242145525854) 2025-04-28T12:02Z [--] followers, [--] engagements "$ORMP Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical #biotechs https://oramed.gcs-web.com/news-releases/news-release-details/oramed-pharmaceuticals-announces-369-million-investment-and https://gravityanalytica.com/analyzer/ORMP https://oramed.gcs-web.com/news-releases/news-release-details/oramed-pharmaceuticals-announces-369-million-investment-and https://gravityanalytica.com/analyzer/ORMP" [X Link](https://x.com/GravAnalytica/status/1916843872178630799) 2025-04-28T13:16Z [--] followers, [--] engagements "$NEO NeoGenomics Reports First Quarter [----] Results #biotechs https://ir.neogenomics.com/news-events/press-releases/detail/296/neogenomics-reports-first-quarter-2025-results https://gravityanalytica.com/analyzer/NEO https://ir.neogenomics.com/news-events/press-releases/detail/296/neogenomics-reports-first-quarter-2025-results https://gravityanalytica.com/analyzer/NEO" [X Link](https://x.com/GravAnalytica/status/1917181057851396176) 2025-04-29T11:35Z [--] followers, [--] engagements "$CRIS Curis to Report First Quarter [----] Financial and Operating Results and Host Conference Call and Webcast on May [--] [----] #biotechs https://investors.curis.com/2025-04-29-Curis-to-Report-First-Quarter-2025-Financial-and-Operating-Results-and-Host-Conference-Call-and-Webcast-on-May-6-2025 https://gravityanalytica.com/analyzer/CRIS https://investors.curis.com/2025-04-29-Curis-to-Report-First-Quarter-2025-Financial-and-Operating-Results-and-Host-Conference-Call-and-Webcast-on-May-6-2025 https://gravityanalytica.com/analyzer/CRIS" [X Link](https://x.com/GravAnalytica/status/1917188546135298415) 2025-04-29T12:05Z [--] followers, [---] engagements "$NAUT Nautilus Biotechnology Reports First Quarter [----] Financial Results #biotechs https://investors.nautilus.bio/news-releases/news-release-details/nautilus-biotechnology-reports-first-quarter-2025-financial https://gravityanalytica.com/analyzer/NAUT https://investors.nautilus.bio/news-releases/news-release-details/nautilus-biotechnology-reports-first-quarter-2025-financial https://gravityanalytica.com/analyzer/NAUT" [X Link](https://x.com/GravAnalytica/status/1917190575435956484) 2025-04-29T12:13Z [--] followers, [--] engagements "$HCAT Health Catalyst Announces Strategic Partnership with Microsoft to Accelerate AI Adoption and Transformation for Care Delivery Organizations #biotechs https://ir.healthcatalyst.com/news-releases/news-release-details/health-catalyst-announces-strategic-partnership-microsoft https://gravityanalytica.com/analyzer/HCAT https://ir.healthcatalyst.com/news-releases/news-release-details/health-catalyst-announces-strategic-partnership-microsoft https://gravityanalytica.com/analyzer/HCAT" [X Link](https://x.com/GravAnalytica/status/1917196182436069671) 2025-04-29T12:36Z [--] followers, [--] engagements "$ATXS Astria Therapeutics to Present at Upcoming Citizens Life Sciences Conference #biotechs https://ir.astriatx.com/news-releases/news-release-details/astria-therapeutics-present-upcoming-citizens-life-sciences https://gravityanalytica.com/analyzer/ATXS https://ir.astriatx.com/news-releases/news-release-details/astria-therapeutics-present-upcoming-citizens-life-sciences https://gravityanalytica.com/analyzer/ATXS" [X Link](https://x.com/GravAnalytica/status/1917550536938713244) 2025-04-30T12:04Z [--] followers, [--] engagements "$ATXS Citizens Life Sciences Conference #biotechs https://ir.astriatx.com/events/event-details/citizens-life-sciences-conference https://gravityanalytica.com/analyzer/ATXS https://ir.astriatx.com/events/event-details/citizens-life-sciences-conference https://gravityanalytica.com/analyzer/ATXS" [X Link](https://x.com/GravAnalytica/status/1917557489412813283) 2025-04-30T12:31Z [--] followers, [--] engagements "$ARVN Arvinas Reports First Quarter [----] Financial Results and Provides Corporate Update #biotechs https://arvinas.gcs-web.com/news-releases/news-release-details/arvinas-reports-first-quarter-2025-financial-results-and https://gravityanalytica.com/analyzer/ARVN https://arvinas.gcs-web.com/news-releases/news-release-details/arvinas-reports-first-quarter-2025-financial-results-and https://gravityanalytica.com/analyzer/ARVN" [X Link](https://x.com/GravAnalytica/status/1917899494718394407) 2025-05-01T11:10Z [--] followers, [---] engagements "$NEO NeoGenomics Pays Off 1.25% Convertible Senior Notes #biotechs https://ir.neogenomics.com/news-events/press-releases/detail/297/neogenomics-pays-off-1-25-convertible-senior-notes https://gravityanalytica.com/analyzer/NEO https://ir.neogenomics.com/news-events/press-releases/detail/297/neogenomics-pays-off-1-25-convertible-senior-notes https://gravityanalytica.com/analyzer/NEO" [X Link](https://x.com/GravAnalytica/status/1917899581574058144) 2025-05-01T11:11Z [--] followers, [--] engagements "$UBX UNITY Biotechnology to Present at the ARVO [----] Annual Meeting #biotechs https://ir.unitybiotechnology.com/news-releases/news-release-details/unity-biotechnology-present-arvo-2025-annual-meeting https://gravityanalytica.com/analyzer/UBX https://ir.unitybiotechnology.com/news-releases/news-release-details/unity-biotechnology-present-arvo-2025-annual-meeting https://gravityanalytica.com/analyzer/UBX" [X Link](https://x.com/GravAnalytica/status/1917912289304256675) 2025-05-01T12:01Z [--] followers, [--] engagements "$UBX UNITY Biotechnology Announces Complete 36-Week Results from the ASPIRE Phase 2b Study of UBX1325 in Diabetic Macular Edema and Provides Corporate Updates #biotechs https://unitybiotechnology.gcs-web.com/news-releases/news-release-details/unity-biotechnology-announces-complete-36-week-results-aspire https://gravityanalytica.com/analyzer/UBX https://unitybiotechnology.gcs-web.com/news-releases/news-release-details/unity-biotechnology-announces-complete-36-week-results-aspire https://gravityanalytica.com/analyzer/UBX" [X Link](https://x.com/GravAnalytica/status/1919361859079069960) 2025-05-05T12:01Z [--] followers, [--] engagements "$ASMB New Preclinical Data for Assembly Biosciences Oral Hepatitis D Virus Entry Inhibitor ABI-6250 and Next-Generation Hepatitis B Virus Capsid Assembly Modulator ABI-4334 Presented at the EASL Congress [----] #biotechs https://assemblybio.gcs-web.com/news-releases/news-release-details/new-preclinical-data-assembly-biosciences-oral-hepatitis-d-virus https://gravityanalytica.com/analyzer/ASMB https://assemblybio.gcs-web.com/news-releases/news-release-details/new-preclinical-data-assembly-biosciences-oral-hepatitis-d-virus https://gravityanalytica.com/analyzer/ASMB" [X Link](https://x.com/GravAnalytica/status/1920086820064309538) 2025-05-07T12:02Z [--] followers, [--] engagements "$ASMB New Preclinical Data for Assembly Biosciences Oral Hepatitis D Virus Entry Inhibitor ABI-6250 and Next-Generation Hepatitis B Virus Capsid Assembly Modulator ABI-4334 Presented at the EASL Congress [----] #biotechs https://investor.assemblybio.com/news-releases/news-release-details/new-preclinical-data-assembly-biosciences-oral-hepatitis-d-virus https://gravityanalytica.com/analyzer/ASMB https://investor.assemblybio.com/news-releases/news-release-details/new-preclinical-data-assembly-biosciences-oral-hepatitis-d-virus https://gravityanalytica.com/analyzer/ASMB" [X Link](https://x.com/GravAnalytica/status/1920087673470877833) 2025-05-07T12:05Z [--] followers, [--] engagements "$NTLA RBC Capital Markets Global Healthcare Conference #biotechs https://ir.intelliatx.com/events/event-details/rbc-capital-markets-global-healthcare-conference-0 https://gravityanalytica.com/analyzer/NTLA https://ir.intelliatx.com/events/event-details/rbc-capital-markets-global-healthcare-conference-0 https://gravityanalytica.com/analyzer/NTLA" [X Link](https://x.com/GravAnalytica/status/1920441438229103096) 2025-05-08T11:31Z [--] followers, [---] engagements "$CRBP Corbus Pharmaceuticals to Present at the [----] RBC Capital Markets Global Healthcare Conference #biotechs https://ir.corbuspharma.com/news/detail/440/corbus-pharmaceuticals-to-present-at-the-2025-rbc-capital-markets-global-healthcare-conference https://gravityanalytica.com/analyzer/CRBP https://ir.corbuspharma.com/news/detail/440/corbus-pharmaceuticals-to-present-at-the-2025-rbc-capital-markets-global-healthcare-conference https://gravityanalytica.com/analyzer/CRBP" [X Link](https://x.com/GravAnalytica/status/1920448863434936831) 2025-05-08T12:01Z [--] followers, [--] engagements "$TARA Protara Therapeutics Announces First Quarter [----] Financial Results and Provides Business Update #biotechs https://protaratx.gcs-web.com/news-releases/news-release-details/protara-therapeutics-announces-first-quarter-2025-financial https://gravityanalytica.com/analyzer/TARA https://protaratx.gcs-web.com/news-releases/news-release-details/protara-therapeutics-announces-first-quarter-2025-financial https://gravityanalytica.com/analyzer/TARA" [X Link](https://x.com/GravAnalytica/status/1920451368982098427) 2025-05-08T12:11Z [--] followers, [--] engagements "$TRDA H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ #biotechs https://entradatx.gcs-web.com/events/event-details/hc-wainwright-3rd-annual-bioconnect-investor-conference-nasdaq https://gravityanalytica.com/analyzer/TRDA https://entradatx.gcs-web.com/events/event-details/hc-wainwright-3rd-annual-bioconnect-investor-conference-nasdaq https://gravityanalytica.com/analyzer/TRDA" [X Link](https://x.com/GravAnalytica/status/1920836690748317900) 2025-05-09T13:42Z [--] followers, [--] engagements "$TRDA H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ #biotechs https://ir.entradatx.com/events/event-details/hc-wainwright-3rd-annual-bioconnect-investor-conference-nasdaq https://gravityanalytica.com/analyzer/TRDA https://ir.entradatx.com/events/event-details/hc-wainwright-3rd-annual-bioconnect-investor-conference-nasdaq https://gravityanalytica.com/analyzer/TRDA" [X Link](https://x.com/GravAnalytica/status/1920836710675464208) 2025-05-09T13:42Z [--] followers, [--] engagements "$CTMX CytomX Announces Positive Interim Data From Phase [--] Dose Escalation Study of EpCAM Antibody Drug Conjugate (CX-2051) Candidate in Patients with Advanced Colorectal Cancer (CRC) #biotechs https://ir.cytomx.com/news-releases/news-release-details/cytomx-announces-positive-interim-data-phase-1-dose-escalation https://gravityanalytica.com/analyzer/CTMX https://ir.cytomx.com/news-releases/news-release-details/cytomx-announces-positive-interim-data-phase-1-dose-escalation https://gravityanalytica.com/analyzer/CTMX" [X Link](https://x.com/GravAnalytica/status/1921874198965714956) 2025-05-12T10:24Z [--] followers, [---] engagements "$ABOS Acumen Pharmaceuticals Reports First Quarter [----] Financial Results and Business Highlights #biotechs https://investors.acumenpharm.com/news-releases/news-release-details/acumen-pharmaceuticals-reports-first-quarter-2025-financial https://gravityanalytica.com/analyzer/ABOS https://investors.acumenpharm.com/news-releases/news-release-details/acumen-pharmaceuticals-reports-first-quarter-2025-financial https://gravityanalytica.com/analyzer/ABOS" [X Link](https://x.com/GravAnalytica/status/1922245797250204063) 2025-05-13T11:01Z [--] followers, [--] engagements "$SEPN Novo Nordisk A/S: Septerna and Novo Nordisk to collaborate on oral small molecule medicines for obesity and other cardiometabolic diseases #biotechs https://ir.septerna.com/news-releases/news-release-details/novo-nordisk-septerna-and-novo-nordisk-collaborate-oral-small https://gravityanalytica.com/analyzer/SEPN https://ir.septerna.com/news-releases/news-release-details/novo-nordisk-septerna-and-novo-nordisk-collaborate-oral-small https://gravityanalytica.com/analyzer/SEPN" [X Link](https://x.com/GravAnalytica/status/1922610980346847531) 2025-05-14T11:12Z [--] followers, [---] engagements "$MIST Milestone Pharmaceuticals Reports First Quarter [----] Financial Results and Provides Regulatory and Corporate Update #biotechs https://milestonepharma.gcs-web.com/news-releases/news-release-details/milestone-pharmaceuticals-reports-first-quarter-2025-financial https://gravityanalytica.com/analyzer/MIST https://milestonepharma.gcs-web.com/news-releases/news-release-details/milestone-pharmaceuticals-reports-first-quarter-2025-financial https://gravityanalytica.com/analyzer/MIST" [X Link](https://x.com/GravAnalytica/status/1922611949491114086) 2025-05-14T11:16Z [--] followers, [--] engagements "$LPCN Lipocine to Present at A.G.P.'s Annual Healthcare Company Showcase #biotechs https://ir.lipocine.com/2025-05-14-Lipocine-to-Present-at-A-G-P-s-Annual-Healthcare-Company-Showcase https://gravityanalytica.com/analyzer/LPCN https://ir.lipocine.com/2025-05-14-Lipocine-to-Present-at-A-G-P-s-Annual-Healthcare-Company-Showcase https://gravityanalytica.com/analyzer/LPCN" [X Link](https://x.com/GravAnalytica/status/1922623245083189750) 2025-05-14T12:01Z [--] followers, [--] engagements "$KALA KALA BIO Reports First Quarter [----] Financial Results and Provides Corporate Update #biotechs https://investors.kalarx.com/news-releases/news-release-details/kala-bio-reports-first-quarter-2025-financial-results-and https://gravityanalytica.com/analyzer/KALA https://investors.kalarx.com/news-releases/news-release-details/kala-bio-reports-first-quarter-2025-financial-results-and https://gravityanalytica.com/analyzer/KALA" [X Link](https://x.com/GravAnalytica/status/1922623270928421321) 2025-05-14T12:01Z [--] followers, [--] engagements "$DAWN 46th Annual Goldman Sachs Global Healthcare Conference #biotechs https://ir.dayonebio.com/events/event-details/46th-annual-goldman-sachs-global-healthcare-conference https://gravityanalytica.com/analyzer/DAWN https://ir.dayonebio.com/events/event-details/46th-annual-goldman-sachs-global-healthcare-conference https://gravityanalytica.com/analyzer/DAWN" [X Link](https://x.com/GravAnalytica/status/1924494202508886360) 2025-05-19T15:55Z [--] followers, [---] engagements "$HCAT Health Catalyst to Participate in Upcoming Investor Conferences #biotechs https://ir.healthcatalyst.com/news-releases/news-release-details/health-catalyst-participate-upcoming-investor-conferences-12 https://gravityanalytica.com/analyzer/HCAT https://ir.healthcatalyst.com/news-releases/news-release-details/health-catalyst-participate-upcoming-investor-conferences-12 https://gravityanalytica.com/analyzer/HCAT" [X Link](https://x.com/GravAnalytica/status/1924799997062623523) 2025-05-20T12:10Z [--] followers, [--] engagements "$WHWK TD Cowen 6th Annual Oncology Innovation Summit #biotechs https://ir.whitehawktx.com/events/event-details/td-cowen-6th-annual-oncology-innovation-summit https://gravityanalytica.com/analyzer/WHWK https://ir.whitehawktx.com/events/event-details/td-cowen-6th-annual-oncology-innovation-summit https://gravityanalytica.com/analyzer/WHWK" [X Link](https://x.com/GravAnalytica/status/1925163582414635313) 2025-05-21T12:15Z [--] followers, [--] engagements "$WHWK Whitehawk Therapeutics to Participate in the TD Cowen 6th Annual Oncology Innovation Summit #biotechs https://ir.whitehawktx.com/news-releases/news-release-details/whitehawk-therapeutics-participate-td-cowen-6th-annual-oncology https://gravityanalytica.com/analyzer/WHWK https://ir.whitehawktx.com/news-releases/news-release-details/whitehawk-therapeutics-participate-td-cowen-6th-annual-oncology https://gravityanalytica.com/analyzer/WHWK" [X Link](https://x.com/GravAnalytica/status/1925163636189753700) 2025-05-21T12:15Z [--] followers, [--] engagements "$ALMS Alumis Completes Merger with ACELYRIN #biotechs https://investors.alumis.com/news-releases/news-release-details/alumis-completes-merger-acelyrin https://gravityanalytica.com/analyzer/ALMS https://investors.alumis.com/news-releases/news-release-details/alumis-completes-merger-acelyrin https://gravityanalytica.com/analyzer/ALMS" [X Link](https://x.com/GravAnalytica/status/1925182684352929896) 2025-05-21T13:31Z [--] followers, [--] engagements "$ALMS Alumis Completes Merger with ACELYRIN #biotechs https://alumis.gcs-web.com/news-releases/news-release-details/alumis-completes-merger-acelyrin https://gravityanalytica.com/analyzer/ALMS https://alumis.gcs-web.com/news-releases/news-release-details/alumis-completes-merger-acelyrin https://gravityanalytica.com/analyzer/ALMS" [X Link](https://x.com/GravAnalytica/status/1925182685544099917) 2025-05-21T13:31Z [--] followers, [--] engagements "$FHTX Goldman Sachs 46th Annual Global Healthcare Conference [----] #biotechs https://ir.foghorntx.com/events/event-details/goldman-sachs-46th-annual-global-healthcare-conference-2025 https://gravityanalytica.com/analyzer/FHTX https://ir.foghorntx.com/events/event-details/goldman-sachs-46th-annual-global-healthcare-conference-2025 https://gravityanalytica.com/analyzer/FHTX" [X Link](https://x.com/GravAnalytica/status/1925509689627840860) 2025-05-22T11:10Z [--] followers, [--] engagements "$FHTX Jefferies Global Healthcare Conference [----] #biotechs https://ir.foghorntx.com/events/event-details/jefferies-global-healthcare-conference-2025 https://gravityanalytica.com/analyzer/FHTX https://ir.foghorntx.com/events/event-details/jefferies-global-healthcare-conference-2025 https://gravityanalytica.com/analyzer/FHTX" [X Link](https://x.com/GravAnalytica/status/1925509714462343577) 2025-05-22T11:11Z [--] followers, [--] engagements "$FHTX TD Cowens 6th Annual Oncology Innovation Summit #biotechs https://foghorntx.gcs-web.com/events/event-details/td-cowens-6th-annual-oncology-innovation-summit https://gravityanalytica.com/analyzer/FHTX https://foghorntx.gcs-web.com/events/event-details/td-cowens-6th-annual-oncology-innovation-summit https://gravityanalytica.com/analyzer/FHTX" [X Link](https://x.com/GravAnalytica/status/1925509740412403911) 2025-05-22T11:11Z [--] followers, [--] engagements "$FHTX Evercore Biotech Diamonds in the Rough Virtual Event #biotechs https://foghorntx.gcs-web.com/events/event-details/evercore-biotech-diamonds-rough-virtual-event https://gravityanalytica.com/analyzer/FHTX https://foghorntx.gcs-web.com/events/event-details/evercore-biotech-diamonds-rough-virtual-event https://gravityanalytica.com/analyzer/FHTX" [X Link](https://x.com/GravAnalytica/status/1925509840136261807) 2025-05-22T11:11Z [--] followers, [--] engagements "$ATXS Astria Therapeutics to Present at Upcoming Eastern Allergy Conference #biotechs https://ir.astriatx.com/news-releases/news-release-details/astria-therapeutics-present-upcoming-eastern-allergy-0 https://gravityanalytica.com/analyzer/ATXS https://ir.astriatx.com/news-releases/news-release-details/astria-therapeutics-present-upcoming-eastern-allergy-0 https://gravityanalytica.com/analyzer/ATXS" [X Link](https://x.com/GravAnalytica/status/1925523015413952978) 2025-05-22T12:03Z [--] followers, [--] engagements "$ORKA Julian Harrison #biotechs https://orukatx.gcs-web.com/analyst/julian-harrison https://gravityanalytica.com/analyzer/ORKA https://orukatx.gcs-web.com/analyst/julian-harrison https://gravityanalytica.com/analyzer/ORKA" [X Link](https://x.com/GravAnalytica/status/1925548696017469937) 2025-05-22T13:45Z [--] followers, [--] engagements "$ORKA Julian Harrison #biotechs https://ir.orukatx.com/analyst/julian-harrison https://gravityanalytica.com/analyzer/ORKA https://ir.orukatx.com/analyst/julian-harrison https://gravityanalytica.com/analyzer/ORKA" [X Link](https://x.com/GravAnalytica/status/1925548696487235836) 2025-05-22T13:45Z [--] followers, [--] engagements "$NAUT Proteomics and the food of the future #biotechs https://www.nautilus.bio/blog/proteomics-and-the-food-of-the-future/ https://gravityanalytica.com/analyzer/NAUT https://www.nautilus.bio/blog/proteomics-and-the-food-of-the-future/ https://gravityanalytica.com/analyzer/NAUT" [X Link](https://x.com/GravAnalytica/status/1925578823606714783) 2025-05-22T15:45Z [--] followers, [--] engagements "$ATXS Astria Therapeutics to Present at Upcoming C1 Inhibitor Deficiency and Angioedema Workshop #biotechs https://ir.astriatx.com/news-releases/news-release-details/astria-therapeutics-present-upcoming-c1-inhibitor-deficiency-and https://gravityanalytica.com/analyzer/ATXS https://ir.astriatx.com/news-releases/news-release-details/astria-therapeutics-present-upcoming-c1-inhibitor-deficiency-and https://gravityanalytica.com/analyzer/ATXS" [X Link](https://x.com/GravAnalytica/status/1925885143119474910) 2025-05-23T12:02Z [--] followers, [--] engagements "$MOVE Movano Health Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q #biotechs https://movanohealth.com/movano-health-receives-notification-of-deficiency-from-nasdaq-related-to-delayed-filing-of-quarterly-report-on-form-10-q/ https://gravityanalytica.com/analyzer/MOVE https://movanohealth.com/movano-health-receives-notification-of-deficiency-from-nasdaq-related-to-delayed-filing-of-quarterly-report-on-form-10-q/ https://gravityanalytica.com/analyzer/MOVE" [X Link](https://x.com/GravAnalytica/status/1926067172851200134) 2025-05-24T00:06Z [--] followers, [--] engagements "$NAUT Nautilus Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference #biotechs https://investors.nautilus.bio/news-releases/news-release-details/nautilus-biotechnology-participate-goldman-sachs-46th-annual https://gravityanalytica.com/analyzer/NAUT https://investors.nautilus.bio/news-releases/news-release-details/nautilus-biotechnology-participate-goldman-sachs-46th-annual https://gravityanalytica.com/analyzer/NAUT" [X Link](https://x.com/GravAnalytica/status/1927334319380480187) 2025-05-27T12:01Z [--] followers, [--] engagements "$TCRX Jefferies Global Healthcare Conference #biotechs https://tscan.gcs-web.com/events/event-details/jefferies-global-healthcare-conference-0 https://gravityanalytica.com/analyzer/TCRX https://tscan.gcs-web.com/events/event-details/jefferies-global-healthcare-conference-0 https://gravityanalytica.com/analyzer/TCRX" [X Link](https://x.com/GravAnalytica/status/1927683956268286176) 2025-05-28T11:10Z [--] followers, [--] engagements "$ZBIO Jefferies Global Healthcare Conference #biotechs https://zenasbio.gcs-web.com/events/event-details/jefferies-global-healthcare-conference https://gravityanalytica.com/analyzer/ZBIO https://zenasbio.gcs-web.com/events/event-details/jefferies-global-healthcare-conference https://gravityanalytica.com/analyzer/ZBIO" [X Link](https://x.com/GravAnalytica/status/1928046681238466729) 2025-05-29T11:12Z [--] followers, [--] engagements "$KALA KALA BIO to Present at Jefferies Global Healthcare Conference #biotechs https://investors.kalarx.com/news-releases/news-release-details/kala-bio-present-jefferies-global-healthcare-conference-0 https://gravityanalytica.com/analyzer/KALA https://investors.kalarx.com/news-releases/news-release-details/kala-bio-present-jefferies-global-healthcare-conference-0 https://gravityanalytica.com/analyzer/KALA" [X Link](https://x.com/GravAnalytica/status/1928059082637783122) 2025-05-29T12:01Z [--] followers, [--] engagements "$ARVN Arvinas to Present at Jefferies Global Healthcare Conference #biotechs https://arvinas.gcs-web.com/news-releases/news-release-details/arvinas-present-jefferies-global-healthcare-conference https://gravityanalytica.com/analyzer/ARVN https://arvinas.gcs-web.com/news-releases/news-release-details/arvinas-present-jefferies-global-healthcare-conference https://gravityanalytica.com/analyzer/ARVN" [X Link](https://x.com/GravAnalytica/status/1928407522425139258) 2025-05-30T11:05Z [--] followers, [---] engagements "$ARVN Arvinas to Present at Jefferies Global Healthcare Conference #biotechs https://ir.arvinas.com/news-releases/news-release-details/arvinas-present-jefferies-global-healthcare-conference https://gravityanalytica.com/analyzer/ARVN https://ir.arvinas.com/news-releases/news-release-details/arvinas-present-jefferies-global-healthcare-conference https://gravityanalytica.com/analyzer/ARVN" [X Link](https://x.com/GravAnalytica/status/1928407548790546923) 2025-05-30T11:06Z [--] followers, [---] engagements "$ARVN Jefferies Global Healthcare Conference #biotechs https://ir.arvinas.com/events/event-details/jefferies-global-healthcare-conference-0 https://gravityanalytica.com/analyzer/ARVN https://ir.arvinas.com/events/event-details/jefferies-global-healthcare-conference-0 https://gravityanalytica.com/analyzer/ARVN" [X Link](https://x.com/GravAnalytica/status/1928431558186148004) 2025-05-30T12:41Z [--] followers, [---] engagements "$FATE Fate Therapeutics Appoints Matthew Abernethy M.B.A. to its Board of Directors #biotechs https://ir.fatetherapeutics.com/news-releases/news-release-details/fate-therapeutics-appoints-matthew-abernethy-mba-its-board https://gravityanalytica.com/analyzer/FATE https://ir.fatetherapeutics.com/news-releases/news-release-details/fate-therapeutics-appoints-matthew-abernethy-mba-its-board https://gravityanalytica.com/analyzer/FATE" [X Link](https://x.com/GravAnalytica/status/1928603244051169627) 2025-05-31T00:03Z [--] followers, [--] engagements "$IMTX Immatics IMA203 PRAME Cell Therapy Data Presented at [----] ASCO Annual Meeting Continues to Show Strong Anti-tumor Activity and Durability in Patients with Metastatic Melanoma #biotechs https://immatics.gcs-web.com/news-releases/news-release-details/immatics-ima203-prame-cell-therapy-data-presented-2025-asco https://gravityanalytica.com/analyzer/IMTX https://immatics.gcs-web.com/news-releases/news-release-details/immatics-ima203-prame-cell-therapy-data-presented-2025-asco https://gravityanalytica.com/analyzer/IMTX" [X Link](https://x.com/GravAnalytica/status/1928784983868477623) 2025-05-31T12:05Z [--] followers, [---] engagements "$ARVN Phase [--] VERITAC-2 Trial Results Investor Call #biotechs https://arvinas.gcs-web.com/events/event-details/phase-3-veritac-2-trial-results-investor-call https://gravityanalytica.com/analyzer/ARVN https://arvinas.gcs-web.com/events/event-details/phase-3-veritac-2-trial-results-investor-call https://gravityanalytica.com/analyzer/ARVN" [X Link](https://x.com/GravAnalytica/status/1928785013547401265) 2025-05-31T12:05Z [--] followers, [---] engagements "$TARA Protara Therapeutics Announces Appointment of William Conkling as Chief Commercial Officer #biotechs https://protaratx.gcs-web.com/news-releases/news-release-details/protara-therapeutics-announces-appointment-william-conkling https://gravityanalytica.com/analyzer/TARA https://protaratx.gcs-web.com/news-releases/news-release-details/protara-therapeutics-announces-appointment-william-conkling https://gravityanalytica.com/analyzer/TARA" [X Link](https://x.com/GravAnalytica/status/1929689758533345541) 2025-06-03T00:01Z [--] followers, [--] engagements "$TARA Protara Therapeutics Announces Appointment of William Conkling as Chief Commercial Officer #biotechs https://www.globenewswire.com/news-release/2025/06/02/3092322/0/en/Protara-Therapeutics-Announces-Appointment-of-William-Conkling-as-Chief-Commercial-Officer.html https://gravityanalytica.com/analyzer/TARA https://www.globenewswire.com/news-release/2025/06/02/3092322/0/en/Protara-Therapeutics-Announces-Appointment-of-William-Conkling-as-Chief-Commercial-Officer.html https://gravityanalytica.com/analyzer/TARA" [X Link](https://x.com/GravAnalytica/status/1929689764875129058) 2025-06-03T00:01Z [--] followers, [--] engagements "$ENVB Enveric Biosciences Announces Issuance of U.S. Patent Covering a Novel Family of Molecules Including Melatonin Receptor-Targeting Compounds #biotechs https://www.enveric.com/news/enveric-biosciences-announces-issuance-of-u-s-patent-covering-a-novel-family-of-molecules-including-melatonin-receptor-targeting-compounds/ https://gravityanalytica.com/analyzer/ENVB https://www.enveric.com/news/enveric-biosciences-announces-issuance-of-u-s-patent-covering-a-novel-family-of-molecules-including-melatonin-receptor-targeting-compounds/ https://gravityanalytica.com/analyzer/ENVB" [X Link](https://x.com/GravAnalytica/status/1929909913418940880) 2025-06-03T14:35Z [--] followers, [--] engagements "$BCAX Goldman Sachs Global Healthcare Conference #biotechs https://ir.bicara.com/events/event-details/goldman-sachs-global-healthcare-conference https://gravityanalytica.com/analyzer/BCAX https://ir.bicara.com/events/event-details/goldman-sachs-global-healthcare-conference https://gravityanalytica.com/analyzer/BCAX" [X Link](https://x.com/GravAnalytica/status/1930052387613377001) 2025-06-04T00:02Z [--] followers, [--] engagements "$NAUT Proteoforms metastasis and cancer therapy responses Applications of proteomics in cancer #biotechs https://www.nautilus.bio/blog/proteoforms-metastasis-and-cancer-therapy-responses-applications-of-proteomics-in-cancer/ https://gravityanalytica.com/analyzer/NAUT https://www.nautilus.bio/blog/proteoforms-metastasis-and-cancer-therapy-responses-applications-of-proteomics-in-cancer/ https://gravityanalytica.com/analyzer/NAUT" [X Link](https://x.com/GravAnalytica/status/1930649801911066963) 2025-06-05T15:35Z [--] followers, [--] engagements "$ATXS Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Annual Congress #biotechs https://ir.astriatx.com/news-releases/news-release-details/astria-therapeutics-present-upcoming-european-academy-allergy-0 https://gravityanalytica.com/analyzer/ATXS https://ir.astriatx.com/news-releases/news-release-details/astria-therapeutics-present-upcoming-european-academy-allergy-0 https://gravityanalytica.com/analyzer/ATXS" [X Link](https://x.com/GravAnalytica/status/1930959189716644117) 2025-06-06T12:05Z [--] followers, [--] engagements "$NKTX Nkarta Appoints Shawn Rose Chief Medical Officer & Head of R&D as Company Resets Senior Leadership Role for Autoimmune Focus #biotechs https://ir.nkartatx.com/news-releases/news-release-details/nkarta-appoints-shawn-rose-chief-medical-officer-head-rd-company https://gravityanalytica.com/analyzer/NKTX https://ir.nkartatx.com/news-releases/news-release-details/nkarta-appoints-shawn-rose-chief-medical-officer-head-rd-company https://gravityanalytica.com/analyzer/NKTX" [X Link](https://x.com/GravAnalytica/status/1930973243957006436) 2025-06-06T13:01Z [--] followers, [--] engagements "$NKTX Nkarta Appoints Shawn Rose Chief Medical Officer & Head of R&D as Company Resets Senior Leadership Role for Autoimmune Focus #biotechs https://nkartatx.gcs-web.com/news-releases/news-release-details/nkarta-appoints-shawn-rose-chief-medical-officer-head-rd-company https://gravityanalytica.com/analyzer/NKTX https://nkartatx.gcs-web.com/news-releases/news-release-details/nkarta-appoints-shawn-rose-chief-medical-officer-head-rd-company https://gravityanalytica.com/analyzer/NKTX" [X Link](https://x.com/GravAnalytica/status/1930973245940904012) 2025-06-06T13:01Z [--] followers, [--] engagements "$CBUS USDA Designates Cibus Herbicide Tolerance Canola Trait HT2 as Not Regulated Under USDAs Biotechnology Regulations #biotechs https://ir.cibus.com/news-releases/news-release-details/usda-designates-cibus-herbicide-tolerance-canola-trait-ht2-not https://gravityanalytica.com/analyzer/CBUS https://ir.cibus.com/news-releases/news-release-details/usda-designates-cibus-herbicide-tolerance-canola-trait-ht2-not https://gravityanalytica.com/analyzer/CBUS" [X Link](https://x.com/GravAnalytica/status/1930982021746024827) 2025-06-06T13:36Z [--] followers, [--] engagements "$CBUS USDA Designates Cibus Herbicide Tolerance Canola Trait HT2 as Not Regulated Under USDAs Biotechnology Regulations #biotechs https://investor.cibus.com/news-releases/news-release-details/usda-designates-cibus-herbicide-tolerance-canola-trait-ht2-not https://gravityanalytica.com/analyzer/CBUS https://investor.cibus.com/news-releases/news-release-details/usda-designates-cibus-herbicide-tolerance-canola-trait-ht2-not https://gravityanalytica.com/analyzer/CBUS" [X Link](https://x.com/GravAnalytica/status/1930982021834129896) 2025-06-06T13:36Z [--] followers, [--] engagements "$CBUS Cibus Inc. Announces Closing of $27.5 Million Public Offering #biotechs https://ir.cibus.com/news-releases/news-release-details/cibus-inc-announces-closing-275-million-public-offering https://gravityanalytica.com/analyzer/CBUS https://ir.cibus.com/news-releases/news-release-details/cibus-inc-announces-closing-275-million-public-offering https://gravityanalytica.com/analyzer/CBUS" [X Link](https://x.com/GravAnalytica/status/1932236563280257319) 2025-06-10T00:41Z [--] followers, [--] engagements "$CBUS Cibus Inc. Announces Closing of $27.5 Million Public Offering #biotechs https://cibus.gcs-web.com/news-releases/news-release-details/cibus-inc-announces-closing-275-million-public-offering https://gravityanalytica.com/analyzer/CBUS https://cibus.gcs-web.com/news-releases/news-release-details/cibus-inc-announces-closing-275-million-public-offering https://gravityanalytica.com/analyzer/CBUS" [X Link](https://x.com/GravAnalytica/status/1932236563301179414) 2025-06-10T00:41Z [--] followers, [--] engagements "$MTVA MetaVia to Present at the Life Sciences Virtual Investor Forum June 12th #biotechs https://ir.metaviatx.com/news-releases/news-release-details/metavia-present-life-sciences-virtual-investor-forum-june-12th https://gravityanalytica.com/analyzer/MTVA https://ir.metaviatx.com/news-releases/news-release-details/metavia-present-life-sciences-virtual-investor-forum-june-12th https://gravityanalytica.com/analyzer/MTVA" [X Link](https://x.com/GravAnalytica/status/1932426523350380749) 2025-06-10T13:16Z [--] followers, [--] engagements "$CABA Cabaletta Bio Announces Proposed Public Offering of Securities #biotechs https://www.cabalettabio.com/news-media/press-releases/detail/131/cabaletta-bio-announces-proposed-public-offering-of https://gravityanalytica.com/analyzer/CABA https://www.cabalettabio.com/news-media/press-releases/detail/131/cabaletta-bio-announces-proposed-public-offering-of https://gravityanalytica.com/analyzer/CABA" [X Link](https://x.com/GravAnalytica/status/1932745977049252184) 2025-06-11T10:25Z [--] followers, [--] engagements "$CABA Cabaletta Bio Announces Proposed Public Offering of Securities #biotechs https://www.cabalettabio.com/investors/news-events/press-releases/detail/131/cabaletta-bio-announces-proposed-public-offering-of https://gravityanalytica.com/analyzer/CABA https://www.cabalettabio.com/investors/news-events/press-releases/detail/131/cabaletta-bio-announces-proposed-public-offering-of https://gravityanalytica.com/analyzer/CABA" [X Link](https://x.com/GravAnalytica/status/1932745990571725247) 2025-06-11T10:25Z [--] followers, [---] engagements "$FATE Fate Therapeutics Announces Updated Clinical Data for FT819 Off-the-shelf CAR T-cell Product Candidate Demonstrating Durability of Drug-free Remission for Severe Lupus Nephritis at EULAR [----] Congress #biotechs https://ir.fatetherapeutics.com/news-releases/news-release-details/fate-therapeutics-announces-updated-clinical-data-ft819-shelf https://gravityanalytica.com/analyzer/FATE https://ir.fatetherapeutics.com/news-releases/news-release-details/fate-therapeutics-announces-updated-clinical-data-ft819-shelf https://gravityanalytica.com/analyzer/FATE" [X Link](https://x.com/GravAnalytica/status/1932785860820308367) 2025-06-11T13:03Z [--] followers, [---] engagements "$CABA Cabaletta Bio Announces Pricing of Public Offering of Securities #biotechs https://www.cabalettabio.com/news-media/press-releases/detail/132/cabaletta-bio-announces-pricing-of-public-offering-of https://gravityanalytica.com/analyzer/CABA https://www.cabalettabio.com/news-media/press-releases/detail/132/cabaletta-bio-announces-pricing-of-public-offering-of https://gravityanalytica.com/analyzer/CABA" [X Link](https://x.com/GravAnalytica/status/1932801456416985301) 2025-06-11T14:05Z [--] followers, [---] engagements "$CABA Cabaletta Bio Announces Pricing of Public Offering of Securities #biotechs https://www.cabalettabio.com/investors/news-events/press-releases/detail/132/cabaletta-bio-announces-pricing-of-public-offering-of https://gravityanalytica.com/analyzer/CABA https://www.cabalettabio.com/investors/news-events/press-releases/detail/132/cabaletta-bio-announces-pricing-of-public-offering-of https://gravityanalytica.com/analyzer/CABA" [X Link](https://x.com/GravAnalytica/status/1932801469423452669) 2025-06-11T14:05Z [--] followers, [---] engagements "$FATE Treatment of Refractory SLE with Off-the-Shelf iPSC-derived Anti-CD19 CAR T-cell Therapy #biotechs https://www.fatetherapeutics.com/treatment-of-refractory-sle-with-off-the-shelf-ipsc-derived-anti-cd19-car-t-cell-therapy/ https://gravityanalytica.com/analyzer/FATE https://www.fatetherapeutics.com/treatment-of-refractory-sle-with-off-the-shelf-ipsc-derived-anti-cd19-car-t-cell-therapy/ https://gravityanalytica.com/analyzer/FATE" [X Link](https://x.com/GravAnalytica/status/1932841727506718790) 2025-06-11T16:45Z [--] followers, [--] engagements "$ENTA Enanta Pharmaceuticals Partner AbbVie Receives U.S. FDA Approval of an Expanded Indication for MAVYRET (glecaprevir/pibrentasvir) as the First and Only Treatment for People with Acute Hepatitis C Virus #biotechs https://enanta.gcs-web.com/news-releases/news-release-details/enanta-pharmaceuticals-partner-abbvie-receives-us-fda-approval https://gravityanalytica.com/analyzer/ENTA https://enanta.gcs-web.com/news-releases/news-release-details/enanta-pharmaceuticals-partner-abbvie-receives-us-fda-approval https://gravityanalytica.com/analyzer/ENTA" [X Link](https://x.com/GravAnalytica/status/1932841757940568232) 2025-06-11T16:46Z [--] followers, [--] engagements "$CALC CalciMedica Announces Upcoming Symposium at the 43rd Vicenza Course AKI-CRRT-EBPT and Critical Care Nephrology Meeting #biotechs https://calcimedica.gcs-web.com/news-releases/news-release-details/calcimedica-announces-upcoming-symposium-43rd-vicenza-course-aki https://gravityanalytica.com/analyzer/CALC https://calcimedica.gcs-web.com/news-releases/news-release-details/calcimedica-announces-upcoming-symposium-43rd-vicenza-course-aki https://gravityanalytica.com/analyzer/CALC" [X Link](https://x.com/GravAnalytica/status/1933119841956712911) 2025-06-12T11:11Z [--] followers, [--] engagements "$CBUS Cibus and John Innes Centre Announce Ongoing Collaboration with Potential to Revolutionize Fertilizer Use in Farming #biotechs https://investor.cibus.com/news-releases/news-release-details/cibus-and-john-innes-centre-announce-ongoing-collaboration https://gravityanalytica.com/analyzer/CBUS https://investor.cibus.com/news-releases/news-release-details/cibus-and-john-innes-centre-announce-ongoing-collaboration https://gravityanalytica.com/analyzer/CBUS" [X Link](https://x.com/GravAnalytica/status/1933134937927901319) 2025-06-12T12:10Z [--] followers, [--] engagements "$NAUT Life at Nautilus interview with Lisen Wang Senior Staff Engineer #biotechs https://www.nautilus.bio/blog/life-at-nautilus-interview-with-lisen-wang-senior-staff-engineer/ https://gravityanalytica.com/analyzer/NAUT https://www.nautilus.bio/blog/life-at-nautilus-interview-with-lisen-wang-senior-staff-engineer/ https://gravityanalytica.com/analyzer/NAUT" [X Link](https://x.com/GravAnalytica/status/1933201602967408805) 2025-06-12T16:35Z [--] followers, [--] engagements "$MOLN Bill Maughan PhD #biotechs https://investors.molecularpartners.com/analyst/bill-maughan-phd https://gravityanalytica.com/analyzer/MOLN https://investors.molecularpartners.com/analyst/bill-maughan-phd https://gravityanalytica.com/analyzer/MOLN" [X Link](https://x.com/GravAnalytica/status/1934610619476443483) 2025-06-16T13:54Z [--] followers, [--] engagements "$MOLN Bill Maughan PhD #biotechs https://molecularpartners.gcs-web.com/analyst/bill-maughan-phd https://gravityanalytica.com/analyzer/MOLN https://molecularpartners.gcs-web.com/analyst/bill-maughan-phd https://gravityanalytica.com/analyzer/MOLN" [X Link](https://x.com/GravAnalytica/status/1934610631266537941) 2025-06-16T13:54Z [--] followers, [--] engagements "$BRTX BioRestorative Announces Share Repurchase Program #biotechs https://www.globenewswire.com/news-release/2025/06/17/3100770/0/en/BioRestorative-Announces-Share-Repurchase-Program.html https://gravityanalytica.com/analyzer/BRTX https://www.globenewswire.com/news-release/2025/06/17/3100770/0/en/BioRestorative-Announces-Share-Repurchase-Program.html https://gravityanalytica.com/analyzer/BRTX" [X Link](https://x.com/GravAnalytica/status/1934968152141549583) 2025-06-17T13:35Z [--] followers, [--] engagements "$ATXS Astria Therapeutics to Participate in Upcoming Oppenheimer Innovators in Immunology & Inflammation Summit #biotechs https://ir.astriatx.com/news-releases/news-release-details/astria-therapeutics-participate-upcoming-oppenheimer-innovators https://gravityanalytica.com/analyzer/ATXS https://ir.astriatx.com/news-releases/news-release-details/astria-therapeutics-participate-upcoming-oppenheimer-innovators https://gravityanalytica.com/analyzer/ATXS" [X Link](https://x.com/GravAnalytica/status/1935310490491637819) 2025-06-18T12:15Z [--] followers, [--] engagements "$ABOS Geoff Meacham #biotechs https://investors.acumenpharm.com/analyst/geoff-meacham https://gravityanalytica.com/analyzer/ABOS https://investors.acumenpharm.com/analyst/geoff-meacham https://gravityanalytica.com/analyzer/ABOS" [X Link](https://x.com/GravAnalytica/status/1935340700523983320) 2025-06-18T14:15Z [--] followers, [--] engagements "$QNCX Quince Therapeutics Announces Closing of Up to $22 Million Private Placement of Securities #biotechs https://ir.quincetx.com/news-releases/news-release-details/quince-therapeutics-announces-closing-22-million-private https://gravityanalytica.com/analyzer/QNCX https://ir.quincetx.com/news-releases/news-release-details/quince-therapeutics-announces-closing-22-million-private https://gravityanalytica.com/analyzer/QNCX" [X Link](https://x.com/GravAnalytica/status/1935446362662859121) 2025-06-18T21:15Z [--] followers, [--] engagements "$ANNX Annexon Bolsters Ophthalmology Expertise with Appointment of Retina Specialist Lloyd Clark M.D. as Pivotal ANX007 Program Advances in Dry Age-Related Macular Degeneration (AMD) with Geographic Atrophy (GA) #biotechs https://ir.annexonbio.com/news-releases/news-release-details/annexon-bolsters-ophthalmology-expertise-appointment-retina https://gravityanalytica.com/analyzer/ANNX https://ir.annexonbio.com/news-releases/news-release-details/annexon-bolsters-ophthalmology-expertise-appointment-retina https://gravityanalytica.com/analyzer/ANNX" [X Link](https://x.com/GravAnalytica/status/1935448928788308473) 2025-06-18T21:25Z [--] followers, [---] engagements "$WHWK Whitehawk Therapeutics to Participate in H.C. Wainwright "HCW@Home" Series #biotechs https://ir.whitehawktx.com/news-releases/news-release-details/whitehawk-therapeutics-participate-hc-wainwright-hcwhome-series https://gravityanalytica.com/analyzer/WHWK https://ir.whitehawktx.com/news-releases/news-release-details/whitehawk-therapeutics-participate-hc-wainwright-hcwhome-series https://gravityanalytica.com/analyzer/WHWK" [X Link](https://x.com/GravAnalytica/status/1935672231113162791) 2025-06-19T12:13Z [--] followers, [--] engagements "$WHWK H.C. Wainwright HCW@Home Fireside Chat #biotechs https://ir.whitehawktx.com/events/event-details/hc-wainwright-hcwhome-fireside-chat https://gravityanalytica.com/analyzer/WHWK https://ir.whitehawktx.com/events/event-details/hc-wainwright-hcwhome-fireside-chat https://gravityanalytica.com/analyzer/WHWK" [X Link](https://x.com/GravAnalytica/status/1935672897869144216) 2025-06-19T12:15Z [--] followers, [--] engagements "$NAUT Biomarkers Are Changing Everything A New Era in Alzheimers Research #biotechs https://www.nautilus.bio/blog/biomarkers-are-changing-everything-a-new-era-in-alzheimers-research/ https://gravityanalytica.com/analyzer/NAUT https://www.nautilus.bio/blog/biomarkers-are-changing-everything-a-new-era-in-alzheimers-research/ https://gravityanalytica.com/analyzer/NAUT" [X Link](https://x.com/GravAnalytica/status/1935720610245578892) 2025-06-19T15:25Z [--] followers, [--] engagements "$PRTA The Longest Day: A Commitment Beyond Diagnosis #biotechs https://www.prothena.com/the-longest-day-a-commitment-beyond-diagnosis/ https://gravityanalytica.com/analyzer/PRTA https://www.prothena.com/the-longest-day-a-commitment-beyond-diagnosis/ https://gravityanalytica.com/analyzer/PRTA" [X Link](https://x.com/GravAnalytica/status/1936065420798161354) 2025-06-20T14:15Z [--] followers, [---] engagements "$LRMR Larimar Therapeutics Announces Regulatory Update Call on the Nomlabofusp Program for the Treatment of Friedreichs Ataxia #biotechs https://www.globenewswire.com/news-release/2025/06/20/3102923/0/en/Larimar-Therapeutics-Announces-Regulatory-Update-Call-on-the-Nomlabofusp-Program-for-the-Treatment-of-Friedreich-s-Ataxia.html https://gravityanalytica.com/analyzer/LRMR https://www.globenewswire.com/news-release/2025/06/20/3102923/0/en/Larimar-Therapeutics-Announces-Regulatory-Update-Call-on-the-Nomlabofusp-Program-for-the-Treatment-of-Friedreich-s-Ataxia.html" [X Link](https://x.com/GravAnalytica/status/1936213859645239539) 2025-06-21T00:05Z [--] followers, [---] engagements "$LRMR Larimar Therapeutics June [--] [----] Regulatory Update #biotechs https://investors.larimartx.com/events/event-details/larimar-therapeutics-june-23-2025-regulatory-update https://gravityanalytica.com/analyzer/LRMR https://investors.larimartx.com/events/event-details/larimar-therapeutics-june-23-2025-regulatory-update https://gravityanalytica.com/analyzer/LRMR" [X Link](https://x.com/GravAnalytica/status/1936213920701669870) 2025-06-21T00:05Z [--] followers, [---] engagements "$LRMR Larimar Therapeutics Announces Regulatory Update Call on the Nomlabofusp Program for the Treatment of Friedreichs Ataxia #biotechs https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-announces-regulatory-update-call https://gravityanalytica.com/analyzer/LRMR https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-announces-regulatory-update-call https://gravityanalytica.com/analyzer/LRMR" [X Link](https://x.com/GravAnalytica/status/1936213950334382095) 2025-06-21T00:05Z [--] followers, [---] engagements "$LPCN Lipocine to Host Virtual R&D Investor Event to Discuss LPCN [----] (BRLIZIO) as a Treatment for Postpartum Depression on July [--] [----] #biotechs https://ir.lipocine.com/2025-06-23-Lipocine-to-Host-Virtual-R-D-Investor-Event-to-Discuss-LPCN-1154-BRLIZIO-TM-as-a-Treatment-for-Postpartum-Depression-on-July-9-2025 https://gravityanalytica.com/analyzer/LPCN https://ir.lipocine.com/2025-06-23-Lipocine-to-Host-Virtual-R-D-Investor-Event-to-Discuss-LPCN-1154-BRLIZIO-TM-as-a-Treatment-for-Postpartum-Depression-on-July-9-2025 https://gravityanalytica.com/analyzer/LPCN" [X Link](https://x.com/GravAnalytica/status/1937119893528121797) 2025-06-23T12:05Z [--] followers, [--] engagements "$MBX Steven Hoerter #biotechs https://investors.mbxbio.com/board-member/steven-hoerter https://gravityanalytica.com/analyzer/MBX https://investors.mbxbio.com/board-member/steven-hoerter https://gravityanalytica.com/analyzer/MBX" [X Link](https://x.com/GravAnalytica/status/1937195402282897438) 2025-06-23T17:05Z [--] followers, [--] engagements "$MBX Steven Hoerter #biotechs https://mbxbio.gcs-web.com/board-member/steven-hoerter https://gravityanalytica.com/analyzer/MBX https://mbxbio.gcs-web.com/board-member/steven-hoerter https://gravityanalytica.com/analyzer/MBX" [X Link](https://x.com/GravAnalytica/status/1937195402500903109) 2025-06-23T17:05Z [--] followers, [--] engagements "$NKTR Nektar to Announce Top-line Data from the 16-Week Induction Period in REZOLVE-AD Phase 2b Study of Rezpegaldesleukin a Regulatory T-cell Proliferator in Atopic Dermatitis on June [--] [----] #biotechs https://nektar.gcs-web.com/news-releases/news-release-details/nektar-announce-top-line-data-16-week-induction-period-rezolve https://gravityanalytica.com/analyzer/NKTR https://nektar.gcs-web.com/news-releases/news-release-details/nektar-announce-top-line-data-16-week-induction-period-rezolve https://gravityanalytica.com/analyzer/NKTR" [X Link](https://x.com/GravAnalytica/status/1937300607951372642) 2025-06-24T00:03Z [--] followers, [---] engagements "$CBUS The U.S. Food and Drug Administration Completes Review of Cibus Altered Lignin Alfalfa Developed in Partnership with S&W Seed Company for use in Livestock Feed #biotechs https://cibus.gcs-web.com/news-releases/news-release-details/us-food-and-drug-administration-completes-review-cibus-altered https://gravityanalytica.com/analyzer/CBUS https://cibus.gcs-web.com/news-releases/news-release-details/us-food-and-drug-administration-completes-review-cibus-altered https://gravityanalytica.com/analyzer/CBUS" [X Link](https://x.com/GravAnalytica/status/1937468565096927419) 2025-06-24T11:11Z [--] followers, [--] engagements "$SEPN Raghuram Selvaraju Ph.D. #biotechs https://septerna.gcs-web.com/analyst/raghuram-selvaraju-phd https://gravityanalytica.com/analyzer/SEPN https://septerna.gcs-web.com/analyst/raghuram-selvaraju-phd https://gravityanalytica.com/analyzer/SEPN" [X Link](https://x.com/GravAnalytica/status/1937522514441183687) 2025-06-24T14:45Z [--] followers, [--] engagements "$CALC CalciMedica Announces Publication in the American Journal of Nephrology Discussing Design and Rationale of Phase [--] KOURAGE Trial of Auxora in AKI with Respiratory Failure #biotechs https://ir.calcimedica.com/news-releases/news-release-details/calcimedica-announces-publication-american-journal-nephrology https://gravityanalytica.com/analyzer/CALC https://ir.calcimedica.com/news-releases/news-release-details/calcimedica-announces-publication-american-journal-nephrology https://gravityanalytica.com/analyzer/CALC" [X Link](https://x.com/GravAnalytica/status/1937828642983116829) 2025-06-25T11:02Z [--] followers, [--] engagements "$NAUT Life at Nautilus interview with Juanfeng Sun #biotechs https://www.nautilus.bio/blog/life-at-nautilus-interview-with-juanfeng-sun/ https://gravityanalytica.com/analyzer/NAUT https://www.nautilus.bio/blog/life-at-nautilus-interview-with-juanfeng-sun/ https://gravityanalytica.com/analyzer/NAUT" [X Link](https://x.com/GravAnalytica/status/1938264947521101939) 2025-06-26T15:55Z [--] followers, [--] engagements "$HSDT Helius Medical Technologies Announces Reverse Stock Split #biotechs https://www.globenewswire.com/news-release/2025/06/27/3106547/0/en/Helius-Medical-Technologies-Announces-Reverse-Stock-Split.html https://gravityanalytica.com/analyzer/HSDT https://www.globenewswire.com/news-release/2025/06/27/3106547/0/en/Helius-Medical-Technologies-Announces-Reverse-Stock-Split.html https://gravityanalytica.com/analyzer/HSDT" [X Link](https://x.com/GravAnalytica/status/1938579195480723780) 2025-06-27T12:44Z [--] followers, [--] engagements "$ACHV Achieve Life Sciences Announces Pricing of $45.0 Million Underwritten Public Offering #biotechs https://achievelifesciences.com/achieve-announces-pricing-of-45-million-underwritten-public-offering/ https://gravityanalytica.com/analyzer/ACHV https://achievelifesciences.com/achieve-announces-pricing-of-45-million-underwritten-public-offering/ https://gravityanalytica.com/analyzer/ACHV" [X Link](https://x.com/GravAnalytica/status/1938919713402187883) 2025-06-28T11:17Z [--] followers, [--] engagements "$CHRO Channel Therapeutics Announces Reverse Common Stock Split in Conjunction with the Close of the Merger with Pelthos Therapeutics and Concurrent $50.1 Million Private Placement #biotechs https://ir.chromocell.com/news-events/press-releases/detail/35/channel-therapeutics-announces-reverse-common-stock-split https://gravityanalytica.com/analyzer/CHRO https://ir.chromocell.com/news-events/press-releases/detail/35/channel-therapeutics-announces-reverse-common-stock-split https://gravityanalytica.com/analyzer/CHRO" [X Link](https://x.com/GravAnalytica/status/1938937977465426381) 2025-06-28T12:30Z [--] followers, [--] engagements "$EVAX October [--] [----] - October [--] [----] : The World Vaccine Congress Europe [----] #biotechs https://investors.evaxion.ai/events/event-details/world-vaccine-congress-europe-2025 https://gravityanalytica.com/analyzer/EVAX https://investors.evaxion.ai/events/event-details/world-vaccine-congress-europe-2025 https://gravityanalytica.com/analyzer/EVAX" [X Link](https://x.com/GravAnalytica/status/1939590953683095923) 2025-06-30T07:44Z [--] followers, [--] engagements "$EVAX [----] BIG9 Conference #biotechs https://investors.evaxion.ai/events/event-details/2025-big9-conference https://gravityanalytica.com/analyzer/EVAX https://investors.evaxion.ai/events/event-details/2025-big9-conference https://gravityanalytica.com/analyzer/EVAX" [X Link](https://x.com/GravAnalytica/status/1939591278976446933) 2025-06-30T07:46Z [--] followers, [--] engagements "$EVAX November [--] [----] - November [--] [----] : Vaccines R&D [----] #biotechs https://investors.evaxion.ai/events/event-details/vaccines-rd-2025 https://gravityanalytica.com/analyzer/EVAX https://investors.evaxion.ai/events/event-details/vaccines-rd-2025 https://gravityanalytica.com/analyzer/EVAX" [X Link](https://x.com/GravAnalytica/status/1939591333926019402) 2025-06-30T07:46Z [--] followers, [--] engagements "$RCKT Rocket Pharmaceuticals Announces FDA IND Clearance of RP-A701 for the Treatment of BAG3-associated Dilated Cardiomyopathy #biotechs https://ir.rocketpharma.com/news-releases/news-release-details/rocket-pharmaceuticals-announces-fda-ind-clearance-rp-a701 https://gravityanalytica.com/analyzer/RCKT https://ir.rocketpharma.com/news-releases/news-release-details/rocket-pharmaceuticals-announces-fda-ind-clearance-rp-a701 https://gravityanalytica.com/analyzer/RCKT" [X Link](https://x.com/GravAnalytica/status/1939641602101678231) 2025-06-30T11:06Z [--] followers, [--] engagements "$SAVA Cassava Presents Promising Preclinical Simufilam Data at TSC Alliance Meeting #biotechs https://www.cassavasciences.com/news-releases/news-release-details/cassava-presents-promising-preclinical-simufilam-data-tsc https://gravityanalytica.com/analyzer/SAVA https://www.cassavasciences.com/news-releases/news-release-details/cassava-presents-promising-preclinical-simufilam-data-tsc https://gravityanalytica.com/analyzer/SAVA" [X Link](https://x.com/GravAnalytica/status/1939642964738744499) 2025-06-30T11:11Z [--] followers, [--] engagements "$CMMB Chemomab Announces Oral Presentation of Positive Nebokitug Phase [--] Clinical Data in Primary Sclerosing Cholangitis at BSG Live25 #biotechs https://investors.chemomab.com/2025-06-30-Chemomab-Announces-Oral-Presentation-of-Positive-Nebokitug-Phase-2-Clinical-Data-in-Primary-Sclerosing-Cholangitis-at-BSG-Live25 https://gravityanalytica.com/analyzer/CMMB https://investors.chemomab.com/2025-06-30-Chemomab-Announces-Oral-Presentation-of-Positive-Nebokitug-Phase-2-Clinical-Data-in-Primary-Sclerosing-Cholangitis-at-BSG-Live25 https://gravityanalytica.com/analyzer/CMMB" [X Link](https://x.com/GravAnalytica/status/1939655522015236453) 2025-06-30T12:01Z [--] followers, [--] engagements "$TPST Tempest Receives Clearance to Proceed with Pivotal Trial of Amezalpat Combination Therapy for First-Line HCC in China #biotechs https://ir.tempesttx.com/news-releases/news-release-details/tempest-receives-clearance-proceed-pivotal-trial-amezalpat https://gravityanalytica.com/analyzer/TPST https://ir.tempesttx.com/news-releases/news-release-details/tempest-receives-clearance-proceed-pivotal-trial-amezalpat https://gravityanalytica.com/analyzer/TPST" [X Link](https://x.com/GravAnalytica/status/1939655548749652094) 2025-06-30T12:01Z [--] followers, [--] engagements "$TARA Protara Therapeutics Announces Addition to the Russell [----] Index #biotechs https://ir.protaratx.com/news-releases/news-release-details/protara-therapeutics-announces-addition-russell-3000r-index https://gravityanalytica.com/analyzer/TARA https://ir.protaratx.com/news-releases/news-release-details/protara-therapeutics-announces-addition-russell-3000r-index https://gravityanalytica.com/analyzer/TARA" [X Link](https://x.com/GravAnalytica/status/1939655577577107938) 2025-06-30T12:01Z [--] followers, [--] engagements Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
@GravAnalytica Gravity Analytica News
Gravity Analytica News posts on X about nasdaq, business, investment, $bntc the most. They currently have [--] followers and [----] posts still getting attention that total [---] engagements in the last [--] hours.
Engagements: [---] #
- [--] Week [-----] +55%
- [--] Month [-----] +13%
- [--] Months [------] +75%
- [--] Year [------] +4,655%
Mentions: [--] #
- [--] Month [--] -56%
- [--] Months [---] +33%
- [--] Year [-----] +2,622%
Followers: [--] #
- [--] Week [--] no change
- [--] Month [--] +3.70%
- [--] Months [--] +93%
- [--] Year [--] +460%
CreatorRank: [---------] #
Social Influence
Social category influence stocks finance exchanges cryptocurrencies countries technology brands financial services travel destinations currencies
Social topic influence nasdaq #1413, business, investment, $bntc #6, $arvn, $kura, announces, gravity, $naut, $algs
Top accounts mentioned or mentioned by @home
Top assets mentioned Arvinas, Inc (ARVN) Gravity (G) Aligos Therapeutics, Inc. (ALGS) Evaxion Biotech A/S (EVAX) Taraxa (TARA) Werewolf Therapeutics, Inc. (HOWL) Xilio Therapeutics, Inc. (XLO) Nyxoah SA (NYXH) Context Therapeutics Inc. (CNTX) Molecular Partners AG (MOLN) Morgan Stanley (MS) ALX Oncology Holdings Inc (ALXO) Bicara Therapeutics Inc. (BCAX) Virax Biolabs Group Limited (VRAX) Entrada Therapeutics, Inc. (TRDA) Foghorn Therapeutics Inc. (FHTX) 4D Molecular Therapeutics Inc. (FDMT) Kyverna Therapeutics, Inc. (KYTX) BioAge Labs, Inc. (BIOA) RenovoRx, Inc. (RNXT) Sage Therapeutics, Inc (SAGE) Marblex (MBX) Liquity BOLD (BOLD) Connect Biopharma Holdings Limited (CNTB) Keros Therapeutics, Inc. (KROS) Sensei Biotherapeutics, Inc. (SNSE) Maravai LifeSciences Holdings, Inc. (MRVI) Pyxis Oncology, Inc. (PYXS) Goldman Sachs (GS) Nurix Therapeutics, Inc. (NRIX) Contineum Therapeutics, Inc (CTNM) UBIX Network (UBX) NEO (NEO) Zenas BioPharma, Inc. (ZBIO) Treace Medical Concepts, Inc. (TMCI) TScan Therapeutics, Inc. (TCRX) Vigil Neuroscience, Inc. (VIGL) Zentalis Pharmaceuticals, LLC (ZNTL) Inhibikase Therapeutics, Inc. (IKT) IO Biotech, Inc. (IOBT)
Top Social Posts
Top posts by engagements in the last [--] hours
"$CRIS Grzegorz Nowakowski MD #biotechs https://www.curis.com/grzegorz-nowakowski-md/ https://gravityanalytica.com/analyzer/CRIS https://www.curis.com/grzegorz-nowakowski-md/ https://gravityanalytica.com/analyzer/CRIS"
X Link 2025-01-11T23:02Z [--] followers, [--] engagements
"$CRIS Christian Grommes MD #biotechs https://www.curis.com/christian-grommes-md/ https://gravityanalytica.com/analyzer/CRIS https://www.curis.com/christian-grommes-md/ https://gravityanalytica.com/analyzer/CRIS"
X Link 2025-01-11T23:02Z [--] followers, [--] engagements
"$CRIS Lakshmi Nayak MD #biotechs https://www.curis.com/lakshmi-nayak-md/ https://gravityanalytica.com/analyzer/CRIS https://www.curis.com/lakshmi-nayak-md/ https://gravityanalytica.com/analyzer/CRIS"
X Link 2025-01-11T23:02Z [--] followers, [--] engagements
"$CRIS Andrs Jos Mara Ferreri MD #biotechs https://www.curis.com/andres-jose-maria-ferreri-md/ https://gravityanalytica.com/analyzer/CRIS https://www.curis.com/andres-jose-maria-ferreri-md/ https://gravityanalytica.com/analyzer/CRIS"
X Link 2025-01-11T23:02Z [--] followers, [--] engagements
"$ALVR Report of proposed sale of securities #biotechs https://www.sec.gov/Archives/edgar/data/1754068/000095017025004443/0000950170-25-004443-index.htm https://gravityanalytica.com/analyzer/ALVR https://www.sec.gov/Archives/edgar/data/1754068/000095017025004443/0000950170-25-004443-index.htm https://gravityanalytica.com/analyzer/ALVR"
X Link 2025-01-11T23:02Z [--] followers, [--] engagements
"$ALVR Prospectuses and communications business combinations #biotechs https://www.sec.gov/Archives/edgar/data/1754068/000119312525004529/0001193125-25-004529-index.htm https://gravityanalytica.com/analyzer/ALVR https://www.sec.gov/Archives/edgar/data/1754068/000119312525004529/0001193125-25-004529-index.htm https://gravityanalytica.com/analyzer/ALVR"
X Link 2025-01-11T23:02Z [--] followers, [--] engagements
"$FULC Sickle Cell Disease (HbF Induction) P1 START #biotechs https://www.sec.gov/Archives/edgar/data/1680581/000119312525004942/d714885dex991.htm https://gravityanalytica.com/analyzer/FULC https://www.sec.gov/Archives/edgar/data/1680581/000119312525004942/d714885dex991.htm https://gravityanalytica.com/analyzer/FULC"
X Link 2025-01-14T23:02Z [--] followers, [--] engagements
"$ALVR Prospectuses and communications business combinations #biotechs https://www.sec.gov/Archives/edgar/data/1754068/000119312525007084/0001193125-25-007084-index.htm https://gravityanalytica.com/analyzer/ALVR https://www.sec.gov/Archives/edgar/data/1754068/000119312525007084/0001193125-25-007084-index.htm https://gravityanalytica.com/analyzer/ALVR"
X Link 2025-01-16T23:02Z [--] followers, [--] engagements
"$SEER Sintilimab in Combination with Cetuximab and Chemotherapy As First-line Treatment for RAS/BRAF Wild-type Advanced Colorectal Cancer #biotechs https://ClinicalTrials.gov/show/NCT06776757 https://gravityanalytica.com/analyzer/SEER https://ClinicalTrials.gov/show/NCT06776757 https://gravityanalytica.com/analyzer/SEER"
X Link 2025-01-16T23:02Z [--] followers, [--] engagements
"$SAGE Statement of Beneficial Ownership by Certain Investors #biotechs https://www.sec.gov/Archives/edgar/data/1597553/000095017025006473/0000950170-25-006473-index.htm https://gravityanalytica.com/analyzer/SAGE https://www.sec.gov/Archives/edgar/data/1597553/000095017025006473/0000950170-25-006473-index.htm https://gravityanalytica.com/analyzer/SAGE"
X Link 2025-01-18T23:02Z [--] followers, [--] engagements
"$ALVR Registration of securities business combinations #biotechs https://www.sec.gov/Archives/edgar/data/1754068/000119312525008421/0001193125-25-008421-index.htm https://gravityanalytica.com/analyzer/ALVR https://www.sec.gov/Archives/edgar/data/1754068/000119312525008421/0001193125-25-008421-index.htm https://gravityanalytica.com/analyzer/ALVR"
X Link 2025-01-18T23:02Z [--] followers, [--] engagements
"$ZVSA Special Meeting of Stockholders (Virtual) #biotechs https://zyversa.gcs-web.com/events/event-details/special-meeting-stockholders-virtual-0 https://gravityanalytica.com/analyzer/ZVSA https://zyversa.gcs-web.com/events/event-details/special-meeting-stockholders-virtual-0 https://gravityanalytica.com/analyzer/ZVSA"
X Link 2025-01-20T23:02Z [--] followers, [--] engagements
"$SAGE Sage and Tractics Announce Partnership to Deliver a Powerhouse Cloud Solution for Heavy Civil Contractors #biotechs https://www.globenewswire.com/news-release/2025/01/21/3012885/0/en/Sage-and-Tractics-Announce-Partnership-to-Deliver-a-Powerhouse-Cloud-Solution-for-Heavy-Civil-Contractors.html https://gravityanalytica.com/analyzer/SAGE https://www.globenewswire.com/news-release/2025/01/21/3012885/0/en/Sage-and-Tractics-Announce-Partnership-to-Deliver-a-Powerhouse-Cloud-Solution-for-Heavy-Civil-Contractors.html https://gravityanalytica.com/analyzer/SAGE"
X Link 2025-01-21T23:02Z [--] followers, [--] engagements
"$RLYB Safety Tolerability Pharmacokinetics and Pharmacodynamics Study of RLYB116 in Healthy Participants #biotechs https://ClinicalTrials.gov/show/NCT06797375 https://gravityanalytica.com/analyzer/RLYB https://ClinicalTrials.gov/show/NCT06797375 https://gravityanalytica.com/analyzer/RLYB"
X Link 2025-01-29T23:02Z [--] followers, [--] engagements
"$STSS Sharps Technology Inc. Announces Pricing of Upsized $20.0 Million Underwritten Public Offering #biotechs https://ir.sharpstechnology.com/sharps-technology-inc-announces-pricing-of-upsized-20-0-million-underwritten-public-offering/ https://gravityanalytica.com/analyzer/STSS https://ir.sharpstechnology.com/sharps-technology-inc-announces-pricing-of-upsized-20-0-million-underwritten-public-offering/ https://gravityanalytica.com/analyzer/STSS"
X Link 2025-01-29T23:02Z [--] followers, [---] engagements
"$STSS Sharps Technology Inc. Announces Closing of Upsized $20.0 Million Underwritten Public Offering #biotechs https://ir.sharpstechnology.com/sharps-technology-inc-announces-closing-of-upsized-20-0-million-underwritten-public-offering/ https://gravityanalytica.com/analyzer/STSS https://ir.sharpstechnology.com/sharps-technology-inc-announces-closing-of-upsized-20-0-million-underwritten-public-offering/ https://gravityanalytica.com/analyzer/STSS"
X Link 2025-01-29T23:02Z [--] followers, [---] engagements
"$MIST Statement of changes in beneficial ownership of securities #biotechs https://www.sec.gov/Archives/edgar/data/1408443/000141588925002269/0001415889-25-002269-index.htm https://gravityanalytica.com/analyzer/MIST https://www.sec.gov/Archives/edgar/data/1408443/000141588925002269/0001415889-25-002269-index.htm https://gravityanalytica.com/analyzer/MIST"
X Link 2025-01-30T23:02Z [--] followers, [--] engagements
"$EVAX Evaxion announces closing of $10.8 million public offering #biotechs https://investors.evaxion.ai/news-releases/news-release-details/evaxion-announces-closing-108-million-public-offering https://gravityanalytica.com/analyzer/EVAX https://investors.evaxion.ai/news-releases/news-release-details/evaxion-announces-closing-108-million-public-offering https://gravityanalytica.com/analyzer/EVAX"
X Link 2025-01-31T23:02Z [--] followers, [--] engagements
"$EVAX Evaxion announces pricing of $10.8 million public offering #biotechs https://investors.evaxion.ai/news-releases/news-release-details/evaxion-announces-pricing-108-million-public-offering https://gravityanalytica.com/analyzer/EVAX https://investors.evaxion.ai/news-releases/news-release-details/evaxion-announces-pricing-108-million-public-offering https://gravityanalytica.com/analyzer/EVAX"
X Link 2025-01-31T23:02Z [--] followers, [--] engagements
"$SRZN Matthew Caufield #biotechs https://surrozen.gcs-web.com/analyst/matthew-caufield https://gravityanalytica.com/analyzer/SRZN https://surrozen.gcs-web.com/analyst/matthew-caufield https://gravityanalytica.com/analyzer/SRZN"
X Link 2025-02-01T23:02Z [--] followers, [--] engagements
"$DNA Report of proposed sale of securities #biotechs https://www.sec.gov/Archives/edgar/data/1830214/000195917325000560/0001959173-25-000560-index.htm https://gravityanalytica.com/analyzer/DNA https://www.sec.gov/Archives/edgar/data/1830214/000195917325000560/0001959173-25-000560-index.htm https://gravityanalytica.com/analyzer/DNA"
X Link 2025-02-01T23:02Z [--] followers, [--] engagements
"$NURO Preliminary proxy statements relating to merger or acquisition #biotechs https://www.sec.gov/Archives/edgar/data/1289850/000149315225004287/0001493152-25-004287-index.htm https://gravityanalytica.com/analyzer/NURO https://www.sec.gov/Archives/edgar/data/1289850/000149315225004287/0001493152-25-004287-index.htm https://gravityanalytica.com/analyzer/NURO"
X Link 2025-02-01T23:02Z [--] followers, [--] engagements
"$AADI Definitive proxy statement relating to merger or acquisition #biotechs https://www.sec.gov/Archives/edgar/data/1422142/000119312525018470/0001193125-25-018470-index.htm https://gravityanalytica.com/analyzer/AADI https://www.sec.gov/Archives/edgar/data/1422142/000119312525018470/0001193125-25-018470-index.htm https://gravityanalytica.com/analyzer/AADI"
X Link 2025-02-01T23:02Z [--] followers, [--] engagements
"$ARVN Arvinas 4Q24 Earnings Call #biotechs https://ir.arvinas.com/events/event-details/arvinas-4q24-earnings-call https://gravityanalytica.com/analyzer/ARVN https://ir.arvinas.com/events/event-details/arvinas-4q24-earnings-call https://gravityanalytica.com/analyzer/ARVN"
X Link 2025-02-03T23:02Z [--] followers, [---] engagements
"$ARVN Arvinas to Report Fourth Quarter and Full Year [----] Financial Results on Tuesday February [--] [----] #biotechs https://ir.arvinas.com/news-releases/news-release-details/arvinas-report-fourth-quarter-and-full-year-2024-financial https://gravityanalytica.com/analyzer/ARVN https://ir.arvinas.com/news-releases/news-release-details/arvinas-report-fourth-quarter-and-full-year-2024-financial https://gravityanalytica.com/analyzer/ARVN"
X Link 2025-02-03T23:02Z [--] followers, [---] engagements
"$ARVN Events and Presentations #biotechs https://arvinas.gcs-web.com/news-releases/news-release-details/arvinas-report-fourth-quarter-and-full-year-2024-financial https://gravityanalytica.com/analyzer/ARVN https://arvinas.gcs-web.com/news-releases/news-release-details/arvinas-report-fourth-quarter-and-full-year-2024-financial https://gravityanalytica.com/analyzer/ARVN"
X Link 2025-02-03T23:02Z [--] followers, [---] engagements
"$IVVD Invivyd Announces Preliminary Fourth Quarter [----] Financial Results Strong Revenue Growth and Reiterates Goal of Near-Term Profitability #biotechs https://adagiotx.gcs-web.com/news-releases/news-release-details/invivyd-announces-preliminary-fourth-quarter-2024-financial https://gravityanalytica.com/analyzer/IVVD https://adagiotx.gcs-web.com/news-releases/news-release-details/invivyd-announces-preliminary-fourth-quarter-2024-financial https://gravityanalytica.com/analyzer/IVVD"
X Link 2025-02-03T23:02Z [--] followers, [--] engagements
"$PMVP TD Cowen 45th Annual Health Care Conference #biotechs https://ir.pmvpharma.com/events/event-details/td-cowen-45th-annual-health-care-conference https://gravityanalytica.com/analyzer/PMVP https://ir.pmvpharma.com/events/event-details/td-cowen-45th-annual-health-care-conference https://gravityanalytica.com/analyzer/PMVP"
X Link 2025-02-04T23:02Z [--] followers, [--] engagements
"$ALVR Registration of securities business combinations #biotechs https://www.sec.gov/Archives/edgar/data/1754068/000119312525019332/0001193125-25-019332-index.htm https://gravityanalytica.com/analyzer/ALVR https://www.sec.gov/Archives/edgar/data/1754068/000119312525019332/0001193125-25-019332-index.htm https://gravityanalytica.com/analyzer/ALVR"
X Link 2025-02-04T23:02Z [--] followers, [--] engagements
"$NXTC Statement of changes in beneficial ownership of securities #biotechs https://www.sec.gov/Archives/edgar/data/1661059/000090514825000337/0000905148-25-000337-index.htm https://gravityanalytica.com/analyzer/NXTC https://www.sec.gov/Archives/edgar/data/1661059/000090514825000337/0000905148-25-000337-index.htm https://gravityanalytica.com/analyzer/NXTC"
X Link 2025-02-04T23:02Z [--] followers, [--] engagements
"$RNAZ TransCode Therapeutics Announces Completion of Cohort [--] Initial Dosing with Lead Candidate in Phase [--] Clinical Trial #biotechs https://ir.transcodetherapeutics.com/news-releases/news-release-details/transcode-therapeutics-announces-completion-cohort-3-initial https://gravityanalytica.com/analyzer/RNAZ https://ir.transcodetherapeutics.com/news-releases/news-release-details/transcode-therapeutics-announces-completion-cohort-3-initial https://gravityanalytica.com/analyzer/RNAZ"
X Link 2025-02-06T23:02Z [--] followers, [--] engagements
"$RNAZ TransCode Therapeutics Inc. Announces Adjournment of Special Meeting and Information for Adjourned Special Meeting #biotechs https://ir.transcodetherapeutics.com/news-releases/news-release-details/transcode-therapeutics-inc-announces-adjournment-special-meeting https://gravityanalytica.com/analyzer/RNAZ https://ir.transcodetherapeutics.com/news-releases/news-release-details/transcode-therapeutics-inc-announces-adjournment-special-meeting https://gravityanalytica.com/analyzer/RNAZ"
X Link 2025-02-06T23:02Z [--] followers, [--] engagements
"$FDMT 4DMT Presents Positive 52-Week Results from Phase 2b Cohort of PRISM Wet AMD Study and Long-term Durability Data Supporting 4D-150 4FRONT Global Registration Program #biotechs https://ir.4dmoleculartherapeutics.com/news-releases/news-release-details/4dmt-presents-positive-52-week-results-phase-2b-cohort-prism-wet https://gravityanalytica.com/analyzer/FDMT https://ir.4dmoleculartherapeutics.com/news-releases/news-release-details/4dmt-presents-positive-52-week-results-phase-2b-cohort-prism-wet https://gravityanalytica.com/analyzer/FDMT"
X Link 2025-02-08T23:02Z [--] followers, [---] engagements
"$PLUR Investor Presentation Q1 [----] #biotechs https://pluri-biotech.com/wp-content/uploads/2025/02/Pluri-Investor-Deck-Q1-2025.pdf https://gravityanalytica.com/analyzer/PLUR https://pluri-biotech.com/wp-content/uploads/2025/02/Pluri-Investor-Deck-Q1-2025.pdf https://gravityanalytica.com/analyzer/PLUR"
X Link 2025-02-09T23:02Z [--] followers, [--] engagements
"$PLUR Pluri secures additional $3.5 million investment #biotechs https://pluri-biotech.com/news/pluri-secures-additional-3-5-million-investment/ https://gravityanalytica.com/analyzer/PLUR https://pluri-biotech.com/news/pluri-secures-additional-3-5-million-investment/ https://gravityanalytica.com/analyzer/PLUR"
X Link 2025-02-09T23:02Z [--] followers, [--] engagements
"$PLUR Yaky Yanay on the Big Biz Show #biotechs https://pluri-biotech.com/news/23253/ https://gravityanalytica.com/analyzer/PLUR https://pluri-biotech.com/news/23253/ https://gravityanalytica.com/analyzer/PLUR"
X Link 2025-02-09T23:02Z [--] followers, [--] engagements
"$PMCB 10-Q - Quarterly report Sections [--] or 15(d) #biotechs https://ir.pharmacyte.com/annual-reportspage=1#document-2771-0001683168-25-001669 https://gravityanalytica.com/analyzer/PMCB https://ir.pharmacyte.com/annual-reportspage=1#document-2771-0001683168-25-001669 https://gravityanalytica.com/analyzer/PMCB"
X Link 2025-03-18T12:01Z [--] followers, [--] engagements
"$NAUT Tau proteoforms as potential drivers of cognitive decline #biotechs https://www.nautilus.bio/blog/tau-proteoforms-as-potential-drivers-of-cognitive-decline/ https://gravityanalytica.com/analyzer/NAUT https://www.nautilus.bio/blog/tau-proteoforms-as-potential-drivers-of-cognitive-decline/ https://gravityanalytica.com/analyzer/NAUT"
X Link 2025-03-20T16:15Z [--] followers, [--] engagements
"$DTIL Precision BioSciences to Report Fourth Quarter and Fiscal Year [----] Results on March [--] [----] #biotechs https://investor.precisionbiosciences.com/news-releases/news-release-details/precision-biosciences-report-fourth-quarter-and-fiscal-year-2024 https://gravityanalytica.com/analyzer/DTIL https://investor.precisionbiosciences.com/news-releases/news-release-details/precision-biosciences-report-fourth-quarter-and-fiscal-year-2024 https://gravityanalytica.com/analyzer/DTIL"
X Link 2025-03-21T11:12Z [--] followers, [---] engagements
"$UBX UNITY Biotechnology to Host Virtual Investor Event to Discuss 24- and 36-Week Data from the Phase 2b ASPIRE Study of UBX1325 in Patients with Diabetic Macular Edema (DME) on March [--] [----] #biotechs https://www.globenewswire.com/news-release/2025/03/23/3047498/0/en/UNITY-Biotechnology-to-Host-Virtual-Investor-Event-to-Discuss-24-and-36-Week-Data-from-the-Phase-2b-ASPIRE-Study-of-UBX1325-in-Patients-with-Diabetic-Macular-Edema-DME-on-March-24-.html https://gravityanalytica.com/analyzer/UBX"
X Link 2025-03-24T00:05Z [--] followers, [--] engagements
"$UBX Virtual Investor Event to Discuss 24- and 36-Week Data from the Phase 2b ASPIRE Study of UBX1325 in Patients with Diabetic Macular Edema (DME) #biotechs https://ir.unitybiotechnology.com/events/event-details/virtual-investor-event-discuss-24-and-36-week-data-phase-2b-aspire-study https://gravityanalytica.com/analyzer/UBX https://ir.unitybiotechnology.com/events/event-details/virtual-investor-event-discuss-24-and-36-week-data-phase-2b-aspire-study https://gravityanalytica.com/analyzer/UBX"
X Link 2025-03-24T00:05Z [--] followers, [--] engagements
"$UBX UNITY Biotechnology to Host Virtual Investor Event to Discuss 24- and 36-Week Data from the Phase 2b ASPIRE Study of UBX1325 in Patients with Diabetic Macular Edema (DME) on March [--] [----] #biotechs https://unitybiotechnology.gcs-web.com/news-releases/news-release-details/unity-biotechnology-host-virtual-investor-event-discuss-24-and https://gravityanalytica.com/analyzer/UBX https://unitybiotechnology.gcs-web.com/news-releases/news-release-details/unity-biotechnology-host-virtual-investor-event-discuss-24-and https://gravityanalytica.com/analyzer/UBX"
X Link 2025-03-24T00:05Z [--] followers, [--] engagements
"$UBX UNITY Biotechnology Announces Topline Results from the ASPIRE Phase 2b Study in Diabetic Macular Edema #biotechs https://unitybiotechnology.gcs-web.com/news-releases/news-release-details/unity-biotechnology-announces-topline-results-aspire-phase-2b https://gravityanalytica.com/analyzer/UBX https://unitybiotechnology.gcs-web.com/news-releases/news-release-details/unity-biotechnology-announces-topline-results-aspire-phase-2b https://gravityanalytica.com/analyzer/UBX"
X Link 2025-03-24T11:10Z [--] followers, [--] engagements
"$LRMR Larimar Therapeutics Provides Nomlabofusp Development Update and Reports Fourth Quarter and Full Year [----] Financial Results #biotechs https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-provides-nomlabofusp-development-update-and https://gravityanalytica.com/analyzer/LRMR https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-provides-nomlabofusp-development-update-and https://gravityanalytica.com/analyzer/LRMR"
X Link 2025-03-24T11:11Z [--] followers, [---] engagements
"$PYXS May [--] [----] - May [--] [----] : [----] RBC Capital Markets Global Healthcare Conference #biotechs https://ir.pyxisoncology.com/events/event-details/2025-rbc-capital-markets-global-healthcare-conference https://gravityanalytica.com/analyzer/PYXS https://ir.pyxisoncology.com/events/event-details/2025-rbc-capital-markets-global-healthcare-conference https://gravityanalytica.com/analyzer/PYXS"
X Link 2025-03-24T12:26Z [--] followers, [--] engagements
"$PHGE BiomX Reports Fourth Quarter and Full Year [----] Financial Results and Provides Business and Program Updates #biotechs https://ir.biomx.com/news-events/press-releases/detail/129/biomx-reports-fourth-quarter-and-full-year-2024-financial https://gravityanalytica.com/analyzer/PHGE https://ir.biomx.com/news-events/press-releases/detail/129/biomx-reports-fourth-quarter-and-full-year-2024-financial https://gravityanalytica.com/analyzer/PHGE"
X Link 2025-03-25T10:30Z [--] followers, [--] engagements
"$NAUT Proteoforms and Alzheimers disease #biotechs https://www.nautilus.bio/blog/proteoforms-and-alzheimers-disease/ https://gravityanalytica.com/analyzer/NAUT https://www.nautilus.bio/blog/proteoforms-and-alzheimers-disease/ https://gravityanalytica.com/analyzer/NAUT"
X Link 2025-03-25T16:05Z [--] followers, [--] engagements
"$CING Cingulate Inc. Reports Full Year [----] Fourth Quarter Resultsand Provides Development Update on Major Milestones Achieved #biotechs https://www.cingulate.com/news-releases/news-release-details/cingulate-inc-reports-full-year-2024-fourth-quarter-results-and https://gravityanalytica.com/analyzer/CING https://www.cingulate.com/news-releases/news-release-details/cingulate-inc-reports-full-year-2024-fourth-quarter-results-and https://gravityanalytica.com/analyzer/CING"
X Link 2025-03-27T00:01Z [--] followers, [--] engagements
"$IVVD Invivyd Appoints Ajay Royan Founder of Mithril Capital to its Board of Directors #biotechs https://adagiotx.gcs-web.com/news-releases/news-release-details/invivyd-appoints-ajay-royan-founder-mithril-capital-its-board https://gravityanalytica.com/analyzer/IVVD https://adagiotx.gcs-web.com/news-releases/news-release-details/invivyd-appoints-ajay-royan-founder-mithril-capital-its-board https://gravityanalytica.com/analyzer/IVVD"
X Link 2025-03-27T00:01Z [--] followers, [---] engagements
"$NAUT US HUPO [----] Key Takeaways Trends and Future Directions for Proteomics #biotechs https://www.nautilus.bio/blog/us-hupo-2025-key-takeaways-trends-and-future-directions-for-proteomics/ https://gravityanalytica.com/analyzer/NAUT https://www.nautilus.bio/blog/us-hupo-2025-key-takeaways-trends-and-future-directions-for-proteomics/ https://gravityanalytica.com/analyzer/NAUT"
X Link 2025-03-27T03:22Z [--] followers, [--] engagements
"$EYPT EyePoint to Present at [----] RBC Capital Markets Ophthalmology Virtual Conference #biotechs https://investors.eyepointpharma.com/news-releases/news-release-details/eyepoint-present-2025-rbc-capital-markets-ophthalmology-virtual https://gravityanalytica.com/analyzer/EYPT https://investors.eyepointpharma.com/news-releases/news-release-details/eyepoint-present-2025-rbc-capital-markets-ophthalmology-virtual https://gravityanalytica.com/analyzer/EYPT"
X Link 2025-03-27T11:01Z [--] followers, [--] engagements
"$EYPT RBC Capital Markets Ophthalmology Virtual Conference #biotechs https://investors.eyepointpharma.com/events/event-details/rbc-capital-markets-ophthalmology-virtual-conference https://gravityanalytica.com/analyzer/EYPT https://investors.eyepointpharma.com/events/event-details/rbc-capital-markets-ophthalmology-virtual-conference https://gravityanalytica.com/analyzer/EYPT"
X Link 2025-03-27T11:01Z [--] followers, [--] engagements
"$VYGR Voyager and KOL AD/PD [----] Recap #biotechs https://ir.voyagertherapeutics.com/events/event-details/voyager-and-kol-adpdtm-2025-recap https://gravityanalytica.com/analyzer/VYGR https://ir.voyagertherapeutics.com/events/event-details/voyager-and-kol-adpdtm-2025-recap https://gravityanalytica.com/analyzer/VYGR"
X Link 2025-03-31T11:10Z [--] followers, [--] engagements
"$NGNE Neurogene Announces Peer-Reviewed Publication Demonstrating Gene Therapy Candidate NGN-401 with EXACT Technology Regulates Transgene Expression in Preclinical Models of Rett Syndrome #biotechs https://neurogene.gcs-web.com/news-releases/news-release-details/neurogene-announces-peer-reviewed-publication-demonstrating-gene https://gravityanalytica.com/analyzer/NGNE https://neurogene.gcs-web.com/news-releases/news-release-details/neurogene-announces-peer-reviewed-publication-demonstrating-gene https://gravityanalytica.com/analyzer/NGNE"
X Link 2025-04-03T00:00Z [--] followers, [--] engagements
"$ATXS Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) #biotechs https://ir.astriatx.com/news-releases/news-release-details/astria-therapeutics-announces-inducement-grants-under-nasdaq-29 https://gravityanalytica.com/analyzer/ATXS https://ir.astriatx.com/news-releases/news-release-details/astria-therapeutics-announces-inducement-grants-under-nasdaq-29 https://gravityanalytica.com/analyzer/ATXS"
X Link 2025-04-03T00:01Z [--] followers, [--] engagements
"$NTLA Intellia Therapeutics Announces First Patient Dosed in the MAGNITUDE-2Phase [--] Study of Nexiguran Ziclumeran (nex-z) a One-Time Gene Editing-Based Treatment for Transthyretin (ATTR) Amyloidosis with Polyneuropathy #biotechs https://ir.intelliatx.com/news-releases/news-release-details/intellia-therapeutics-announces-first-patient-dosed-magnitude-2 https://gravityanalytica.com/analyzer/NTLA https://ir.intelliatx.com/news-releases/news-release-details/intellia-therapeutics-announces-first-patient-dosed-magnitude-2 https://gravityanalytica.com/analyzer/NTLA"
X Link 2025-04-03T11:31Z [--] followers, [--] engagements
"$NAUT How AI is Changing the Future of Biotech Research #biotechs https://www.nautilus.bio/blog/how-ai-is-changing-the-future-of-biotech-research/ https://gravityanalytica.com/analyzer/NAUT https://www.nautilus.bio/blog/how-ai-is-changing-the-future-of-biotech-research/ https://gravityanalytica.com/analyzer/NAUT"
X Link 2025-04-03T15:46Z [--] followers, [--] engagements
"$NXTC 24th Annual Needham Virtual Healthcare Conference #biotechs https://ir.nextcure.com/events/event-details/24th-annual-needham-virtual-healthcare-conference https://gravityanalytica.com/analyzer/NXTC https://ir.nextcure.com/events/event-details/24th-annual-needham-virtual-healthcare-conference https://gravityanalytica.com/analyzer/NXTC"
X Link 2025-04-04T11:13Z [--] followers, [--] engagements
"$CNTX April [--] [----] - April [--] [----] : Stifel Virtual Targeted Oncology Forum #biotechs https://ir.contexttherapeutics.com/events/event-details/stifel-virtual-targeted-oncology-forum https://gravityanalytica.com/analyzer/CNTX https://ir.contexttherapeutics.com/events/event-details/stifel-virtual-targeted-oncology-forum https://gravityanalytica.com/analyzer/CNTX"
X Link 2025-04-05T02:16Z [--] followers, [---] engagements
"$PLUR Pluri CEO Yaky Yanay on pioneering cell-tech solutions for global needs #biotechs https://pluri-biotech.com/news/pluri-ceo-yaky-yanay-on-pioneering-cell-tech-solutions-for-global-needs/ https://gravityanalytica.com/analyzer/PLUR https://pluri-biotech.com/news/pluri-ceo-yaky-yanay-on-pioneering-cell-tech-solutions-for-global-needs/ https://gravityanalytica.com/analyzer/PLUR"
X Link 2025-04-09T11:45Z [--] followers, [--] engagements
"$TARA Protara Therapeutics to Present Interim Analysis from the Phase [--] ADVANCED-2 Trial of TARA-002 in Patients with NMIBC at the American Urological Association Annual Meeting #biotechs https://protaratx.gcs-web.com/news-releases/news-release-details/protara-therapeutics-present-interim-analysis-phase-2-advanced-2 https://gravityanalytica.com/analyzer/TARA https://protaratx.gcs-web.com/news-releases/news-release-details/protara-therapeutics-present-interim-analysis-phase-2-advanced-2 https://gravityanalytica.com/analyzer/TARA"
X Link 2025-04-11T00:01Z [--] followers, [---] engagements
"$VERV Verve Therapeutics Receives U.S. FDA Fast Track Designation for VERVE-102 an In Vivo Base Editing Medicine Targeting PCSK9 #biotechs https://ir.vervetx.com/news-releases/news-release-details/verve-therapeutics-receives-us-fda-fast-track-designation-verve https://gravityanalytica.com/analyzer/VERV https://ir.vervetx.com/news-releases/news-release-details/verve-therapeutics-receives-us-fda-fast-track-designation-verve https://gravityanalytica.com/analyzer/VERV"
X Link 2025-04-11T11:01Z [--] followers, [--] engagements
"$VERV Verve Therapeutics Announces Positive Initial Data from the Heart-2 Phase 1b Clinical Trial of VERVE-102 an In Vivo Base Editing Medicine Targeting PCSK9 #biotechs https://vervetx.gcs-web.com/news-releases/news-release-details/verve-therapeutics-announces-positive-initial-data-heart-2-phase https://gravityanalytica.com/analyzer/VERV https://vervetx.gcs-web.com/news-releases/news-release-details/verve-therapeutics-announces-positive-initial-data-heart-2-phase https://gravityanalytica.com/analyzer/VERV"
X Link 2025-04-14T11:06Z [--] followers, [--] engagements
"$VERV Verve Therapeutics Announces Positive Initial Data from the Heart-2 Phase 1b Clinical Trial of VERVE-102 an In Vivo Base Editing Medicine Targeting PCSK9 #biotechs https://ir.vervetx.com/news-releases/news-release-details/verve-therapeutics-announces-positive-initial-data-heart-2-phase https://gravityanalytica.com/analyzer/VERV https://ir.vervetx.com/news-releases/news-release-details/verve-therapeutics-announces-positive-initial-data-heart-2-phase https://gravityanalytica.com/analyzer/VERV"
X Link 2025-04-14T11:06Z [--] followers, [--] engagements
"$SPRB Corporate Update Conference Call #biotechs https://investors.sprucebio.com/events/event-details/corporate-update-conference-call https://gravityanalytica.com/analyzer/SPRB https://investors.sprucebio.com/events/event-details/corporate-update-conference-call https://gravityanalytica.com/analyzer/SPRB"
X Link 2025-04-15T11:05Z [--] followers, [--] engagements
"$NAUT Nautilus Biotechnology to Announce First Quarter [----] Financial Results on April [--] [----] #biotechs https://investors.nautilus.bio/news-releases/news-release-details/nautilus-biotechnology-announce-first-quarter-2025-financial https://gravityanalytica.com/analyzer/NAUT https://investors.nautilus.bio/news-releases/news-release-details/nautilus-biotechnology-announce-first-quarter-2025-financial https://gravityanalytica.com/analyzer/NAUT"
X Link 2025-04-16T12:14Z [--] followers, [--] engagements
"$NAUT Intro to Proteomics Translating Proteomics #biotechs https://www.nautilus.bio/blog/intro-to-proteomics-on-translating-proteomics/ https://gravityanalytica.com/analyzer/NAUT https://www.nautilus.bio/blog/intro-to-proteomics-on-translating-proteomics/ https://gravityanalytica.com/analyzer/NAUT"
X Link 2025-04-17T00:06Z [--] followers, [--] engagements
"$PLUR Miracle cure to save Ukrainians in case of nuclear attack (German) #biotechs https://pluri-biotech.com/news/miracle-cure-to-save-ukrainians-in-case-of-nuclear-attack-german/ https://gravityanalytica.com/analyzer/PLUR https://pluri-biotech.com/news/miracle-cure-to-save-ukrainians-in-case-of-nuclear-attack-german/ https://gravityanalytica.com/analyzer/PLUR"
X Link 2025-04-17T06:14Z [--] followers, [--] engagements
"$DRIO DarioHealth Collaborates with Leading National Benefit Plan Administrator to Offer Cardiometabolic Solution including a GLP-1 Support Program to Employers #biotechs https://dariohealth.investorroom.com/2025-04-17-DarioHealth-Collaborates-with-Leading-National-Benefit-Plan-Administrator-to-Offer-Cardiometabolic-Solution-including-a-GLP-1-Support-Program-to-Employers https://gravityanalytica.com/analyzer/DRIO"
X Link 2025-04-17T12:32Z [--] followers, [--] engagements
"$PLUR Coffee that Costs More Than Whiskey: the Israeli Foodtech Revolution (Hebrew) #biotechs https://pluri-biotech.com/news/coffee-that-costs-more-than-whiskey-the-israeli-foodtech-revolution-hebrew/ https://gravityanalytica.com/analyzer/PLUR https://pluri-biotech.com/news/coffee-that-costs-more-than-whiskey-the-israeli-foodtech-revolution-hebrew/ https://gravityanalytica.com/analyzer/PLUR"
X Link 2025-04-20T07:25Z [--] followers, [--] engagements
"$PLUR Radiation and Bone Marrow Regeneration Podcast (Hebrew) #biotechs https://pluri-biotech.com/news/radiation-and-bone-marrow-regeneration-hebrew/ https://gravityanalytica.com/analyzer/PLUR https://pluri-biotech.com/news/radiation-and-bone-marrow-regeneration-hebrew/ https://gravityanalytica.com/analyzer/PLUR"
X Link 2025-04-20T07:45Z [--] followers, [--] engagements
"$ARVN Arvinas to Present Preclinical Data for PROTAC BCL6 Degrader ARV-393 at [----] American Association for Cancer Research (AACR) Annual Meeting #biotechs https://ir.arvinas.com/news-releases/news-release-details/arvinas-present-preclinical-data-protac-bcl6-degrader-arv-393 https://gravityanalytica.com/analyzer/ARVN https://ir.arvinas.com/news-releases/news-release-details/arvinas-present-preclinical-data-protac-bcl6-degrader-arv-393 https://gravityanalytica.com/analyzer/ARVN"
X Link 2025-04-21T11:15Z [--] followers, [---] engagements
"$ARVN Arvinas to Present Preclinical Data for PROTAC BCL6 Degrader ARV-393 at [----] American Association for Cancer Research (AACR) Annual Meeting #biotechs https://arvinas.gcs-web.com/news-releases/news-release-details/arvinas-present-preclinical-data-protac-bcl6-degrader-arv-393 https://gravityanalytica.com/analyzer/ARVN https://arvinas.gcs-web.com/news-releases/news-release-details/arvinas-present-preclinical-data-protac-bcl6-degrader-arv-393 https://gravityanalytica.com/analyzer/ARVN"
X Link 2025-04-21T11:15Z [--] followers, [---] engagements
"$DRIO DarioHealth Announces CFO Transition #biotechs https://dariohealth.investorroom.com/2025-04-21-DarioHealth-Announces-CFO-Transition https://gravityanalytica.com/analyzer/DRIO https://dariohealth.investorroom.com/2025-04-21-DarioHealth-Announces-CFO-Transition https://gravityanalytica.com/analyzer/DRIO"
X Link 2025-04-21T12:35Z [--] followers, [--] engagements
"$MBX Jonathan Wolleben #biotechs https://mbxbio.gcs-web.com/analyst/jonathan-wolleben https://gravityanalytica.com/analyzer/MBX https://mbxbio.gcs-web.com/analyst/jonathan-wolleben https://gravityanalytica.com/analyzer/MBX"
X Link 2025-04-21T13:33Z [--] followers, [--] engagements
"$MBX Jonathan Wolleben #biotechs https://investors.mbxbio.com/analyst/jonathan-wolleben https://gravityanalytica.com/analyzer/MBX https://investors.mbxbio.com/analyst/jonathan-wolleben https://gravityanalytica.com/analyzer/MBX"
X Link 2025-04-21T13:34Z [--] followers, [--] engagements
"$MBX May [--] [----] 3:00 PM EDT - May [--] [----] 3:25 PM EDT : The Citizens Life Sciences Conference #biotechs https://mbxbio.gcs-web.com/events/event-details/citizens-life-sciences-conference https://gravityanalytica.com/analyzer/MBX https://mbxbio.gcs-web.com/events/event-details/citizens-life-sciences-conference https://gravityanalytica.com/analyzer/MBX"
X Link 2025-04-22T12:01Z [--] followers, [--] engagements
"$MBX May [--] [----] 3:35 PM EDT - May [--] [----] 4:00 PM EDT : RBC [----] Global Healthcare Conference #biotechs https://mbxbio.gcs-web.com/events/event-details/rbc-2025-global-healthcare-conference https://gravityanalytica.com/analyzer/MBX https://mbxbio.gcs-web.com/events/event-details/rbc-2025-global-healthcare-conference https://gravityanalytica.com/analyzer/MBX"
X Link 2025-04-22T12:01Z [--] followers, [--] engagements
"$DAWN Day One to Report First Quarter [----] Financial Results Tuesday May [--] [----] #biotechs https://ir.dayonebio.com/news-releases/news-release-details/day-one-report-first-quarter-2025-financial-results-tuesday-may https://gravityanalytica.com/analyzer/DAWN https://ir.dayonebio.com/news-releases/news-release-details/day-one-report-first-quarter-2025-financial-results-tuesday-may https://gravityanalytica.com/analyzer/DAWN"
X Link 2025-04-22T12:33Z [--] followers, [--] engagements
"$DAWN Day One Biopharmaceuticals Q1 [----] Earnings Conference Call #biotechs https://ir.dayonebio.com/events/event-details/day-one-biopharmaceuticals-q1-2025-earnings-conference-call https://gravityanalytica.com/analyzer/DAWN https://ir.dayonebio.com/events/event-details/day-one-biopharmaceuticals-q1-2025-earnings-conference-call https://gravityanalytica.com/analyzer/DAWN"
X Link 2025-04-22T12:46Z [--] followers, [--] engagements
"$NAUT Nautilus Q1 [----] Earnings Conference Call #biotechs https://investors.nautilus.bio/events/event-details/nautilus-q1-2025-earnings-conference-call https://gravityanalytica.com/analyzer/NAUT https://investors.nautilus.bio/events/event-details/nautilus-q1-2025-earnings-conference-call https://gravityanalytica.com/analyzer/NAUT"
X Link 2025-04-23T00:01Z [--] followers, [--] engagements
"$APTO Aptose to Present at the [----] Bloom Burton & Co. Healthcare Investor Conference #biotechs https://www.aptose.com/investors/news-events/press-releases/detail/315/aptose-to-present-at-the-2025-bloom-burton-co-healthcare https://gravityanalytica.com/analyzer/APTO https://www.aptose.com/investors/news-events/press-releases/detail/315/aptose-to-present-at-the-2025-bloom-burton-co-healthcare https://gravityanalytica.com/analyzer/APTO"
X Link 2025-04-23T11:34Z [--] followers, [--] engagements
"$TARA Protara Therapeutics to Host Conference Call and Webcast to Review Interim Data from Phase [--] ADVANCED-2 Trial of TARA-002 in Patients with NMIBC on Monday April [--] [----] #biotechs https://ir.protaratx.com/news-releases/news-release-details/protara-therapeutics-host-conference-call-and-webcast-review https://gravityanalytica.com/analyzer/TARA https://ir.protaratx.com/news-releases/news-release-details/protara-therapeutics-host-conference-call-and-webcast-review https://gravityanalytica.com/analyzer/TARA"
X Link 2025-04-23T12:01Z [--] followers, [--] engagements
"$TARA ADVANCED-2 Data Update Call #biotechs https://protaratx.gcs-web.com/events/event-details/advanced-2-data-update-call https://gravityanalytica.com/analyzer/TARA https://protaratx.gcs-web.com/events/event-details/advanced-2-data-update-call https://gravityanalytica.com/analyzer/TARA"
X Link 2025-04-23T12:15Z [--] followers, [---] engagements
"$PRTC PureTech to Present [----] Annual Report and Financial Results #biotechs https://investors.puretechhealth.com/events/event-details/puretech-present-2024-annual-report-and-financial-results https://gravityanalytica.com/analyzer/PRTC https://investors.puretechhealth.com/events/event-details/puretech-present-2024-annual-report-and-financial-results https://gravityanalytica.com/analyzer/PRTC"
X Link 2025-04-24T16:05Z [--] followers, [--] engagements
"$PRTC PureTech to Present [----] Annual Report and Financial Results #biotechs https://puretechhealth.gcs-web.com/events/event-details/puretech-present-2024-annual-report-and-financial-results https://gravityanalytica.com/analyzer/PRTC https://puretechhealth.gcs-web.com/events/event-details/puretech-present-2024-annual-report-and-financial-results https://gravityanalytica.com/analyzer/PRTC"
X Link 2025-04-24T16:05Z [--] followers, [--] engagements
"$TARA Protara Therapeutics Announces Positive Interim Results Demonstrating Durable Responses in the Ongoing Phase [--] ADVANCED-2 Trial of TARA-002 in Patients with NMIBC #biotechs https://ir.protaratx.com/news-releases/news-release-details/protara-therapeutics-announces-positive-interim-results https://gravityanalytica.com/analyzer/TARA https://ir.protaratx.com/news-releases/news-release-details/protara-therapeutics-announces-positive-interim-results https://gravityanalytica.com/analyzer/TARA"
X Link 2025-04-26T14:04Z [--] followers, [---] engagements
"$TARA Protara Therapeutics Announces Positive Interim Results Demonstrating Durable Responses in the Ongoing Phase [--] ADVANCED-2 Trial of TARA-002 in Patients with NMIBC #biotechs https://protaratx.gcs-web.com/news-releases/news-release-details/protara-therapeutics-announces-positive-interim-results https://gravityanalytica.com/analyzer/TARA https://protaratx.gcs-web.com/news-releases/news-release-details/protara-therapeutics-announces-positive-interim-results https://gravityanalytica.com/analyzer/TARA"
X Link 2025-04-26T14:04Z [--] followers, [---] engagements
"$ARVN Arvinas Shares New Preclinical Combination Data for the PROTAC BCL6 Degrader ARV-393 at the [----] American Association for Cancer Research Annual Meeting #biotechs https://ir.arvinas.com/news-releases/news-release-details/arvinas-shares-new-preclinical-combination-data-protac-bcl6 https://gravityanalytica.com/analyzer/ARVN https://ir.arvinas.com/news-releases/news-release-details/arvinas-shares-new-preclinical-combination-data-protac-bcl6 https://gravityanalytica.com/analyzer/ARVN"
X Link 2025-04-28T10:56Z [--] followers, [---] engagements
"$ARVN Arvinas to Report First Quarter [----] Financial Results on Thursday May [--] [----] #biotechs https://arvinas.gcs-web.com/news-releases/news-release-details/arvinas-report-first-quarter-2025-financial-results-thursday-may https://gravityanalytica.com/analyzer/ARVN https://arvinas.gcs-web.com/news-releases/news-release-details/arvinas-report-first-quarter-2025-financial-results-thursday-may https://gravityanalytica.com/analyzer/ARVN"
X Link 2025-04-28T11:04Z [--] followers, [---] engagements
"$ARVN Arvinas to Report First Quarter [----] Financial Results on Thursday May [--] [----] #biotechs https://ir.arvinas.com/news-releases/news-release-details/arvinas-report-first-quarter-2025-financial-results-thursday-may https://gravityanalytica.com/analyzer/ARVN https://ir.arvinas.com/news-releases/news-release-details/arvinas-report-first-quarter-2025-financial-results-thursday-may https://gravityanalytica.com/analyzer/ARVN"
X Link 2025-04-28T11:06Z [--] followers, [---] engagements
"$ARVN Arvinas 1Q25 Earnings Call #biotechs https://ir.arvinas.com/events/event-details/arvinas-1q25-earnings-call https://gravityanalytica.com/analyzer/ARVN https://ir.arvinas.com/events/event-details/arvinas-1q25-earnings-call https://gravityanalytica.com/analyzer/ARVN"
X Link 2025-04-28T11:15Z [--] followers, [---] engagements
"$PHAT Phathom Pharmaceuticals to Present VOQUEZNA (vonoprazan) Data at DDW [----] Annual Meeting #biotechs https://www.globenewswire.com/news-release/2025/04/28/3069111/0/en/Phathom-Pharmaceuticals-to-Present-VOQUEZNA-vonoprazan-Data-at-DDW-2025-Annual-Meeting.html https://gravityanalytica.com/analyzer/PHAT https://www.globenewswire.com/news-release/2025/04/28/3069111/0/en/Phathom-Pharmaceuticals-to-Present-VOQUEZNA-vonoprazan-Data-at-DDW-2025-Annual-Meeting.html https://gravityanalytica.com/analyzer/PHAT"
X Link 2025-04-28T12:01Z [--] followers, [--] engagements
"$PHAT Phathom Pharmaceuticals to Present VOQUEZNA (vonoprazan) Data at DDW [----] Annual Meeting #biotechs https://investors.phathompharma.com/news-releases/news-release-details/phathom-pharmaceuticals-present-voqueznar-vonoprazan-data-ddw-0 https://gravityanalytica.com/analyzer/PHAT https://investors.phathompharma.com/news-releases/news-release-details/phathom-pharmaceuticals-present-voqueznar-vonoprazan-data-ddw-0 https://gravityanalytica.com/analyzer/PHAT"
X Link 2025-04-28T12:02Z [--] followers, [--] engagements
"$ORMP Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical #biotechs https://oramed.gcs-web.com/news-releases/news-release-details/oramed-pharmaceuticals-announces-369-million-investment-and https://gravityanalytica.com/analyzer/ORMP https://oramed.gcs-web.com/news-releases/news-release-details/oramed-pharmaceuticals-announces-369-million-investment-and https://gravityanalytica.com/analyzer/ORMP"
X Link 2025-04-28T13:16Z [--] followers, [--] engagements
"$NEO NeoGenomics Reports First Quarter [----] Results #biotechs https://ir.neogenomics.com/news-events/press-releases/detail/296/neogenomics-reports-first-quarter-2025-results https://gravityanalytica.com/analyzer/NEO https://ir.neogenomics.com/news-events/press-releases/detail/296/neogenomics-reports-first-quarter-2025-results https://gravityanalytica.com/analyzer/NEO"
X Link 2025-04-29T11:35Z [--] followers, [--] engagements
"$CRIS Curis to Report First Quarter [----] Financial and Operating Results and Host Conference Call and Webcast on May [--] [----] #biotechs https://investors.curis.com/2025-04-29-Curis-to-Report-First-Quarter-2025-Financial-and-Operating-Results-and-Host-Conference-Call-and-Webcast-on-May-6-2025 https://gravityanalytica.com/analyzer/CRIS https://investors.curis.com/2025-04-29-Curis-to-Report-First-Quarter-2025-Financial-and-Operating-Results-and-Host-Conference-Call-and-Webcast-on-May-6-2025 https://gravityanalytica.com/analyzer/CRIS"
X Link 2025-04-29T12:05Z [--] followers, [---] engagements
"$NAUT Nautilus Biotechnology Reports First Quarter [----] Financial Results #biotechs https://investors.nautilus.bio/news-releases/news-release-details/nautilus-biotechnology-reports-first-quarter-2025-financial https://gravityanalytica.com/analyzer/NAUT https://investors.nautilus.bio/news-releases/news-release-details/nautilus-biotechnology-reports-first-quarter-2025-financial https://gravityanalytica.com/analyzer/NAUT"
X Link 2025-04-29T12:13Z [--] followers, [--] engagements
"$HCAT Health Catalyst Announces Strategic Partnership with Microsoft to Accelerate AI Adoption and Transformation for Care Delivery Organizations #biotechs https://ir.healthcatalyst.com/news-releases/news-release-details/health-catalyst-announces-strategic-partnership-microsoft https://gravityanalytica.com/analyzer/HCAT https://ir.healthcatalyst.com/news-releases/news-release-details/health-catalyst-announces-strategic-partnership-microsoft https://gravityanalytica.com/analyzer/HCAT"
X Link 2025-04-29T12:36Z [--] followers, [--] engagements
"$ATXS Astria Therapeutics to Present at Upcoming Citizens Life Sciences Conference #biotechs https://ir.astriatx.com/news-releases/news-release-details/astria-therapeutics-present-upcoming-citizens-life-sciences https://gravityanalytica.com/analyzer/ATXS https://ir.astriatx.com/news-releases/news-release-details/astria-therapeutics-present-upcoming-citizens-life-sciences https://gravityanalytica.com/analyzer/ATXS"
X Link 2025-04-30T12:04Z [--] followers, [--] engagements
"$ATXS Citizens Life Sciences Conference #biotechs https://ir.astriatx.com/events/event-details/citizens-life-sciences-conference https://gravityanalytica.com/analyzer/ATXS https://ir.astriatx.com/events/event-details/citizens-life-sciences-conference https://gravityanalytica.com/analyzer/ATXS"
X Link 2025-04-30T12:31Z [--] followers, [--] engagements
"$ARVN Arvinas Reports First Quarter [----] Financial Results and Provides Corporate Update #biotechs https://arvinas.gcs-web.com/news-releases/news-release-details/arvinas-reports-first-quarter-2025-financial-results-and https://gravityanalytica.com/analyzer/ARVN https://arvinas.gcs-web.com/news-releases/news-release-details/arvinas-reports-first-quarter-2025-financial-results-and https://gravityanalytica.com/analyzer/ARVN"
X Link 2025-05-01T11:10Z [--] followers, [---] engagements
"$NEO NeoGenomics Pays Off 1.25% Convertible Senior Notes #biotechs https://ir.neogenomics.com/news-events/press-releases/detail/297/neogenomics-pays-off-1-25-convertible-senior-notes https://gravityanalytica.com/analyzer/NEO https://ir.neogenomics.com/news-events/press-releases/detail/297/neogenomics-pays-off-1-25-convertible-senior-notes https://gravityanalytica.com/analyzer/NEO"
X Link 2025-05-01T11:11Z [--] followers, [--] engagements
"$UBX UNITY Biotechnology to Present at the ARVO [----] Annual Meeting #biotechs https://ir.unitybiotechnology.com/news-releases/news-release-details/unity-biotechnology-present-arvo-2025-annual-meeting https://gravityanalytica.com/analyzer/UBX https://ir.unitybiotechnology.com/news-releases/news-release-details/unity-biotechnology-present-arvo-2025-annual-meeting https://gravityanalytica.com/analyzer/UBX"
X Link 2025-05-01T12:01Z [--] followers, [--] engagements
"$UBX UNITY Biotechnology Announces Complete 36-Week Results from the ASPIRE Phase 2b Study of UBX1325 in Diabetic Macular Edema and Provides Corporate Updates #biotechs https://unitybiotechnology.gcs-web.com/news-releases/news-release-details/unity-biotechnology-announces-complete-36-week-results-aspire https://gravityanalytica.com/analyzer/UBX https://unitybiotechnology.gcs-web.com/news-releases/news-release-details/unity-biotechnology-announces-complete-36-week-results-aspire https://gravityanalytica.com/analyzer/UBX"
X Link 2025-05-05T12:01Z [--] followers, [--] engagements
"$ASMB New Preclinical Data for Assembly Biosciences Oral Hepatitis D Virus Entry Inhibitor ABI-6250 and Next-Generation Hepatitis B Virus Capsid Assembly Modulator ABI-4334 Presented at the EASL Congress [----] #biotechs https://assemblybio.gcs-web.com/news-releases/news-release-details/new-preclinical-data-assembly-biosciences-oral-hepatitis-d-virus https://gravityanalytica.com/analyzer/ASMB https://assemblybio.gcs-web.com/news-releases/news-release-details/new-preclinical-data-assembly-biosciences-oral-hepatitis-d-virus https://gravityanalytica.com/analyzer/ASMB"
X Link 2025-05-07T12:02Z [--] followers, [--] engagements
"$ASMB New Preclinical Data for Assembly Biosciences Oral Hepatitis D Virus Entry Inhibitor ABI-6250 and Next-Generation Hepatitis B Virus Capsid Assembly Modulator ABI-4334 Presented at the EASL Congress [----] #biotechs https://investor.assemblybio.com/news-releases/news-release-details/new-preclinical-data-assembly-biosciences-oral-hepatitis-d-virus https://gravityanalytica.com/analyzer/ASMB https://investor.assemblybio.com/news-releases/news-release-details/new-preclinical-data-assembly-biosciences-oral-hepatitis-d-virus https://gravityanalytica.com/analyzer/ASMB"
X Link 2025-05-07T12:05Z [--] followers, [--] engagements
"$NTLA RBC Capital Markets Global Healthcare Conference #biotechs https://ir.intelliatx.com/events/event-details/rbc-capital-markets-global-healthcare-conference-0 https://gravityanalytica.com/analyzer/NTLA https://ir.intelliatx.com/events/event-details/rbc-capital-markets-global-healthcare-conference-0 https://gravityanalytica.com/analyzer/NTLA"
X Link 2025-05-08T11:31Z [--] followers, [---] engagements
"$CRBP Corbus Pharmaceuticals to Present at the [----] RBC Capital Markets Global Healthcare Conference #biotechs https://ir.corbuspharma.com/news/detail/440/corbus-pharmaceuticals-to-present-at-the-2025-rbc-capital-markets-global-healthcare-conference https://gravityanalytica.com/analyzer/CRBP https://ir.corbuspharma.com/news/detail/440/corbus-pharmaceuticals-to-present-at-the-2025-rbc-capital-markets-global-healthcare-conference https://gravityanalytica.com/analyzer/CRBP"
X Link 2025-05-08T12:01Z [--] followers, [--] engagements
"$TARA Protara Therapeutics Announces First Quarter [----] Financial Results and Provides Business Update #biotechs https://protaratx.gcs-web.com/news-releases/news-release-details/protara-therapeutics-announces-first-quarter-2025-financial https://gravityanalytica.com/analyzer/TARA https://protaratx.gcs-web.com/news-releases/news-release-details/protara-therapeutics-announces-first-quarter-2025-financial https://gravityanalytica.com/analyzer/TARA"
X Link 2025-05-08T12:11Z [--] followers, [--] engagements
"$TRDA H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ #biotechs https://entradatx.gcs-web.com/events/event-details/hc-wainwright-3rd-annual-bioconnect-investor-conference-nasdaq https://gravityanalytica.com/analyzer/TRDA https://entradatx.gcs-web.com/events/event-details/hc-wainwright-3rd-annual-bioconnect-investor-conference-nasdaq https://gravityanalytica.com/analyzer/TRDA"
X Link 2025-05-09T13:42Z [--] followers, [--] engagements
"$TRDA H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ #biotechs https://ir.entradatx.com/events/event-details/hc-wainwright-3rd-annual-bioconnect-investor-conference-nasdaq https://gravityanalytica.com/analyzer/TRDA https://ir.entradatx.com/events/event-details/hc-wainwright-3rd-annual-bioconnect-investor-conference-nasdaq https://gravityanalytica.com/analyzer/TRDA"
X Link 2025-05-09T13:42Z [--] followers, [--] engagements
"$CTMX CytomX Announces Positive Interim Data From Phase [--] Dose Escalation Study of EpCAM Antibody Drug Conjugate (CX-2051) Candidate in Patients with Advanced Colorectal Cancer (CRC) #biotechs https://ir.cytomx.com/news-releases/news-release-details/cytomx-announces-positive-interim-data-phase-1-dose-escalation https://gravityanalytica.com/analyzer/CTMX https://ir.cytomx.com/news-releases/news-release-details/cytomx-announces-positive-interim-data-phase-1-dose-escalation https://gravityanalytica.com/analyzer/CTMX"
X Link 2025-05-12T10:24Z [--] followers, [---] engagements
"$ABOS Acumen Pharmaceuticals Reports First Quarter [----] Financial Results and Business Highlights #biotechs https://investors.acumenpharm.com/news-releases/news-release-details/acumen-pharmaceuticals-reports-first-quarter-2025-financial https://gravityanalytica.com/analyzer/ABOS https://investors.acumenpharm.com/news-releases/news-release-details/acumen-pharmaceuticals-reports-first-quarter-2025-financial https://gravityanalytica.com/analyzer/ABOS"
X Link 2025-05-13T11:01Z [--] followers, [--] engagements
"$SEPN Novo Nordisk A/S: Septerna and Novo Nordisk to collaborate on oral small molecule medicines for obesity and other cardiometabolic diseases #biotechs https://ir.septerna.com/news-releases/news-release-details/novo-nordisk-septerna-and-novo-nordisk-collaborate-oral-small https://gravityanalytica.com/analyzer/SEPN https://ir.septerna.com/news-releases/news-release-details/novo-nordisk-septerna-and-novo-nordisk-collaborate-oral-small https://gravityanalytica.com/analyzer/SEPN"
X Link 2025-05-14T11:12Z [--] followers, [---] engagements
"$MIST Milestone Pharmaceuticals Reports First Quarter [----] Financial Results and Provides Regulatory and Corporate Update #biotechs https://milestonepharma.gcs-web.com/news-releases/news-release-details/milestone-pharmaceuticals-reports-first-quarter-2025-financial https://gravityanalytica.com/analyzer/MIST https://milestonepharma.gcs-web.com/news-releases/news-release-details/milestone-pharmaceuticals-reports-first-quarter-2025-financial https://gravityanalytica.com/analyzer/MIST"
X Link 2025-05-14T11:16Z [--] followers, [--] engagements
"$LPCN Lipocine to Present at A.G.P.'s Annual Healthcare Company Showcase #biotechs https://ir.lipocine.com/2025-05-14-Lipocine-to-Present-at-A-G-P-s-Annual-Healthcare-Company-Showcase https://gravityanalytica.com/analyzer/LPCN https://ir.lipocine.com/2025-05-14-Lipocine-to-Present-at-A-G-P-s-Annual-Healthcare-Company-Showcase https://gravityanalytica.com/analyzer/LPCN"
X Link 2025-05-14T12:01Z [--] followers, [--] engagements
"$KALA KALA BIO Reports First Quarter [----] Financial Results and Provides Corporate Update #biotechs https://investors.kalarx.com/news-releases/news-release-details/kala-bio-reports-first-quarter-2025-financial-results-and https://gravityanalytica.com/analyzer/KALA https://investors.kalarx.com/news-releases/news-release-details/kala-bio-reports-first-quarter-2025-financial-results-and https://gravityanalytica.com/analyzer/KALA"
X Link 2025-05-14T12:01Z [--] followers, [--] engagements
"$DAWN 46th Annual Goldman Sachs Global Healthcare Conference #biotechs https://ir.dayonebio.com/events/event-details/46th-annual-goldman-sachs-global-healthcare-conference https://gravityanalytica.com/analyzer/DAWN https://ir.dayonebio.com/events/event-details/46th-annual-goldman-sachs-global-healthcare-conference https://gravityanalytica.com/analyzer/DAWN"
X Link 2025-05-19T15:55Z [--] followers, [---] engagements
"$HCAT Health Catalyst to Participate in Upcoming Investor Conferences #biotechs https://ir.healthcatalyst.com/news-releases/news-release-details/health-catalyst-participate-upcoming-investor-conferences-12 https://gravityanalytica.com/analyzer/HCAT https://ir.healthcatalyst.com/news-releases/news-release-details/health-catalyst-participate-upcoming-investor-conferences-12 https://gravityanalytica.com/analyzer/HCAT"
X Link 2025-05-20T12:10Z [--] followers, [--] engagements
"$WHWK TD Cowen 6th Annual Oncology Innovation Summit #biotechs https://ir.whitehawktx.com/events/event-details/td-cowen-6th-annual-oncology-innovation-summit https://gravityanalytica.com/analyzer/WHWK https://ir.whitehawktx.com/events/event-details/td-cowen-6th-annual-oncology-innovation-summit https://gravityanalytica.com/analyzer/WHWK"
X Link 2025-05-21T12:15Z [--] followers, [--] engagements
"$WHWK Whitehawk Therapeutics to Participate in the TD Cowen 6th Annual Oncology Innovation Summit #biotechs https://ir.whitehawktx.com/news-releases/news-release-details/whitehawk-therapeutics-participate-td-cowen-6th-annual-oncology https://gravityanalytica.com/analyzer/WHWK https://ir.whitehawktx.com/news-releases/news-release-details/whitehawk-therapeutics-participate-td-cowen-6th-annual-oncology https://gravityanalytica.com/analyzer/WHWK"
X Link 2025-05-21T12:15Z [--] followers, [--] engagements
"$ALMS Alumis Completes Merger with ACELYRIN #biotechs https://investors.alumis.com/news-releases/news-release-details/alumis-completes-merger-acelyrin https://gravityanalytica.com/analyzer/ALMS https://investors.alumis.com/news-releases/news-release-details/alumis-completes-merger-acelyrin https://gravityanalytica.com/analyzer/ALMS"
X Link 2025-05-21T13:31Z [--] followers, [--] engagements
"$ALMS Alumis Completes Merger with ACELYRIN #biotechs https://alumis.gcs-web.com/news-releases/news-release-details/alumis-completes-merger-acelyrin https://gravityanalytica.com/analyzer/ALMS https://alumis.gcs-web.com/news-releases/news-release-details/alumis-completes-merger-acelyrin https://gravityanalytica.com/analyzer/ALMS"
X Link 2025-05-21T13:31Z [--] followers, [--] engagements
"$FHTX Goldman Sachs 46th Annual Global Healthcare Conference [----] #biotechs https://ir.foghorntx.com/events/event-details/goldman-sachs-46th-annual-global-healthcare-conference-2025 https://gravityanalytica.com/analyzer/FHTX https://ir.foghorntx.com/events/event-details/goldman-sachs-46th-annual-global-healthcare-conference-2025 https://gravityanalytica.com/analyzer/FHTX"
X Link 2025-05-22T11:10Z [--] followers, [--] engagements
"$FHTX Jefferies Global Healthcare Conference [----] #biotechs https://ir.foghorntx.com/events/event-details/jefferies-global-healthcare-conference-2025 https://gravityanalytica.com/analyzer/FHTX https://ir.foghorntx.com/events/event-details/jefferies-global-healthcare-conference-2025 https://gravityanalytica.com/analyzer/FHTX"
X Link 2025-05-22T11:11Z [--] followers, [--] engagements
"$FHTX TD Cowens 6th Annual Oncology Innovation Summit #biotechs https://foghorntx.gcs-web.com/events/event-details/td-cowens-6th-annual-oncology-innovation-summit https://gravityanalytica.com/analyzer/FHTX https://foghorntx.gcs-web.com/events/event-details/td-cowens-6th-annual-oncology-innovation-summit https://gravityanalytica.com/analyzer/FHTX"
X Link 2025-05-22T11:11Z [--] followers, [--] engagements
"$FHTX Evercore Biotech Diamonds in the Rough Virtual Event #biotechs https://foghorntx.gcs-web.com/events/event-details/evercore-biotech-diamonds-rough-virtual-event https://gravityanalytica.com/analyzer/FHTX https://foghorntx.gcs-web.com/events/event-details/evercore-biotech-diamonds-rough-virtual-event https://gravityanalytica.com/analyzer/FHTX"
X Link 2025-05-22T11:11Z [--] followers, [--] engagements
"$ATXS Astria Therapeutics to Present at Upcoming Eastern Allergy Conference #biotechs https://ir.astriatx.com/news-releases/news-release-details/astria-therapeutics-present-upcoming-eastern-allergy-0 https://gravityanalytica.com/analyzer/ATXS https://ir.astriatx.com/news-releases/news-release-details/astria-therapeutics-present-upcoming-eastern-allergy-0 https://gravityanalytica.com/analyzer/ATXS"
X Link 2025-05-22T12:03Z [--] followers, [--] engagements
"$ORKA Julian Harrison #biotechs https://orukatx.gcs-web.com/analyst/julian-harrison https://gravityanalytica.com/analyzer/ORKA https://orukatx.gcs-web.com/analyst/julian-harrison https://gravityanalytica.com/analyzer/ORKA"
X Link 2025-05-22T13:45Z [--] followers, [--] engagements
"$ORKA Julian Harrison #biotechs https://ir.orukatx.com/analyst/julian-harrison https://gravityanalytica.com/analyzer/ORKA https://ir.orukatx.com/analyst/julian-harrison https://gravityanalytica.com/analyzer/ORKA"
X Link 2025-05-22T13:45Z [--] followers, [--] engagements
"$NAUT Proteomics and the food of the future #biotechs https://www.nautilus.bio/blog/proteomics-and-the-food-of-the-future/ https://gravityanalytica.com/analyzer/NAUT https://www.nautilus.bio/blog/proteomics-and-the-food-of-the-future/ https://gravityanalytica.com/analyzer/NAUT"
X Link 2025-05-22T15:45Z [--] followers, [--] engagements
"$ATXS Astria Therapeutics to Present at Upcoming C1 Inhibitor Deficiency and Angioedema Workshop #biotechs https://ir.astriatx.com/news-releases/news-release-details/astria-therapeutics-present-upcoming-c1-inhibitor-deficiency-and https://gravityanalytica.com/analyzer/ATXS https://ir.astriatx.com/news-releases/news-release-details/astria-therapeutics-present-upcoming-c1-inhibitor-deficiency-and https://gravityanalytica.com/analyzer/ATXS"
X Link 2025-05-23T12:02Z [--] followers, [--] engagements
"$MOVE Movano Health Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q #biotechs https://movanohealth.com/movano-health-receives-notification-of-deficiency-from-nasdaq-related-to-delayed-filing-of-quarterly-report-on-form-10-q/ https://gravityanalytica.com/analyzer/MOVE https://movanohealth.com/movano-health-receives-notification-of-deficiency-from-nasdaq-related-to-delayed-filing-of-quarterly-report-on-form-10-q/ https://gravityanalytica.com/analyzer/MOVE"
X Link 2025-05-24T00:06Z [--] followers, [--] engagements
"$NAUT Nautilus Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference #biotechs https://investors.nautilus.bio/news-releases/news-release-details/nautilus-biotechnology-participate-goldman-sachs-46th-annual https://gravityanalytica.com/analyzer/NAUT https://investors.nautilus.bio/news-releases/news-release-details/nautilus-biotechnology-participate-goldman-sachs-46th-annual https://gravityanalytica.com/analyzer/NAUT"
X Link 2025-05-27T12:01Z [--] followers, [--] engagements
"$TCRX Jefferies Global Healthcare Conference #biotechs https://tscan.gcs-web.com/events/event-details/jefferies-global-healthcare-conference-0 https://gravityanalytica.com/analyzer/TCRX https://tscan.gcs-web.com/events/event-details/jefferies-global-healthcare-conference-0 https://gravityanalytica.com/analyzer/TCRX"
X Link 2025-05-28T11:10Z [--] followers, [--] engagements
"$ZBIO Jefferies Global Healthcare Conference #biotechs https://zenasbio.gcs-web.com/events/event-details/jefferies-global-healthcare-conference https://gravityanalytica.com/analyzer/ZBIO https://zenasbio.gcs-web.com/events/event-details/jefferies-global-healthcare-conference https://gravityanalytica.com/analyzer/ZBIO"
X Link 2025-05-29T11:12Z [--] followers, [--] engagements
"$KALA KALA BIO to Present at Jefferies Global Healthcare Conference #biotechs https://investors.kalarx.com/news-releases/news-release-details/kala-bio-present-jefferies-global-healthcare-conference-0 https://gravityanalytica.com/analyzer/KALA https://investors.kalarx.com/news-releases/news-release-details/kala-bio-present-jefferies-global-healthcare-conference-0 https://gravityanalytica.com/analyzer/KALA"
X Link 2025-05-29T12:01Z [--] followers, [--] engagements
"$ARVN Arvinas to Present at Jefferies Global Healthcare Conference #biotechs https://arvinas.gcs-web.com/news-releases/news-release-details/arvinas-present-jefferies-global-healthcare-conference https://gravityanalytica.com/analyzer/ARVN https://arvinas.gcs-web.com/news-releases/news-release-details/arvinas-present-jefferies-global-healthcare-conference https://gravityanalytica.com/analyzer/ARVN"
X Link 2025-05-30T11:05Z [--] followers, [---] engagements
"$ARVN Arvinas to Present at Jefferies Global Healthcare Conference #biotechs https://ir.arvinas.com/news-releases/news-release-details/arvinas-present-jefferies-global-healthcare-conference https://gravityanalytica.com/analyzer/ARVN https://ir.arvinas.com/news-releases/news-release-details/arvinas-present-jefferies-global-healthcare-conference https://gravityanalytica.com/analyzer/ARVN"
X Link 2025-05-30T11:06Z [--] followers, [---] engagements
"$ARVN Jefferies Global Healthcare Conference #biotechs https://ir.arvinas.com/events/event-details/jefferies-global-healthcare-conference-0 https://gravityanalytica.com/analyzer/ARVN https://ir.arvinas.com/events/event-details/jefferies-global-healthcare-conference-0 https://gravityanalytica.com/analyzer/ARVN"
X Link 2025-05-30T12:41Z [--] followers, [---] engagements
"$FATE Fate Therapeutics Appoints Matthew Abernethy M.B.A. to its Board of Directors #biotechs https://ir.fatetherapeutics.com/news-releases/news-release-details/fate-therapeutics-appoints-matthew-abernethy-mba-its-board https://gravityanalytica.com/analyzer/FATE https://ir.fatetherapeutics.com/news-releases/news-release-details/fate-therapeutics-appoints-matthew-abernethy-mba-its-board https://gravityanalytica.com/analyzer/FATE"
X Link 2025-05-31T00:03Z [--] followers, [--] engagements
"$IMTX Immatics IMA203 PRAME Cell Therapy Data Presented at [----] ASCO Annual Meeting Continues to Show Strong Anti-tumor Activity and Durability in Patients with Metastatic Melanoma #biotechs https://immatics.gcs-web.com/news-releases/news-release-details/immatics-ima203-prame-cell-therapy-data-presented-2025-asco https://gravityanalytica.com/analyzer/IMTX https://immatics.gcs-web.com/news-releases/news-release-details/immatics-ima203-prame-cell-therapy-data-presented-2025-asco https://gravityanalytica.com/analyzer/IMTX"
X Link 2025-05-31T12:05Z [--] followers, [---] engagements
"$ARVN Phase [--] VERITAC-2 Trial Results Investor Call #biotechs https://arvinas.gcs-web.com/events/event-details/phase-3-veritac-2-trial-results-investor-call https://gravityanalytica.com/analyzer/ARVN https://arvinas.gcs-web.com/events/event-details/phase-3-veritac-2-trial-results-investor-call https://gravityanalytica.com/analyzer/ARVN"
X Link 2025-05-31T12:05Z [--] followers, [---] engagements
"$TARA Protara Therapeutics Announces Appointment of William Conkling as Chief Commercial Officer #biotechs https://protaratx.gcs-web.com/news-releases/news-release-details/protara-therapeutics-announces-appointment-william-conkling https://gravityanalytica.com/analyzer/TARA https://protaratx.gcs-web.com/news-releases/news-release-details/protara-therapeutics-announces-appointment-william-conkling https://gravityanalytica.com/analyzer/TARA"
X Link 2025-06-03T00:01Z [--] followers, [--] engagements
"$TARA Protara Therapeutics Announces Appointment of William Conkling as Chief Commercial Officer #biotechs https://www.globenewswire.com/news-release/2025/06/02/3092322/0/en/Protara-Therapeutics-Announces-Appointment-of-William-Conkling-as-Chief-Commercial-Officer.html https://gravityanalytica.com/analyzer/TARA https://www.globenewswire.com/news-release/2025/06/02/3092322/0/en/Protara-Therapeutics-Announces-Appointment-of-William-Conkling-as-Chief-Commercial-Officer.html https://gravityanalytica.com/analyzer/TARA"
X Link 2025-06-03T00:01Z [--] followers, [--] engagements
"$ENVB Enveric Biosciences Announces Issuance of U.S. Patent Covering a Novel Family of Molecules Including Melatonin Receptor-Targeting Compounds #biotechs https://www.enveric.com/news/enveric-biosciences-announces-issuance-of-u-s-patent-covering-a-novel-family-of-molecules-including-melatonin-receptor-targeting-compounds/ https://gravityanalytica.com/analyzer/ENVB https://www.enveric.com/news/enveric-biosciences-announces-issuance-of-u-s-patent-covering-a-novel-family-of-molecules-including-melatonin-receptor-targeting-compounds/ https://gravityanalytica.com/analyzer/ENVB"
X Link 2025-06-03T14:35Z [--] followers, [--] engagements
"$BCAX Goldman Sachs Global Healthcare Conference #biotechs https://ir.bicara.com/events/event-details/goldman-sachs-global-healthcare-conference https://gravityanalytica.com/analyzer/BCAX https://ir.bicara.com/events/event-details/goldman-sachs-global-healthcare-conference https://gravityanalytica.com/analyzer/BCAX"
X Link 2025-06-04T00:02Z [--] followers, [--] engagements
"$NAUT Proteoforms metastasis and cancer therapy responses Applications of proteomics in cancer #biotechs https://www.nautilus.bio/blog/proteoforms-metastasis-and-cancer-therapy-responses-applications-of-proteomics-in-cancer/ https://gravityanalytica.com/analyzer/NAUT https://www.nautilus.bio/blog/proteoforms-metastasis-and-cancer-therapy-responses-applications-of-proteomics-in-cancer/ https://gravityanalytica.com/analyzer/NAUT"
X Link 2025-06-05T15:35Z [--] followers, [--] engagements
"$ATXS Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Annual Congress #biotechs https://ir.astriatx.com/news-releases/news-release-details/astria-therapeutics-present-upcoming-european-academy-allergy-0 https://gravityanalytica.com/analyzer/ATXS https://ir.astriatx.com/news-releases/news-release-details/astria-therapeutics-present-upcoming-european-academy-allergy-0 https://gravityanalytica.com/analyzer/ATXS"
X Link 2025-06-06T12:05Z [--] followers, [--] engagements
"$NKTX Nkarta Appoints Shawn Rose Chief Medical Officer & Head of R&D as Company Resets Senior Leadership Role for Autoimmune Focus #biotechs https://ir.nkartatx.com/news-releases/news-release-details/nkarta-appoints-shawn-rose-chief-medical-officer-head-rd-company https://gravityanalytica.com/analyzer/NKTX https://ir.nkartatx.com/news-releases/news-release-details/nkarta-appoints-shawn-rose-chief-medical-officer-head-rd-company https://gravityanalytica.com/analyzer/NKTX"
X Link 2025-06-06T13:01Z [--] followers, [--] engagements
"$NKTX Nkarta Appoints Shawn Rose Chief Medical Officer & Head of R&D as Company Resets Senior Leadership Role for Autoimmune Focus #biotechs https://nkartatx.gcs-web.com/news-releases/news-release-details/nkarta-appoints-shawn-rose-chief-medical-officer-head-rd-company https://gravityanalytica.com/analyzer/NKTX https://nkartatx.gcs-web.com/news-releases/news-release-details/nkarta-appoints-shawn-rose-chief-medical-officer-head-rd-company https://gravityanalytica.com/analyzer/NKTX"
X Link 2025-06-06T13:01Z [--] followers, [--] engagements
"$CBUS USDA Designates Cibus Herbicide Tolerance Canola Trait HT2 as Not Regulated Under USDAs Biotechnology Regulations #biotechs https://ir.cibus.com/news-releases/news-release-details/usda-designates-cibus-herbicide-tolerance-canola-trait-ht2-not https://gravityanalytica.com/analyzer/CBUS https://ir.cibus.com/news-releases/news-release-details/usda-designates-cibus-herbicide-tolerance-canola-trait-ht2-not https://gravityanalytica.com/analyzer/CBUS"
X Link 2025-06-06T13:36Z [--] followers, [--] engagements
"$CBUS USDA Designates Cibus Herbicide Tolerance Canola Trait HT2 as Not Regulated Under USDAs Biotechnology Regulations #biotechs https://investor.cibus.com/news-releases/news-release-details/usda-designates-cibus-herbicide-tolerance-canola-trait-ht2-not https://gravityanalytica.com/analyzer/CBUS https://investor.cibus.com/news-releases/news-release-details/usda-designates-cibus-herbicide-tolerance-canola-trait-ht2-not https://gravityanalytica.com/analyzer/CBUS"
X Link 2025-06-06T13:36Z [--] followers, [--] engagements
"$CBUS Cibus Inc. Announces Closing of $27.5 Million Public Offering #biotechs https://ir.cibus.com/news-releases/news-release-details/cibus-inc-announces-closing-275-million-public-offering https://gravityanalytica.com/analyzer/CBUS https://ir.cibus.com/news-releases/news-release-details/cibus-inc-announces-closing-275-million-public-offering https://gravityanalytica.com/analyzer/CBUS"
X Link 2025-06-10T00:41Z [--] followers, [--] engagements
"$CBUS Cibus Inc. Announces Closing of $27.5 Million Public Offering #biotechs https://cibus.gcs-web.com/news-releases/news-release-details/cibus-inc-announces-closing-275-million-public-offering https://gravityanalytica.com/analyzer/CBUS https://cibus.gcs-web.com/news-releases/news-release-details/cibus-inc-announces-closing-275-million-public-offering https://gravityanalytica.com/analyzer/CBUS"
X Link 2025-06-10T00:41Z [--] followers, [--] engagements
"$MTVA MetaVia to Present at the Life Sciences Virtual Investor Forum June 12th #biotechs https://ir.metaviatx.com/news-releases/news-release-details/metavia-present-life-sciences-virtual-investor-forum-june-12th https://gravityanalytica.com/analyzer/MTVA https://ir.metaviatx.com/news-releases/news-release-details/metavia-present-life-sciences-virtual-investor-forum-june-12th https://gravityanalytica.com/analyzer/MTVA"
X Link 2025-06-10T13:16Z [--] followers, [--] engagements
"$CABA Cabaletta Bio Announces Proposed Public Offering of Securities #biotechs https://www.cabalettabio.com/news-media/press-releases/detail/131/cabaletta-bio-announces-proposed-public-offering-of https://gravityanalytica.com/analyzer/CABA https://www.cabalettabio.com/news-media/press-releases/detail/131/cabaletta-bio-announces-proposed-public-offering-of https://gravityanalytica.com/analyzer/CABA"
X Link 2025-06-11T10:25Z [--] followers, [--] engagements
"$CABA Cabaletta Bio Announces Proposed Public Offering of Securities #biotechs https://www.cabalettabio.com/investors/news-events/press-releases/detail/131/cabaletta-bio-announces-proposed-public-offering-of https://gravityanalytica.com/analyzer/CABA https://www.cabalettabio.com/investors/news-events/press-releases/detail/131/cabaletta-bio-announces-proposed-public-offering-of https://gravityanalytica.com/analyzer/CABA"
X Link 2025-06-11T10:25Z [--] followers, [---] engagements
"$FATE Fate Therapeutics Announces Updated Clinical Data for FT819 Off-the-shelf CAR T-cell Product Candidate Demonstrating Durability of Drug-free Remission for Severe Lupus Nephritis at EULAR [----] Congress #biotechs https://ir.fatetherapeutics.com/news-releases/news-release-details/fate-therapeutics-announces-updated-clinical-data-ft819-shelf https://gravityanalytica.com/analyzer/FATE https://ir.fatetherapeutics.com/news-releases/news-release-details/fate-therapeutics-announces-updated-clinical-data-ft819-shelf https://gravityanalytica.com/analyzer/FATE"
X Link 2025-06-11T13:03Z [--] followers, [---] engagements
"$CABA Cabaletta Bio Announces Pricing of Public Offering of Securities #biotechs https://www.cabalettabio.com/news-media/press-releases/detail/132/cabaletta-bio-announces-pricing-of-public-offering-of https://gravityanalytica.com/analyzer/CABA https://www.cabalettabio.com/news-media/press-releases/detail/132/cabaletta-bio-announces-pricing-of-public-offering-of https://gravityanalytica.com/analyzer/CABA"
X Link 2025-06-11T14:05Z [--] followers, [---] engagements
"$CABA Cabaletta Bio Announces Pricing of Public Offering of Securities #biotechs https://www.cabalettabio.com/investors/news-events/press-releases/detail/132/cabaletta-bio-announces-pricing-of-public-offering-of https://gravityanalytica.com/analyzer/CABA https://www.cabalettabio.com/investors/news-events/press-releases/detail/132/cabaletta-bio-announces-pricing-of-public-offering-of https://gravityanalytica.com/analyzer/CABA"
X Link 2025-06-11T14:05Z [--] followers, [---] engagements
"$FATE Treatment of Refractory SLE with Off-the-Shelf iPSC-derived Anti-CD19 CAR T-cell Therapy #biotechs https://www.fatetherapeutics.com/treatment-of-refractory-sle-with-off-the-shelf-ipsc-derived-anti-cd19-car-t-cell-therapy/ https://gravityanalytica.com/analyzer/FATE https://www.fatetherapeutics.com/treatment-of-refractory-sle-with-off-the-shelf-ipsc-derived-anti-cd19-car-t-cell-therapy/ https://gravityanalytica.com/analyzer/FATE"
X Link 2025-06-11T16:45Z [--] followers, [--] engagements
"$ENTA Enanta Pharmaceuticals Partner AbbVie Receives U.S. FDA Approval of an Expanded Indication for MAVYRET (glecaprevir/pibrentasvir) as the First and Only Treatment for People with Acute Hepatitis C Virus #biotechs https://enanta.gcs-web.com/news-releases/news-release-details/enanta-pharmaceuticals-partner-abbvie-receives-us-fda-approval https://gravityanalytica.com/analyzer/ENTA https://enanta.gcs-web.com/news-releases/news-release-details/enanta-pharmaceuticals-partner-abbvie-receives-us-fda-approval https://gravityanalytica.com/analyzer/ENTA"
X Link 2025-06-11T16:46Z [--] followers, [--] engagements
"$CALC CalciMedica Announces Upcoming Symposium at the 43rd Vicenza Course AKI-CRRT-EBPT and Critical Care Nephrology Meeting #biotechs https://calcimedica.gcs-web.com/news-releases/news-release-details/calcimedica-announces-upcoming-symposium-43rd-vicenza-course-aki https://gravityanalytica.com/analyzer/CALC https://calcimedica.gcs-web.com/news-releases/news-release-details/calcimedica-announces-upcoming-symposium-43rd-vicenza-course-aki https://gravityanalytica.com/analyzer/CALC"
X Link 2025-06-12T11:11Z [--] followers, [--] engagements
"$CBUS Cibus and John Innes Centre Announce Ongoing Collaboration with Potential to Revolutionize Fertilizer Use in Farming #biotechs https://investor.cibus.com/news-releases/news-release-details/cibus-and-john-innes-centre-announce-ongoing-collaboration https://gravityanalytica.com/analyzer/CBUS https://investor.cibus.com/news-releases/news-release-details/cibus-and-john-innes-centre-announce-ongoing-collaboration https://gravityanalytica.com/analyzer/CBUS"
X Link 2025-06-12T12:10Z [--] followers, [--] engagements
"$NAUT Life at Nautilus interview with Lisen Wang Senior Staff Engineer #biotechs https://www.nautilus.bio/blog/life-at-nautilus-interview-with-lisen-wang-senior-staff-engineer/ https://gravityanalytica.com/analyzer/NAUT https://www.nautilus.bio/blog/life-at-nautilus-interview-with-lisen-wang-senior-staff-engineer/ https://gravityanalytica.com/analyzer/NAUT"
X Link 2025-06-12T16:35Z [--] followers, [--] engagements
"$MOLN Bill Maughan PhD #biotechs https://investors.molecularpartners.com/analyst/bill-maughan-phd https://gravityanalytica.com/analyzer/MOLN https://investors.molecularpartners.com/analyst/bill-maughan-phd https://gravityanalytica.com/analyzer/MOLN"
X Link 2025-06-16T13:54Z [--] followers, [--] engagements
"$MOLN Bill Maughan PhD #biotechs https://molecularpartners.gcs-web.com/analyst/bill-maughan-phd https://gravityanalytica.com/analyzer/MOLN https://molecularpartners.gcs-web.com/analyst/bill-maughan-phd https://gravityanalytica.com/analyzer/MOLN"
X Link 2025-06-16T13:54Z [--] followers, [--] engagements
"$BRTX BioRestorative Announces Share Repurchase Program #biotechs https://www.globenewswire.com/news-release/2025/06/17/3100770/0/en/BioRestorative-Announces-Share-Repurchase-Program.html https://gravityanalytica.com/analyzer/BRTX https://www.globenewswire.com/news-release/2025/06/17/3100770/0/en/BioRestorative-Announces-Share-Repurchase-Program.html https://gravityanalytica.com/analyzer/BRTX"
X Link 2025-06-17T13:35Z [--] followers, [--] engagements
"$ATXS Astria Therapeutics to Participate in Upcoming Oppenheimer Innovators in Immunology & Inflammation Summit #biotechs https://ir.astriatx.com/news-releases/news-release-details/astria-therapeutics-participate-upcoming-oppenheimer-innovators https://gravityanalytica.com/analyzer/ATXS https://ir.astriatx.com/news-releases/news-release-details/astria-therapeutics-participate-upcoming-oppenheimer-innovators https://gravityanalytica.com/analyzer/ATXS"
X Link 2025-06-18T12:15Z [--] followers, [--] engagements
"$ABOS Geoff Meacham #biotechs https://investors.acumenpharm.com/analyst/geoff-meacham https://gravityanalytica.com/analyzer/ABOS https://investors.acumenpharm.com/analyst/geoff-meacham https://gravityanalytica.com/analyzer/ABOS"
X Link 2025-06-18T14:15Z [--] followers, [--] engagements
"$QNCX Quince Therapeutics Announces Closing of Up to $22 Million Private Placement of Securities #biotechs https://ir.quincetx.com/news-releases/news-release-details/quince-therapeutics-announces-closing-22-million-private https://gravityanalytica.com/analyzer/QNCX https://ir.quincetx.com/news-releases/news-release-details/quince-therapeutics-announces-closing-22-million-private https://gravityanalytica.com/analyzer/QNCX"
X Link 2025-06-18T21:15Z [--] followers, [--] engagements
"$ANNX Annexon Bolsters Ophthalmology Expertise with Appointment of Retina Specialist Lloyd Clark M.D. as Pivotal ANX007 Program Advances in Dry Age-Related Macular Degeneration (AMD) with Geographic Atrophy (GA) #biotechs https://ir.annexonbio.com/news-releases/news-release-details/annexon-bolsters-ophthalmology-expertise-appointment-retina https://gravityanalytica.com/analyzer/ANNX https://ir.annexonbio.com/news-releases/news-release-details/annexon-bolsters-ophthalmology-expertise-appointment-retina https://gravityanalytica.com/analyzer/ANNX"
X Link 2025-06-18T21:25Z [--] followers, [---] engagements
"$WHWK Whitehawk Therapeutics to Participate in H.C. Wainwright "HCW@Home" Series #biotechs https://ir.whitehawktx.com/news-releases/news-release-details/whitehawk-therapeutics-participate-hc-wainwright-hcwhome-series https://gravityanalytica.com/analyzer/WHWK https://ir.whitehawktx.com/news-releases/news-release-details/whitehawk-therapeutics-participate-hc-wainwright-hcwhome-series https://gravityanalytica.com/analyzer/WHWK"
X Link 2025-06-19T12:13Z [--] followers, [--] engagements
"$WHWK H.C. Wainwright HCW@Home Fireside Chat #biotechs https://ir.whitehawktx.com/events/event-details/hc-wainwright-hcwhome-fireside-chat https://gravityanalytica.com/analyzer/WHWK https://ir.whitehawktx.com/events/event-details/hc-wainwright-hcwhome-fireside-chat https://gravityanalytica.com/analyzer/WHWK"
X Link 2025-06-19T12:15Z [--] followers, [--] engagements
"$NAUT Biomarkers Are Changing Everything A New Era in Alzheimers Research #biotechs https://www.nautilus.bio/blog/biomarkers-are-changing-everything-a-new-era-in-alzheimers-research/ https://gravityanalytica.com/analyzer/NAUT https://www.nautilus.bio/blog/biomarkers-are-changing-everything-a-new-era-in-alzheimers-research/ https://gravityanalytica.com/analyzer/NAUT"
X Link 2025-06-19T15:25Z [--] followers, [--] engagements
"$PRTA The Longest Day: A Commitment Beyond Diagnosis #biotechs https://www.prothena.com/the-longest-day-a-commitment-beyond-diagnosis/ https://gravityanalytica.com/analyzer/PRTA https://www.prothena.com/the-longest-day-a-commitment-beyond-diagnosis/ https://gravityanalytica.com/analyzer/PRTA"
X Link 2025-06-20T14:15Z [--] followers, [---] engagements
"$LRMR Larimar Therapeutics Announces Regulatory Update Call on the Nomlabofusp Program for the Treatment of Friedreichs Ataxia #biotechs https://www.globenewswire.com/news-release/2025/06/20/3102923/0/en/Larimar-Therapeutics-Announces-Regulatory-Update-Call-on-the-Nomlabofusp-Program-for-the-Treatment-of-Friedreich-s-Ataxia.html https://gravityanalytica.com/analyzer/LRMR https://www.globenewswire.com/news-release/2025/06/20/3102923/0/en/Larimar-Therapeutics-Announces-Regulatory-Update-Call-on-the-Nomlabofusp-Program-for-the-Treatment-of-Friedreich-s-Ataxia.html"
X Link 2025-06-21T00:05Z [--] followers, [---] engagements
"$LRMR Larimar Therapeutics June [--] [----] Regulatory Update #biotechs https://investors.larimartx.com/events/event-details/larimar-therapeutics-june-23-2025-regulatory-update https://gravityanalytica.com/analyzer/LRMR https://investors.larimartx.com/events/event-details/larimar-therapeutics-june-23-2025-regulatory-update https://gravityanalytica.com/analyzer/LRMR"
X Link 2025-06-21T00:05Z [--] followers, [---] engagements
"$LRMR Larimar Therapeutics Announces Regulatory Update Call on the Nomlabofusp Program for the Treatment of Friedreichs Ataxia #biotechs https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-announces-regulatory-update-call https://gravityanalytica.com/analyzer/LRMR https://investors.larimartx.com/news-releases/news-release-details/larimar-therapeutics-announces-regulatory-update-call https://gravityanalytica.com/analyzer/LRMR"
X Link 2025-06-21T00:05Z [--] followers, [---] engagements
"$LPCN Lipocine to Host Virtual R&D Investor Event to Discuss LPCN [----] (BRLIZIO) as a Treatment for Postpartum Depression on July [--] [----] #biotechs https://ir.lipocine.com/2025-06-23-Lipocine-to-Host-Virtual-R-D-Investor-Event-to-Discuss-LPCN-1154-BRLIZIO-TM-as-a-Treatment-for-Postpartum-Depression-on-July-9-2025 https://gravityanalytica.com/analyzer/LPCN https://ir.lipocine.com/2025-06-23-Lipocine-to-Host-Virtual-R-D-Investor-Event-to-Discuss-LPCN-1154-BRLIZIO-TM-as-a-Treatment-for-Postpartum-Depression-on-July-9-2025 https://gravityanalytica.com/analyzer/LPCN"
X Link 2025-06-23T12:05Z [--] followers, [--] engagements
"$MBX Steven Hoerter #biotechs https://investors.mbxbio.com/board-member/steven-hoerter https://gravityanalytica.com/analyzer/MBX https://investors.mbxbio.com/board-member/steven-hoerter https://gravityanalytica.com/analyzer/MBX"
X Link 2025-06-23T17:05Z [--] followers, [--] engagements
"$MBX Steven Hoerter #biotechs https://mbxbio.gcs-web.com/board-member/steven-hoerter https://gravityanalytica.com/analyzer/MBX https://mbxbio.gcs-web.com/board-member/steven-hoerter https://gravityanalytica.com/analyzer/MBX"
X Link 2025-06-23T17:05Z [--] followers, [--] engagements
"$NKTR Nektar to Announce Top-line Data from the 16-Week Induction Period in REZOLVE-AD Phase 2b Study of Rezpegaldesleukin a Regulatory T-cell Proliferator in Atopic Dermatitis on June [--] [----] #biotechs https://nektar.gcs-web.com/news-releases/news-release-details/nektar-announce-top-line-data-16-week-induction-period-rezolve https://gravityanalytica.com/analyzer/NKTR https://nektar.gcs-web.com/news-releases/news-release-details/nektar-announce-top-line-data-16-week-induction-period-rezolve https://gravityanalytica.com/analyzer/NKTR"
X Link 2025-06-24T00:03Z [--] followers, [---] engagements
"$CBUS The U.S. Food and Drug Administration Completes Review of Cibus Altered Lignin Alfalfa Developed in Partnership with S&W Seed Company for use in Livestock Feed #biotechs https://cibus.gcs-web.com/news-releases/news-release-details/us-food-and-drug-administration-completes-review-cibus-altered https://gravityanalytica.com/analyzer/CBUS https://cibus.gcs-web.com/news-releases/news-release-details/us-food-and-drug-administration-completes-review-cibus-altered https://gravityanalytica.com/analyzer/CBUS"
X Link 2025-06-24T11:11Z [--] followers, [--] engagements
"$SEPN Raghuram Selvaraju Ph.D. #biotechs https://septerna.gcs-web.com/analyst/raghuram-selvaraju-phd https://gravityanalytica.com/analyzer/SEPN https://septerna.gcs-web.com/analyst/raghuram-selvaraju-phd https://gravityanalytica.com/analyzer/SEPN"
X Link 2025-06-24T14:45Z [--] followers, [--] engagements
"$CALC CalciMedica Announces Publication in the American Journal of Nephrology Discussing Design and Rationale of Phase [--] KOURAGE Trial of Auxora in AKI with Respiratory Failure #biotechs https://ir.calcimedica.com/news-releases/news-release-details/calcimedica-announces-publication-american-journal-nephrology https://gravityanalytica.com/analyzer/CALC https://ir.calcimedica.com/news-releases/news-release-details/calcimedica-announces-publication-american-journal-nephrology https://gravityanalytica.com/analyzer/CALC"
X Link 2025-06-25T11:02Z [--] followers, [--] engagements
"$NAUT Life at Nautilus interview with Juanfeng Sun #biotechs https://www.nautilus.bio/blog/life-at-nautilus-interview-with-juanfeng-sun/ https://gravityanalytica.com/analyzer/NAUT https://www.nautilus.bio/blog/life-at-nautilus-interview-with-juanfeng-sun/ https://gravityanalytica.com/analyzer/NAUT"
X Link 2025-06-26T15:55Z [--] followers, [--] engagements
"$HSDT Helius Medical Technologies Announces Reverse Stock Split #biotechs https://www.globenewswire.com/news-release/2025/06/27/3106547/0/en/Helius-Medical-Technologies-Announces-Reverse-Stock-Split.html https://gravityanalytica.com/analyzer/HSDT https://www.globenewswire.com/news-release/2025/06/27/3106547/0/en/Helius-Medical-Technologies-Announces-Reverse-Stock-Split.html https://gravityanalytica.com/analyzer/HSDT"
X Link 2025-06-27T12:44Z [--] followers, [--] engagements
"$ACHV Achieve Life Sciences Announces Pricing of $45.0 Million Underwritten Public Offering #biotechs https://achievelifesciences.com/achieve-announces-pricing-of-45-million-underwritten-public-offering/ https://gravityanalytica.com/analyzer/ACHV https://achievelifesciences.com/achieve-announces-pricing-of-45-million-underwritten-public-offering/ https://gravityanalytica.com/analyzer/ACHV"
X Link 2025-06-28T11:17Z [--] followers, [--] engagements
"$CHRO Channel Therapeutics Announces Reverse Common Stock Split in Conjunction with the Close of the Merger with Pelthos Therapeutics and Concurrent $50.1 Million Private Placement #biotechs https://ir.chromocell.com/news-events/press-releases/detail/35/channel-therapeutics-announces-reverse-common-stock-split https://gravityanalytica.com/analyzer/CHRO https://ir.chromocell.com/news-events/press-releases/detail/35/channel-therapeutics-announces-reverse-common-stock-split https://gravityanalytica.com/analyzer/CHRO"
X Link 2025-06-28T12:30Z [--] followers, [--] engagements
"$EVAX October [--] [----] - October [--] [----] : The World Vaccine Congress Europe [----] #biotechs https://investors.evaxion.ai/events/event-details/world-vaccine-congress-europe-2025 https://gravityanalytica.com/analyzer/EVAX https://investors.evaxion.ai/events/event-details/world-vaccine-congress-europe-2025 https://gravityanalytica.com/analyzer/EVAX"
X Link 2025-06-30T07:44Z [--] followers, [--] engagements
"$EVAX [----] BIG9 Conference #biotechs https://investors.evaxion.ai/events/event-details/2025-big9-conference https://gravityanalytica.com/analyzer/EVAX https://investors.evaxion.ai/events/event-details/2025-big9-conference https://gravityanalytica.com/analyzer/EVAX"
X Link 2025-06-30T07:46Z [--] followers, [--] engagements
"$EVAX November [--] [----] - November [--] [----] : Vaccines R&D [----] #biotechs https://investors.evaxion.ai/events/event-details/vaccines-rd-2025 https://gravityanalytica.com/analyzer/EVAX https://investors.evaxion.ai/events/event-details/vaccines-rd-2025 https://gravityanalytica.com/analyzer/EVAX"
X Link 2025-06-30T07:46Z [--] followers, [--] engagements
"$RCKT Rocket Pharmaceuticals Announces FDA IND Clearance of RP-A701 for the Treatment of BAG3-associated Dilated Cardiomyopathy #biotechs https://ir.rocketpharma.com/news-releases/news-release-details/rocket-pharmaceuticals-announces-fda-ind-clearance-rp-a701 https://gravityanalytica.com/analyzer/RCKT https://ir.rocketpharma.com/news-releases/news-release-details/rocket-pharmaceuticals-announces-fda-ind-clearance-rp-a701 https://gravityanalytica.com/analyzer/RCKT"
X Link 2025-06-30T11:06Z [--] followers, [--] engagements
"$SAVA Cassava Presents Promising Preclinical Simufilam Data at TSC Alliance Meeting #biotechs https://www.cassavasciences.com/news-releases/news-release-details/cassava-presents-promising-preclinical-simufilam-data-tsc https://gravityanalytica.com/analyzer/SAVA https://www.cassavasciences.com/news-releases/news-release-details/cassava-presents-promising-preclinical-simufilam-data-tsc https://gravityanalytica.com/analyzer/SAVA"
X Link 2025-06-30T11:11Z [--] followers, [--] engagements
"$CMMB Chemomab Announces Oral Presentation of Positive Nebokitug Phase [--] Clinical Data in Primary Sclerosing Cholangitis at BSG Live25 #biotechs https://investors.chemomab.com/2025-06-30-Chemomab-Announces-Oral-Presentation-of-Positive-Nebokitug-Phase-2-Clinical-Data-in-Primary-Sclerosing-Cholangitis-at-BSG-Live25 https://gravityanalytica.com/analyzer/CMMB https://investors.chemomab.com/2025-06-30-Chemomab-Announces-Oral-Presentation-of-Positive-Nebokitug-Phase-2-Clinical-Data-in-Primary-Sclerosing-Cholangitis-at-BSG-Live25 https://gravityanalytica.com/analyzer/CMMB"
X Link 2025-06-30T12:01Z [--] followers, [--] engagements
"$TPST Tempest Receives Clearance to Proceed with Pivotal Trial of Amezalpat Combination Therapy for First-Line HCC in China #biotechs https://ir.tempesttx.com/news-releases/news-release-details/tempest-receives-clearance-proceed-pivotal-trial-amezalpat https://gravityanalytica.com/analyzer/TPST https://ir.tempesttx.com/news-releases/news-release-details/tempest-receives-clearance-proceed-pivotal-trial-amezalpat https://gravityanalytica.com/analyzer/TPST"
X Link 2025-06-30T12:01Z [--] followers, [--] engagements
"$TARA Protara Therapeutics Announces Addition to the Russell [----] Index #biotechs https://ir.protaratx.com/news-releases/news-release-details/protara-therapeutics-announces-addition-russell-3000r-index https://gravityanalytica.com/analyzer/TARA https://ir.protaratx.com/news-releases/news-release-details/protara-therapeutics-announces-addition-russell-3000r-index https://gravityanalytica.com/analyzer/TARA"
X Link 2025-06-30T12:01Z [--] followers, [--] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing